id	sid	tid	token	lemma	pos
bam-8877	1	1	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	1	2	or	or	CCONJ
bam-8877	1	3	remifentanil	remifentanil	NOUN
bam-8877	1	4	added	add	VERB
bam-8877	1	5	to	to	AUX
bam-8877	1	6	thiopental	thiopental	PROPN
bam-8877	1	7	eur	eur	PROPN
bam-8877	1	8	j	j	PROPN
bam-8877	1	9	transl	transl	PROPN
bam-8877	1	10	myol	myol	NOUN
bam-8877	1	11	2020	2020	NUM
bam-8877	1	12	;	;	PUNCT
bam-8877	1	13	30	30	NUM
bam-8877	1	14	(	(	PUNCT
bam-8877	1	15	3	3	NUM
bam-8877	1	16	):	):	PUNCT
bam-8877	1	17	8877	8877	NUM
bam-8877	1	18	.	.	PUNCT
bam-8877	2	1	doi	doi	NOUN
bam-8877	2	2	:	:	PUNCT
bam-8877	2	3	10.4081	10.4081	NUM
bam-8877	2	4	/	/	SYM
bam-8877	2	5	ejtm.2020.8877	ejtm.2020.8877	PROPN
bam-8877	2	6	1	1	NUM
bam-8877	2	7	effect	effect	NOUN
bam-8877	2	8	of	of	ADP
bam-8877	2	9	adding	add	VERB
bam-8877	2	10	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	2	11	or	or	CCONJ
bam-8877	2	12	remifentanil	remifentanil	VERB
bam-8877	2	13	to	to	PART
bam-8877	2	14	thiopental	thiopental	NOUN
bam-8877	2	15	in	in	ADP
bam-8877	2	16	patients	patient	NOUN
bam-8877	2	17	with	with	ADP
bam-8877	2	18	mood	mood	NOUN
bam-8877	2	19	disorder	disorder	NOUN
bam-8877	2	20	candidate	candidate	NOUN
bam-8877	2	21	for	for	ADP
bam-8877	2	22	electroconvulsive	electroconvulsive	ADJ
bam-8877	2	23	therapy	therapy	NOUN
bam-8877	2	24	faezeh	faezeh	VERB
bam-8877	2	25	heidarbeigi	heidarbeigi	PROPN
bam-8877	2	26	(	(	PUNCT
bam-8877	2	27	1	1	NUM
bam-8877	2	28	)	)	PUNCT
bam-8877	2	29	,	,	PUNCT
bam-8877	2	30	hamidreza	hamidreza	PROPN
bam-8877	2	31	jamilian	jamilian	NOUN
bam-8877	2	32	(	(	PUNCT
bam-8877	2	33	1	1	NUM
bam-8877	2	34	)	)	PUNCT
bam-8877	2	35	,	,	PUNCT
bam-8877	2	36	anita	anita	PROPN
bam-8877	2	37	alaghemand	alaghemand	VERB
bam-8877	2	38	(	(	PUNCT
bam-8877	2	39	1	1	NUM
bam-8877	2	40	)	)	PUNCT
bam-8877	2	41	,	,	PUNCT
bam-8877	2	42	alireza	alireza	PROPN
bam-8877	2	43	kamali	kamali	PROPN
bam-8877	2	44	(	(	PUNCT
bam-8877	2	45	2	2	NUM
bam-8877	2	46	)	)	PUNCT
bam-8877	2	47	(	(	PUNCT
bam-8877	2	48	1	1	X
bam-8877	2	49	)	)	PUNCT
bam-8877	2	50	department	department	NOUN
bam-8877	2	51	of	of	ADP
bam-8877	2	52	psychiatry	psychiatry	PROPN
bam-8877	2	53	,	,	PUNCT
bam-8877	2	54	arak	arak	PROPN
bam-8877	2	55	university	university	PROPN
bam-8877	2	56	of	of	ADP
bam-8877	2	57	medical	medical	PROPN
bam-8877	2	58	sciences	sciences	PROPN
bam-8877	2	59	,	,	PUNCT
bam-8877	2	60	arak	arak	PROPN
bam-8877	2	61	,	,	PUNCT
bam-8877	2	62	iran	iran	PROPN
bam-8877	2	63	;	;	PUNCT
bam-8877	2	64	(	(	PUNCT
bam-8877	2	65	2	2	X
bam-8877	2	66	)	)	PUNCT
bam-8877	2	67	department	department	NOUN
bam-8877	2	68	of	of	ADP
bam-8877	2	69	anesthesiology	anesthesiology	NOUN
bam-8877	2	70	and	and	CCONJ
bam-8877	2	71	critical	critical	ADJ
bam-8877	2	72	care	care	NOUN
bam-8877	2	73	,	,	PUNCT
bam-8877	2	74	arak	arak	PROPN
bam-8877	2	75	university	university	PROPN
bam-8877	2	76	of	of	ADP
bam-8877	2	77	medical	medical	PROPN
bam-8877	2	78	sciences	sciences	PROPN
bam-8877	2	79	,	,	PUNCT
bam-8877	2	80	arak	arak	PROPN
bam-8877	2	81	,	,	PUNCT
bam-8877	2	82	iran	iran	PROPN
bam-8877	2	83	this	this	DET
bam-8877	2	84	article	article	NOUN
bam-8877	2	85	is	be	AUX
bam-8877	2	86	distributed	distribute	VERB
bam-8877	2	87	under	under	ADP
bam-8877	2	88	the	the	DET
bam-8877	2	89	terms	term	NOUN
bam-8877	2	90	of	of	ADP
bam-8877	2	91	the	the	DET
bam-8877	2	92	creative	creative	ADJ
bam-8877	2	93	commons	common	NOUN
bam-8877	2	94	attribution	attribution	NOUN
bam-8877	2	95	noncommercial	noncommercial	ADJ
bam-8877	2	96	license	license	NOUN
bam-8877	2	97	(	(	PUNCT
bam-8877	2	98	cc	cc	NOUN
bam-8877	2	99	by	by	ADP
bam-8877	2	100	-	-	PUNCT
bam-8877	2	101	nc	nc	PROPN
bam-8877	2	102	4.0	4.0	NUM
bam-8877	2	103	)	)	PUNCT
bam-8877	2	104	which	which	PRON
bam-8877	2	105	permits	permit	VERB
bam-8877	2	106	any	any	DET
bam-8877	2	107	noncommercial	noncommercial	ADJ
bam-8877	2	108	use	use	NOUN
bam-8877	2	109	,	,	PUNCT
bam-8877	2	110	distribution	distribution	NOUN
bam-8877	2	111	,	,	PUNCT
bam-8877	2	112	and	and	CCONJ
bam-8877	2	113	reproduction	reproduction	NOUN
bam-8877	2	114	in	in	ADP
bam-8877	2	115	any	any	DET
bam-8877	2	116	medium	medium	NOUN
bam-8877	2	117	,	,	PUNCT
bam-8877	2	118	provided	provide	VERB
bam-8877	2	119	the	the	DET
bam-8877	2	120	original	original	ADJ
bam-8877	2	121	author(s	author(s	NOUN
bam-8877	2	122	)	)	PUNCT
bam-8877	2	123	and	and	CCONJ
bam-8877	2	124	source	source	NOUN
bam-8877	2	125	are	be	AUX
bam-8877	2	126	credited	credit	VERB
bam-8877	2	127	.	.	PUNCT
bam-8877	3	1	abstract	abstract	ADJ
bam-8877	3	2	electroconvulsive	electroconvulsive	ADJ
bam-8877	3	3	therapy	therapy	NOUN
bam-8877	3	4	(	(	PUNCT
bam-8877	3	5	ect	ect	X
bam-8877	3	6	)	)	PUNCT
bam-8877	3	7	is	be	AUX
bam-8877	3	8	one	one	NUM
bam-8877	3	9	of	of	ADP
bam-8877	3	10	the	the	DET
bam-8877	3	11	appropriate	appropriate	ADJ
bam-8877	3	12	treatments	treatment	NOUN
bam-8877	3	13	for	for	ADP
bam-8877	3	14	many	many	ADJ
bam-8877	3	15	neuropsychiatric	neuropsychiatric	ADJ
bam-8877	3	16	patients	patient	NOUN
bam-8877	3	17	,	,	PUNCT
bam-8877	3	18	especially	especially	ADV
bam-8877	3	19	those	those	PRON
bam-8877	3	20	with	with	ADP
bam-8877	3	21	mood	mood	NOUN
bam-8877	3	22	disorders	disorder	NOUN
bam-8877	3	23	.	.	PUNCT
bam-8877	4	1	short	short	ADJ
bam-8877	4	2	-	-	PUNCT
bam-8877	4	3	term	term	NOUN
bam-8877	4	4	complications	complication	NOUN
bam-8877	4	5	of	of	ADP
bam-8877	4	6	ect	ect	NOUN
bam-8877	4	7	include	include	VERB
bam-8877	4	8	agitation	agitation	NOUN
bam-8877	4	9	and	and	CCONJ
bam-8877	4	10	postictal	postictal	NOUN
bam-8877	4	11	.	.	PUNCT
bam-8877	5	1	in	in	ADP
bam-8877	5	2	this	this	DET
bam-8877	5	3	study	study	NOUN
bam-8877	5	4	,	,	PUNCT
bam-8877	5	5	we	we	PRON
bam-8877	5	6	compared	compare	VERB
bam-8877	5	7	the	the	DET
bam-8877	5	8	addition	addition	NOUN
bam-8877	5	9	of	of	ADP
bam-8877	5	10	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	5	11	or	or	CCONJ
bam-8877	5	12	remifentanil	remifentanil	VERB
bam-8877	5	13	to	to	PART
bam-8877	5	14	thiopental	thiopental	VERB
bam-8877	5	15	as	as	ADP
bam-8877	5	16	the	the	DET
bam-8877	5	17	main	main	ADJ
bam-8877	5	18	anaesthetic	anaesthetic	NOUN
bam-8877	5	19	used	use	VERB
bam-8877	5	20	in	in	ADP
bam-8877	5	21	ect	ect	NOUN
bam-8877	5	22	.	.	PUNCT
bam-8877	6	1	in	in	ADP
bam-8877	6	2	this	this	DET
bam-8877	6	3	double	double	ADJ
bam-8877	6	4	-	-	PUNCT
bam-8877	6	5	blind	blind	ADJ
bam-8877	6	6	randomised	randomise	VERB
bam-8877	6	7	clinical	clinical	ADJ
bam-8877	6	8	trial	trial	NOUN
bam-8877	6	9	,	,	PUNCT
bam-8877	6	10	90	90	NUM
bam-8877	6	11	patients	patient	NOUN
bam-8877	6	12	with	with	ADP
bam-8877	6	13	mood	mood	NOUN
bam-8877	6	14	disorders	disorder	NOUN
bam-8877	6	15	(	(	PUNCT
bam-8877	6	16	candidates	candidate	NOUN
bam-8877	6	17	for	for	ADP
bam-8877	6	18	ect	ect	NOUN
bam-8877	6	19	)	)	PUNCT
bam-8877	6	20	were	be	AUX
bam-8877	6	21	divided	divide	VERB
bam-8877	6	22	into	into	ADP
bam-8877	6	23	two	two	NUM
bam-8877	6	24	groups	group	NOUN
bam-8877	6	25	based	base	VERB
bam-8877	6	26	on	on	ADP
bam-8877	6	27	their	their	PRON
bam-8877	6	28	therapy	therapy	NOUN
bam-8877	6	29	:	:	PUNCT
bam-8877	6	30	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	6	31	or	or	CCONJ
bam-8877	6	32	remifentanil	remifentanil	VERB
bam-8877	6	33	.	.	PUNCT
bam-8877	7	1	in	in	ADP
bam-8877	7	2	the	the	DET
bam-8877	7	3	first	first	ADJ
bam-8877	7	4	group	group	NOUN
bam-8877	7	5	(	(	PUNCT
bam-8877	7	6	dg	dg	PROPN
bam-8877	7	7	)	)	PUNCT
bam-8877	7	8	,	,	PUNCT
bam-8877	7	9	patients	patient	NOUN
bam-8877	7	10	were	be	AUX
bam-8877	7	11	slowly	slowly	ADV
bam-8877	7	12	injected	inject	VERB
bam-8877	7	13	intravenously	intravenously	ADV
bam-8877	7	14	with	with	ADP
bam-8877	7	15	0.5	0.5	NUM
bam-8877	7	16	μg	μg	PROPN
bam-8877	7	17	/	/	SYM
bam-8877	7	18	kg	kg	PROPN
bam-8877	7	19	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	7	20	before	before	ADP
bam-8877	7	21	induction	induction	NOUN
bam-8877	7	22	of	of	ADP
bam-8877	7	23	anesthesia	anesthesia	NOUN
bam-8877	7	24	.	.	PUNCT
bam-8877	8	1	in	in	ADP
bam-8877	8	2	the	the	DET
bam-8877	8	3	second	second	ADJ
bam-8877	8	4	group	group	NOUN
bam-8877	8	5	(	(	PUNCT
bam-8877	8	6	gr	gr	PROPN
bam-8877	8	7	)	)	PUNCT
bam-8877	8	8	,	,	PUNCT
bam-8877	8	9	100	100	NUM
bam-8877	8	10	μg	μg	NOUN
bam-8877	8	11	of	of	ADP
bam-8877	8	12	remifentanil	remifentanil	NOUN
bam-8877	8	13	was	be	AUX
bam-8877	8	14	slowly	slowly	ADV
bam-8877	8	15	injected	inject	VERB
bam-8877	8	16	intravenously.in	intravenously.in	PRON
bam-8877	8	17	addition	addition	NOUN
bam-8877	8	18	,	,	PUNCT
bam-8877	8	19	we	we	PRON
bam-8877	8	20	collected	collect	VERB
bam-8877	8	21	demographic	demographic	ADJ
bam-8877	8	22	information	information	NOUN
bam-8877	8	23	such	such	ADJ
bam-8877	8	24	as	as	ADP
bam-8877	8	25	respiratory	respiratory	ADJ
bam-8877	8	26	rate	rate	NOUN
bam-8877	8	27	,	,	PUNCT
bam-8877	8	28	heart	heart	NOUN
bam-8877	8	29	pulse	pulse	NOUN
bam-8877	8	30	rate	rate	NOUN
bam-8877	8	31	,	,	PUNCT
bam-8877	8	32	seizure	seizure	NOUN
bam-8877	8	33	time	time	NOUN
bam-8877	8	34	,	,	PUNCT
bam-8877	8	35	mean	mean	NOUN
bam-8877	8	36	of	of	ADP
bam-8877	8	37	arterial	arterial	ADJ
bam-8877	8	38	blood	blood	NOUN
bam-8877	8	39	pressure	pressure	NOUN
bam-8877	8	40	,	,	PUNCT
bam-8877	8	41	recovery	recovery	NOUN
bam-8877	8	42	duration	duration	NOUN
bam-8877	8	43	and	and	CCONJ
bam-8877	8	44	the	the	DET
bam-8877	8	45	oxygen	oxygen	NOUN
bam-8877	8	46	arterial	arterial	NOUN
bam-8877	8	47	saturation	saturation	NOUN
bam-8877	8	48	recorded	record	VERB
bam-8877	8	49	after	after	ADP
bam-8877	8	50	recovery	recovery	NOUN
bam-8877	8	51	.	.	PUNCT
bam-8877	9	1	data	datum	NOUN
bam-8877	9	2	obtained	obtain	VERB
bam-8877	9	3	were	be	AUX
bam-8877	9	4	analysed	analyse	VERB
bam-8877	9	5	by	by	ADP
bam-8877	9	6	use	use	NOUN
bam-8877	9	7	of	of	ADP
bam-8877	9	8	statistical	statistical	ADJ
bam-8877	9	9	software	software	NOUN
bam-8877	9	10	,	,	PUNCT
bam-8877	9	11	spss-23	spss-23	PROPN
bam-8877	9	12	.	.	PUNCT
bam-8877	10	1	the	the	DET
bam-8877	10	2	mean	mean	ADJ
bam-8877	10	3	age	age	NOUN
bam-8877	10	4	of	of	ADP
bam-8877	10	5	both	both	DET
bam-8877	10	6	groups	group	NOUN
bam-8877	10	7	was	be	AUX
bam-8877	10	8	approximately	approximately	ADV
bam-8877	10	9	37	37	NUM
bam-8877	10	10	years	year	NOUN
bam-8877	10	11	with	with	ADP
bam-8877	10	12	the	the	DET
bam-8877	10	13	majority	majority	NOUN
bam-8877	10	14	being	be	AUX
bam-8877	10	15	men	man	NOUN
bam-8877	10	16	.	.	PUNCT
bam-8877	11	1	there	there	PRON
bam-8877	11	2	was	be	VERB
bam-8877	11	3	no	no	DET
bam-8877	11	4	significant	significant	ADJ
bam-8877	11	5	difference	difference	NOUN
bam-8877	11	6	between	between	ADP
bam-8877	11	7	the	the	DET
bam-8877	11	8	two	two	NUM
bam-8877	11	9	groups	group	NOUN
bam-8877	11	10	in	in	ADP
bam-8877	11	11	terms	term	NOUN
bam-8877	11	12	of	of	ADP
bam-8877	11	13	age	age	NOUN
bam-8877	11	14	and	and	CCONJ
bam-8877	11	15	sex	sex	NOUN
bam-8877	11	16	,	,	PUNCT
bam-8877	11	17	blood	blood	NOUN
bam-8877	11	18	pressure	pressure	NOUN
bam-8877	11	19	,	,	PUNCT
bam-8877	11	20	heart	heart	NOUN
bam-8877	11	21	rate	rate	NOUN
bam-8877	11	22	,	,	PUNCT
bam-8877	11	23	duration	duration	NOUN
bam-8877	11	24	of	of	ADP
bam-8877	11	25	seizures	seizure	NOUN
bam-8877	11	26	and	and	CCONJ
bam-8877	11	27	arterial	arterial	ADJ
bam-8877	11	28	oxygen	oxygen	NOUN
bam-8877	11	29	saturation	saturation	NOUN
bam-8877	11	30	before	before	ADP
bam-8877	11	31	ect	ect	PROPN
bam-8877	11	32	.	.	PUNCT
bam-8877	12	1	the	the	DET
bam-8877	12	2	mean	mean	ADJ
bam-8877	12	3	blood	blood	NOUN
bam-8877	12	4	pressure	pressure	NOUN
bam-8877	12	5	and	and	CCONJ
bam-8877	12	6	heart	heart	NOUN
bam-8877	12	7	rate	rate	NOUN
bam-8877	12	8	in	in	ADP
bam-8877	12	9	the	the	DET
bam-8877	12	10	recovery	recovery	NOUN
bam-8877	12	11	group	group	NOUN
bam-8877	12	12	were	be	AUX
bam-8877	12	13	lower	low	ADJ
bam-8877	12	14	in	in	ADP
bam-8877	12	15	the	the	DET
bam-8877	12	16	dexmedetomidine	dexmedetomidine	ADJ
bam-8877	12	17	group	group	NOUN
bam-8877	12	18	than	than	ADP
bam-8877	12	19	in	in	ADP
bam-8877	12	20	the	the	DET
bam-8877	12	21	remifentanil	remifentanil	NOUN
bam-8877	12	22	group	group	NOUN
bam-8877	12	23	and	and	CCONJ
bam-8877	12	24	the	the	DET
bam-8877	12	25	hemodynamics	hemodynamic	NOUN
bam-8877	12	26	in	in	ADP
bam-8877	12	27	the	the	DET
bam-8877	12	28	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	12	29	group	group	NOUN
bam-8877	12	30	were	be	AUX
bam-8877	12	31	more	more	ADV
bam-8877	12	32	stable	stable	ADJ
bam-8877	12	33	.	.	PUNCT
bam-8877	13	1	the	the	DET
bam-8877	13	2	recovery	recovery	NOUN
bam-8877	13	3	time	time	NOUN
bam-8877	13	4	in	in	ADP
bam-8877	13	5	the	the	DET
bam-8877	13	6	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	13	7	group	group	NOUN
bam-8877	13	8	was	be	AUX
bam-8877	13	9	longer	long	ADJ
bam-8877	13	10	than	than	ADP
bam-8877	13	11	that	that	PRON
bam-8877	13	12	of	of	ADP
bam-8877	13	13	the	the	DET
bam-8877	13	14	remifentanil	remifentanil	NOUN
bam-8877	13	15	group	group	NOUN
bam-8877	13	16	(	(	PUNCT
bam-8877	13	17	p	p	NOUN
bam-8877	13	18	=	=	NOUN
bam-8877	13	19	0.001	0.001	NUM
bam-8877	13	20	)	)	PUNCT
bam-8877	13	21	.	.	PUNCT
bam-8877	14	1	both	both	DET
bam-8877	14	2	groups	group	NOUN
bam-8877	14	3	had	have	VERB
bam-8877	14	4	approximately	approximately	ADV
bam-8877	14	5	the	the	DET
bam-8877	14	6	same	same	ADJ
bam-8877	14	7	satisfaction	satisfaction	NOUN
bam-8877	14	8	and	and	CCONJ
bam-8877	14	9	the	the	DET
bam-8877	14	10	rate	rate	NOUN
bam-8877	14	11	of	of	ADP
bam-8877	14	12	agitation	agitation	NOUN
bam-8877	14	13	after	after	ADP
bam-8877	14	14	ect	ect	ADV
bam-8877	14	15	was	be	AUX
bam-8877	14	16	the	the	DET
bam-8877	14	17	same	same	ADJ
bam-8877	14	18	.	.	PUNCT
bam-8877	15	1	both	both	PRON
bam-8877	15	2	remifentanil	remifentanil	NOUN
bam-8877	15	3	and	and	CCONJ
bam-8877	15	4	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	15	5	as	as	ADP
bam-8877	15	6	adjuvants	adjuvant	NOUN
bam-8877	15	7	lead	lead	VERB
bam-8877	15	8	to	to	ADP
bam-8877	15	9	a	a	DET
bam-8877	15	10	decrease	decrease	NOUN
bam-8877	15	11	in	in	ADP
bam-8877	15	12	patients	patient	NOUN
bam-8877	15	13	'	'	PART
bam-8877	15	14	post	post	ADJ
bam-8877	15	15	-	-	ADJ
bam-8877	15	16	ect	ect	ADJ
bam-8877	15	17	hyperdynamic	hyperdynamic	ADJ
bam-8877	15	18	responses	response	NOUN
bam-8877	15	19	.	.	PUNCT
bam-8877	16	1	in	in	ADP
bam-8877	16	2	our	our	PRON
bam-8877	16	3	study	study	NOUN
bam-8877	16	4	,	,	PUNCT
bam-8877	16	5	we	we	PRON
bam-8877	16	6	demonstrated	demonstrate	VERB
bam-8877	16	7	that	that	SCONJ
bam-8877	16	8	the	the	DET
bam-8877	16	9	effect	effect	NOUN
bam-8877	16	10	of	of	ADP
bam-8877	16	11	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	16	12	is	be	AUX
bam-8877	16	13	greater	great	ADJ
bam-8877	16	14	than	than	ADP
bam-8877	16	15	remifentanil	remifentanil	NOUN
bam-8877	16	16	.	.	PUNCT
bam-8877	17	1	on	on	ADP
bam-8877	17	2	the	the	DET
bam-8877	17	3	other	other	ADJ
bam-8877	17	4	hand	hand	NOUN
bam-8877	17	5	,	,	PUNCT
bam-8877	17	6	neither	neither	CCONJ
bam-8877	17	7	dexmedetomidine	dexmedetomidine	ADJ
bam-8877	17	8	nor	nor	CCONJ
bam-8877	17	9	remifentanil	remifentanil	NOUN
bam-8877	17	10	had	have	VERB
bam-8877	17	11	a	a	DET
bam-8877	17	12	negative	negative	ADJ
bam-8877	17	13	effect	effect	NOUN
bam-8877	17	14	on	on	ADP
bam-8877	17	15	seizure	seizure	NOUN
bam-8877	17	16	duration	duration	NOUN
bam-8877	17	17	,	,	PUNCT
bam-8877	17	18	but	but	CCONJ
bam-8877	17	19	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	17	20	significantly	significantly	ADV
bam-8877	17	21	prolonged	prolong	VERB
bam-8877	17	22	recovery	recovery	NOUN
bam-8877	17	23	time	time	NOUN
bam-8877	17	24	,	,	PUNCT
bam-8877	17	25	when	when	SCONJ
bam-8877	17	26	compared	compare	VERB
bam-8877	17	27	to	to	PART
bam-8877	17	28	remifentanil	remifentanil	VERB
bam-8877	17	29	.	.	PUNCT
bam-8877	18	1	key	key	ADJ
bam-8877	18	2	words	word	NOUN
bam-8877	18	3	:	:	PUNCT
bam-8877	18	4	mood	mood	NOUN
bam-8877	18	5	disorder	disorder	NOUN
bam-8877	18	6	,	,	PUNCT
bam-8877	18	7	electroconvulsive	electroconvulsive	ADJ
bam-8877	18	8	therapy	therapy	NOUN
bam-8877	18	9	(	(	PUNCT
bam-8877	18	10	ect	ect	X
bam-8877	18	11	)	)	PUNCT
bam-8877	18	12	,	,	PUNCT
bam-8877	18	13	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	18	14	,	,	PUNCT
bam-8877	18	15	remifentanil	remifentanil	VERB
bam-8877	18	16	eur	eur	PROPN
bam-8877	18	17	j	j	PROPN
bam-8877	18	18	transl	transl	PROPN
bam-8877	18	19	myol	myol	NOUN
bam-8877	18	20	2020	2020	NUM
bam-8877	18	21	;	;	PUNCT
bam-8877	18	22	30	30	NUM
bam-8877	18	23	(	(	PUNCT
bam-8877	18	24	3	3	NUM
bam-8877	18	25	):	):	PUNCT
bam-8877	18	26	8877	8877	NUM
bam-8877	18	27	.	.	PUNCT
bam-8877	19	1	doi	doi	NOUN
bam-8877	19	2	:	:	PUNCT
bam-8877	19	3	10.4081	10.4081	NUM
bam-8877	19	4	/	/	SYM
bam-8877	19	5	ejtm.2020.8877	ejtm.2020.8877	PROPN
bam-8877	19	6	psychiatric	psychiatric	ADJ
bam-8877	19	7	illnesses	illness	NOUN
bam-8877	19	8	are	be	AUX
bam-8877	19	9	common	common	ADJ
bam-8877	19	10	health	health	NOUN
bam-8877	19	11	problems	problem	NOUN
bam-8877	19	12	due	due	ADJ
bam-8877	19	13	to	to	ADP
bam-8877	19	14	the	the	DET
bam-8877	19	15	disability	disability	NOUN
bam-8877	19	16	and	and	CCONJ
bam-8877	19	17	functional	functional	ADJ
bam-8877	19	18	impairment	impairment	NOUN
bam-8877	19	19	they	they	PRON
bam-8877	19	20	cause	cause	VERB
bam-8877	19	21	.	.	PUNCT
bam-8877	20	1	the	the	DET
bam-8877	20	2	burden	burden	NOUN
bam-8877	20	3	of	of	ADP
bam-8877	20	4	psychiatric	psychiatric	ADJ
bam-8877	20	5	illnesses	illness	NOUN
bam-8877	20	6	in	in	ADP
bam-8877	20	7	developing	develop	VERB
bam-8877	20	8	countries	country	NOUN
bam-8877	20	9	causes	cause	VERB
bam-8877	20	10	many	many	ADJ
bam-8877	20	11	problems	problem	NOUN
bam-8877	20	12	and	and	CCONJ
bam-8877	20	13	imposes	impose	VERB
bam-8877	20	14	high	high	ADJ
bam-8877	20	15	costs	cost	NOUN
bam-8877	20	16	on	on	ADP
bam-8877	20	17	the	the	DET
bam-8877	20	18	health	health	NOUN
bam-8877	20	19	system.1	system.1	NOUN
bam-8877	20	20	results	result	NOUN
bam-8877	20	21	from	from	ADP
bam-8877	20	22	recent	recent	ADJ
bam-8877	20	23	research	research	NOUN
bam-8877	20	24	indicate	indicate	VERB
bam-8877	20	25	a	a	DET
bam-8877	20	26	high	high	ADJ
bam-8877	20	27	prevalence	prevalence	NOUN
bam-8877	20	28	of	of	ADP
bam-8877	20	29	mood	mood	NOUN
bam-8877	20	30	disorder	disorder	NOUN
bam-8877	20	31	in	in	ADP
bam-8877	20	32	society.2	society.2	NOUN
bam-8877	20	33	electroconvulsive	electroconvulsive	ADJ
bam-8877	20	34	therapy	therapy	NOUN
bam-8877	20	35	(	(	PUNCT
bam-8877	20	36	ect	ect	X
bam-8877	20	37	)	)	PUNCT
bam-8877	20	38	has	have	AUX
bam-8877	20	39	been	be	AUX
bam-8877	20	40	recognised	recognise	VERB
bam-8877	20	41	as	as	ADP
bam-8877	20	42	a	a	DET
bam-8877	20	43	safe	safe	ADJ
bam-8877	20	44	and	and	CCONJ
bam-8877	20	45	effective	effective	ADJ
bam-8877	20	46	choice	choice	NOUN
bam-8877	20	47	for	for	ADP
bam-8877	20	48	treatment	treatment	NOUN
bam-8877	20	49	of	of	ADP
bam-8877	20	50	mood	mood	NOUN
bam-8877	20	51	disorders.3,4	disorders.3,4	ADJ
bam-8877	20	52	ect	ect	VERB
bam-8877	20	53	causes	cause	VERB
bam-8877	20	54	seizures	seizure	NOUN
bam-8877	20	55	by	by	ADP
bam-8877	20	56	electrical	electrical	ADJ
bam-8877	20	57	stimulation	stimulation	NOUN
bam-8877	20	58	at	at	ADP
bam-8877	20	59	various	various	ADJ
bam-8877	20	60	frequencies	frequency	NOUN
bam-8877	20	61	,	,	PUNCT
bam-8877	20	62	that	that	PRON
bam-8877	20	63	is	be	AUX
bam-8877	20	64	run	run	VERB
bam-8877	20	65	through	through	ADP
bam-8877	20	66	electrodes	electrode	NOUN
bam-8877	20	67	placed	place	VERB
bam-8877	20	68	on	on	ADP
bam-8877	20	69	the	the	DET
bam-8877	20	70	scalp.5	scalp.5	PROPN
bam-8877	20	71	although	although	SCONJ
bam-8877	20	72	ect	ect	ADJ
bam-8877	20	73	is	be	AUX
bam-8877	20	74	a	a	DET
bam-8877	20	75	very	very	ADV
bam-8877	20	76	safe	safe	ADJ
bam-8877	20	77	treatment	treatment	NOUN
bam-8877	20	78	and	and	CCONJ
bam-8877	20	79	has	have	VERB
bam-8877	20	80	no	no	DET
bam-8877	20	81	absolute	absolute	ADJ
bam-8877	20	82	contraindication	contraindication	NOUN
bam-8877	20	83	,	,	PUNCT
bam-8877	20	84	both	both	CCONJ
bam-8877	20	85	the	the	DET
bam-8877	20	86	physician	physician	NOUN
bam-8877	20	87	and	and	CCONJ
bam-8877	20	88	the	the	DET
bam-8877	20	89	patient	patient	NOUN
bam-8877	20	90	must	must	AUX
bam-8877	20	91	be	be	AUX
bam-8877	20	92	aware	aware	ADJ
bam-8877	20	93	of	of	ADP
bam-8877	20	94	a	a	DET
bam-8877	20	95	number	number	NOUN
bam-8877	20	96	of	of	ADP
bam-8877	20	97	side	side	NOUN
bam-8877	20	98	effects	effect	NOUN
bam-8877	20	99	,	,	PUNCT
bam-8877	20	100	such	such	ADJ
bam-8877	20	101	as	as	ADP
bam-8877	20	102	cognitive	cognitive	ADJ
bam-8877	20	103	impairment	impairment	NOUN
bam-8877	20	104	(	(	PUNCT
bam-8877	20	105	which	which	PRON
bam-8877	20	106	rapidly	rapidly	ADV
bam-8877	20	107	resolves	resolve	VERB
bam-8877	20	108	in	in	ADP
bam-8877	20	109	most	most	ADJ
bam-8877	20	110	cases	case	NOUN
bam-8877	20	111	)	)	PUNCT
bam-8877	20	112	,	,	PUNCT
bam-8877	20	113	the	the	DET
bam-8877	20	114	rare	rare	ADJ
bam-8877	20	115	occurrence	occurrence	NOUN
bam-8877	20	116	of	of	ADP
bam-8877	20	117	seizures	seizure	NOUN
bam-8877	20	118	,	,	PUNCT
bam-8877	20	119	short	short	ADJ
bam-8877	20	120	-	-	PUNCT
bam-8877	20	121	term	term	NOUN
bam-8877	20	122	complications	complication	NOUN
bam-8877	20	123	such	such	ADJ
bam-8877	20	124	as	as	ADP
bam-8877	20	125	headaches	headache	NOUN
bam-8877	20	126	,	,	PUNCT
bam-8877	20	127	muscle	muscle	NOUN
bam-8877	20	128	pain	pain	NOUN
bam-8877	20	129	,	,	PUNCT
bam-8877	20	130	nausea	nausea	NOUN
bam-8877	20	131	,	,	PUNCT
bam-8877	20	132	vomiting	vomiting	NOUN
bam-8877	20	133	,	,	PUNCT
bam-8877	20	134	and	and	CCONJ
bam-8877	20	135	fatigue.6	fatigue.6	PROPN
bam-8877	20	136	ect	ect	VERB
bam-8877	20	137	typically	typically	ADV
bam-8877	20	138	induces	induce	VERB
bam-8877	20	139	transient	transient	ADJ
bam-8877	20	140	hypertension	hypertension	NOUN
bam-8877	20	141	(	(	PUNCT
bam-8877	20	142	htn	htn	NOUN
bam-8877	20	143	)	)	PUNCT
bam-8877	20	144	and	and	CCONJ
bam-8877	20	145	immediate	immediate	ADJ
bam-8877	20	146	tachycardia	tachycardia	NOUN
bam-8877	20	147	after	after	ADP
bam-8877	20	148	stimulation	stimulation	NOUN
bam-8877	20	149	,	,	PUNCT
bam-8877	20	150	which	which	PRON
bam-8877	20	151	may	may	AUX
bam-8877	20	152	result	result	VERB
bam-8877	20	153	in	in	ADP
bam-8877	20	154	severe	severe	ADJ
bam-8877	20	155	hyperdynamic	hyperdynamic	ADJ
bam-8877	20	156	responses	response	NOUN
bam-8877	20	157	in	in	ADP
bam-8877	20	158	patients	patient	NOUN
bam-8877	20	159	treated	treat	VERB
bam-8877	20	160	with	with	ADP
bam-8877	20	161	ect.7	ect.7	PROPN
bam-8877	20	162	one	one	NUM
bam-8877	20	163	of	of	ADP
bam-8877	20	164	the	the	DET
bam-8877	20	165	short	short	ADJ
bam-8877	20	166	-	-	PUNCT
bam-8877	20	167	term	term	NOUN
bam-8877	20	168	side	side	NOUN
bam-8877	20	169	effects	effect	NOUN
bam-8877	20	170	of	of	ADP
bam-8877	20	171	ect	ect	ADJ
bam-8877	20	172	is	be	AUX
bam-8877	20	173	postictal	postictal	ADJ
bam-8877	20	174	agitation,5	agitation,5	NOUN
bam-8877	20	175	which	which	PRON
bam-8877	20	176	causes	cause	VERB
bam-8877	20	177	motor	motor	NOUN
bam-8877	20	178	dysfunction	dysfunction	NOUN
bam-8877	20	179	,	,	PUNCT
bam-8877	20	180	poor	poor	ADJ
bam-8877	20	181	response	response	NOUN
bam-8877	20	182	to	to	ADP
bam-8877	20	183	verbal	verbal	ADJ
bam-8877	20	184	materials	material	NOUN
bam-8877	20	185	,	,	PUNCT
bam-8877	20	186	and	and	CCONJ
bam-8877	20	187	disorientation	disorientation	NOUN
bam-8877	20	188	.	.	PUNCT
bam-8877	21	1	the	the	DET
bam-8877	21	2	overall	overall	ADJ
bam-8877	21	3	incidence	incidence	NOUN
bam-8877	21	4	of	of	ADP
bam-8877	21	5	this	this	DET
bam-8877	21	6	complication	complication	NOUN
bam-8877	21	7	during	during	ADP
bam-8877	21	8	ect	ect	ADJ
bam-8877	21	9	is	be	AUX
bam-8877	21	10	about	about	ADV
bam-8877	21	11	12%.8	12%.8	NUM
bam-8877	21	12	the	the	DET
bam-8877	21	13	choice	choice	NOUN
bam-8877	21	14	of	of	ADP
bam-8877	21	15	anesthetic	anesthetic	NOUN
bam-8877	21	16	for	for	ADP
bam-8877	21	17	ect	ect	ADJ
bam-8877	21	18	depends	depend	VERB
bam-8877	21	19	on	on	ADP
bam-8877	21	20	its	its	PRON
bam-8877	21	21	effect	effect	NOUN
bam-8877	21	22	on	on	ADP
bam-8877	21	23	hemodynamics	hemodynamic	NOUN
bam-8877	21	24	,	,	PUNCT
bam-8877	21	25	duration	duration	NOUN
bam-8877	21	26	of	of	ADP
bam-8877	21	27	seizures	seizure	NOUN
bam-8877	21	28	and	and	CCONJ
bam-8877	21	29	recovery	recovery	NOUN
bam-8877	21	30	parameters.9	parameters.9	PROPN
bam-8877	21	31	therefore	therefore	ADV
bam-8877	21	32	,	,	PUNCT
bam-8877	21	33	there	there	PRON
bam-8877	21	34	are	be	VERB
bam-8877	21	35	a	a	DET
bam-8877	21	36	wide	wide	ADJ
bam-8877	21	37	range	range	NOUN
bam-8877	21	38	of	of	ADP
bam-8877	21	39	drugs	drug	NOUN
bam-8877	21	40	prescribed	prescribe	VERB
bam-8877	21	41	to	to	PART
bam-8877	21	42	reduce	reduce	VERB
bam-8877	21	43	acute	acute	ADJ
bam-8877	21	44	hemodynamic	hemodynamic	ADJ
bam-8877	21	45	changes	change	NOUN
bam-8877	21	46	due	due	ADJ
bam-8877	21	47	to	to	ADP
bam-8877	21	48	cardiovascular	cardiovascular	ADJ
bam-8877	21	49	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	21	50	or	or	CCONJ
bam-8877	21	51	remifentanil	remifentanil	NOUN
bam-8877	21	52	added	add	VERB
bam-8877	21	53	to	to	AUX
bam-8877	21	54	thiopental	thiopental	PROPN
bam-8877	21	55	eur	eur	PROPN
bam-8877	21	56	j	j	PROPN
bam-8877	21	57	transl	transl	PROPN
bam-8877	21	58	myol	myol	ADV
bam-8877	21	59	2020;30	2020;30	PROPN
bam-8877	21	60	(	(	PUNCT
bam-8877	21	61	3	3	NUM
bam-8877	21	62	):	):	PUNCT
bam-8877	21	63	8877	8877	NUM
bam-8877	21	64	.	.	PUNCT
bam-8877	22	1	doi	doi	NOUN
bam-8877	22	2	:	:	PUNCT
bam-8877	22	3	10.4081	10.4081	NUM
bam-8877	22	4	/	/	SYM
bam-8877	22	5	ejtm.2020.8877	ejtm.2020.8877	PROPN
bam-8877	22	6	2	2	NUM
bam-8877	22	7	complications	complication	NOUN
bam-8877	22	8	associated	associate	VERB
bam-8877	22	9	with	with	ADP
bam-8877	22	10	ect	ect	PROPN
bam-8877	22	11	.	.	PUNCT
bam-8877	23	1	remifentanil	remifentanil	NOUN
bam-8877	23	2	is	be	AUX
bam-8877	23	3	a	a	DET
bam-8877	23	4	short	short	ADV
bam-8877	23	5	-	-	PUNCT
bam-8877	23	6	acting	act	VERB
bam-8877	23	7	opioid	opioid	NOUN
bam-8877	23	8	with	with	ADP
bam-8877	23	9	a	a	DET
bam-8877	23	10	potent	potent	ADJ
bam-8877	23	11	analgesic	analgesic	ADJ
bam-8877	23	12	effect	effect	NOUN
bam-8877	23	13	.	.	PUNCT
bam-8877	24	1	remifentanil	remifentanil	NOUN
bam-8877	24	2	has	have	AUX
bam-8877	24	3	been	be	AUX
bam-8877	24	4	shown	show	VERB
bam-8877	24	5	to	to	PART
bam-8877	24	6	be	be	AUX
bam-8877	24	7	effective	effective	ADJ
bam-8877	24	8	in	in	ADP
bam-8877	24	9	lowering	lower	VERB
bam-8877	24	10	blood	blood	NOUN
bam-8877	24	11	pressure	pressure	NOUN
bam-8877	24	12	and	and	CCONJ
bam-8877	24	13	heart	heart	NOUN
bam-8877	24	14	rate	rate	NOUN
bam-8877	24	15	(	(	PUNCT
bam-8877	24	16	hr	hr	NOUN
bam-8877	24	17	)	)	PUNCT
bam-8877	24	18	when	when	SCONJ
bam-8877	24	19	used	use	VERB
bam-8877	24	20	as	as	ADP
bam-8877	24	21	an	an	DET
bam-8877	24	22	adjuvant	adjuvant	NOUN
bam-8877	24	23	in	in	ADP
bam-8877	24	24	anesthesia.7	anesthesia.7	PROPN
bam-8877	24	25	the	the	DET
bam-8877	24	26	opioid	opioid	NOUN
bam-8877	24	27	acts	act	VERB
bam-8877	24	28	by	by	ADP
bam-8877	24	29	reducing	reduce	VERB
bam-8877	24	30	the	the	DET
bam-8877	24	31	dose	dose	NOUN
bam-8877	24	32	of	of	ADP
bam-8877	24	33	anesthetic	anesthetic	ADJ
bam-8877	24	34	agents	agent	NOUN
bam-8877	24	35	and	and	CCONJ
bam-8877	24	36	usually	usually	ADV
bam-8877	24	37	improves	improve	VERB
bam-8877	24	38	the	the	DET
bam-8877	24	39	response	response	NOUN
bam-8877	24	40	to	to	ADP
bam-8877	24	41	stimulation.10	stimulation.10	PROPN
bam-8877	24	42	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	24	43	is	be	AUX
bam-8877	24	44	a	a	DET
bam-8877	24	45	selective	selective	ADJ
bam-8877	24	46	α2	α2	ADJ
bam-8877	24	47	agonist	agonist	NOUN
bam-8877	24	48	that	that	PRON
bam-8877	24	49	predominantly	predominantly	ADV
bam-8877	24	50	affects	affect	VERB
bam-8877	24	51	the	the	DET
bam-8877	24	52	locus	locus	PROPN
bam-8877	24	53	coeruleus.5	coeruleus.5	PROPN
bam-8877	24	54	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	24	55	attenuates	attenuate	VERB
bam-8877	24	56	central	central	ADJ
bam-8877	24	57	nervous	nervous	ADJ
bam-8877	24	58	system	system	NOUN
bam-8877	24	59	(	(	PUNCT
bam-8877	24	60	cns	cns	NOUN
bam-8877	24	61	)	)	PUNCT
bam-8877	24	62	stimulation	stimulation	NOUN
bam-8877	24	63	by	by	ADP
bam-8877	24	64	reducing	reduce	VERB
bam-8877	24	65	presynaptic	presynaptic	ADJ
bam-8877	24	66	norepinephrine	norepinephrine	NOUN
bam-8877	24	67	release	release	NOUN
bam-8877	24	68	,	,	PUNCT
bam-8877	24	69	causing	cause	VERB
bam-8877	24	70	sedative	sedative	ADJ
bam-8877	24	71	effects	effect	NOUN
bam-8877	24	72	.	.	PUNCT
bam-8877	25	1	more	more	ADV
bam-8877	25	2	broadly	broadly	ADV
bam-8877	25	3	,	,	PUNCT
bam-8877	25	4	the	the	DET
bam-8877	25	5	drug	drug	NOUN
bam-8877	25	6	leads	lead	VERB
bam-8877	25	7	to	to	ADP
bam-8877	25	8	analgesic	analgesic	ADJ
bam-8877	25	9	effects	effect	NOUN
bam-8877	25	10	,	,	PUNCT
bam-8877	25	11	anxiolytic	anxiolytic	ADJ
bam-8877	25	12	,	,	PUNCT
bam-8877	25	13	and	and	CCONJ
bam-8877	25	14	sympatholytic	sympatholytic	ADJ
bam-8877	25	15	effects	effect	NOUN
bam-8877	25	16	without	without	ADP
bam-8877	25	17	affecting	affect	VERB
bam-8877	25	18	the	the	DET
bam-8877	25	19	respiratory	respiratory	ADJ
bam-8877	25	20	system	system	NOUN
bam-8877	25	21	.	.	PUNCT
bam-8877	26	1	the	the	DET
bam-8877	26	2	hyperdynamic	hyperdynamic	ADJ
bam-8877	26	3	responses	response	NOUN
bam-8877	26	4	to	to	PART
bam-8877	26	5	ect	ect	VERB
bam-8877	26	6	are	be	AUX
bam-8877	26	7	associated	associate	VERB
bam-8877	26	8	with	with	ADP
bam-8877	26	9	an	an	DET
bam-8877	26	10	acute	acute	ADJ
bam-8877	26	11	increase	increase	NOUN
bam-8877	26	12	in	in	ADP
bam-8877	26	13	plasma	plasma	NOUN
bam-8877	26	14	epinephrine	epinephrine	NOUN
bam-8877	26	15	and	and	CCONJ
bam-8877	26	16	norepinephrine	norepinephrine	NOUN
bam-8877	26	17	concentrations.4	concentrations.4	PROPN
bam-8877	26	18	the	the	DET
bam-8877	26	19	most	most	ADV
bam-8877	26	20	common	common	ADJ
bam-8877	26	21	side	side	NOUN
bam-8877	26	22	effects	effect	NOUN
bam-8877	26	23	of	of	ADP
bam-8877	26	24	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	26	25	are	be	AUX
bam-8877	26	26	due	due	ADJ
bam-8877	26	27	to	to	ADP
bam-8877	26	28	its	its	PRON
bam-8877	26	29	mechanism	mechanism	NOUN
bam-8877	26	30	of	of	ADP
bam-8877	26	31	action	action	NOUN
bam-8877	26	32	,	,	PUNCT
bam-8877	26	33	including	include	VERB
bam-8877	26	34	hypotension	hypotension	NOUN
bam-8877	26	35	and	and	CCONJ
bam-8877	26	36	bradycardia	bradycardia	NOUN
bam-8877	26	37	.	.	PUNCT
bam-8877	27	1	therefore	therefore	ADV
bam-8877	27	2	,	,	PUNCT
bam-8877	27	3	both	both	CCONJ
bam-8877	27	4	remifentanil	remifentanil	NOUN
bam-8877	27	5	and	and	CCONJ
bam-8877	27	6	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	27	7	can	can	AUX
bam-8877	27	8	be	be	AUX
bam-8877	27	9	effective	effective	ADJ
bam-8877	27	10	in	in	ADP
bam-8877	27	11	controlling	control	VERB
bam-8877	27	12	ectinduced	ectinduce	VERB
bam-8877	27	13	hemodynamic	hemodynamic	ADJ
bam-8877	27	14	symptoms.10	symptoms.10	NOUN
bam-8877	27	15	the	the	DET
bam-8877	27	16	aim	aim	NOUN
bam-8877	27	17	of	of	ADP
bam-8877	27	18	this	this	DET
bam-8877	27	19	study	study	NOUN
bam-8877	27	20	was	be	AUX
bam-8877	27	21	to	to	PART
bam-8877	27	22	compare	compare	VERB
bam-8877	27	23	the	the	DET
bam-8877	27	24	effects	effect	NOUN
bam-8877	27	25	of	of	ADP
bam-8877	27	26	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	27	27	and	and	CCONJ
bam-8877	27	28	remifentanil	remifentanil	VERB
bam-8877	27	29	in	in	ADP
bam-8877	27	30	the	the	DET
bam-8877	27	31	treatment	treatment	NOUN
bam-8877	27	32	of	of	ADP
bam-8877	27	33	mood	mood	NOUN
bam-8877	27	34	patients	patient	NOUN
bam-8877	27	35	who	who	PRON
bam-8877	27	36	had	have	AUX
bam-8877	27	37	undergone	undergo	VERB
bam-8877	27	38	ect	ect	ADP
bam-8877	27	39	.	.	PUNCT
bam-8877	28	1	we	we	PRON
bam-8877	28	2	examined	examine	VERB
bam-8877	28	3	the	the	DET
bam-8877	28	4	effect	effect	NOUN
bam-8877	28	5	of	of	ADP
bam-8877	28	6	the	the	DET
bam-8877	28	7	drugs	drug	NOUN
bam-8877	28	8	on	on	ADP
bam-8877	28	9	the	the	DET
bam-8877	28	10	hemodynamic	hemodynamic	ADJ
bam-8877	28	11	status	status	NOUN
bam-8877	28	12	,	,	PUNCT
bam-8877	28	13	duration	duration	NOUN
bam-8877	28	14	of	of	ADP
bam-8877	28	15	seizures	seizure	NOUN
bam-8877	28	16	,	,	PUNCT
bam-8877	28	17	as	as	ADV
bam-8877	28	18	well	well	ADV
bam-8877	28	19	as	as	ADP
bam-8877	28	20	agitation	agitation	NOUN
bam-8877	28	21	and	and	CCONJ
bam-8877	28	22	recovery	recovery	NOUN
bam-8877	28	23	time	time	NOUN
bam-8877	28	24	in	in	ADP
bam-8877	28	25	patients	patient	NOUN
bam-8877	28	26	.	.	PUNCT
bam-8877	29	1	materials	material	NOUN
bam-8877	29	2	and	and	CCONJ
bam-8877	29	3	methods	method	NOUN
bam-8877	29	4	ethical	ethical	ADJ
bam-8877	29	5	considerations	consideration	NOUN
bam-8877	29	6	this	this	DET
bam-8877	29	7	study	study	NOUN
bam-8877	29	8	was	be	AUX
bam-8877	29	9	approved	approve	VERB
bam-8877	29	10	by	by	ADP
bam-8877	29	11	the	the	DET
bam-8877	29	12	research	research	NOUN
bam-8877	29	13	ethics	ethic	NOUN
bam-8877	29	14	committee	committee	PROPN
bam-8877	29	15	of	of	ADP
bam-8877	29	16	the	the	DET
bam-8877	29	17	arak	arak	PROPN
bam-8877	29	18	university	university	PROPN
bam-8877	29	19	of	of	ADP
bam-8877	29	20	the	the	DET
bam-8877	29	21	medical	medical	ADJ
bam-8877	29	22	science	science	NOUN
bam-8877	29	23	.	.	PUNCT
bam-8877	30	1	the	the	DET
bam-8877	30	2	code	code	NOUN
bam-8877	30	3	of	of	ADP
bam-8877	30	4	ethics	ethic	NOUN
bam-8877	30	5	was	be	AUX
bam-8877	30	6	:	:	PUNCT
bam-8877	30	7	ir.arakmu.rec.1396.298	ir.arakmu.rec.1396.298	NOUN
bam-8877	30	8	,	,	PUNCT
bam-8877	30	9	and	and	CCONJ
bam-8877	30	10	the	the	DET
bam-8877	30	11	study	study	NOUN
bam-8877	30	12	was	be	AUX
bam-8877	30	13	approved	approve	VERB
bam-8877	30	14	on	on	ADP
bam-8877	30	15	the	the	DET
bam-8877	30	16	26	26	NUM
bam-8877	30	17	jul	jul	PROPN
bam-8877	30	18	,	,	PUNCT
bam-8877	30	19	2018	2018	NUM
bam-8877	30	20	.	.	PUNCT
bam-8877	31	1	the	the	DET
bam-8877	31	2	registration	registration	NOUN
bam-8877	31	3	code	code	NOUN
bam-8877	31	4	at	at	ADP
bam-8877	31	5	the	the	DET
bam-8877	31	6	iran	iran	PROPN
bam-8877	31	7	clinical	clinical	ADJ
bam-8877	31	8	trial	trial	NOUN
bam-8877	31	9	center	center	NOUN
bam-8877	31	10	for	for	ADP
bam-8877	31	11	this	this	DET
bam-8877	31	12	project	project	NOUN
bam-8877	31	13	is	be	AUX
bam-8877	31	14	irct20141209020258n90	irct20141209020258n90	ADJ
bam-8877	31	15	.	.	PUNCT
bam-8877	32	1	procedures	procedure	NOUN
bam-8877	32	2	were	be	AUX
bam-8877	32	3	conducted	conduct	VERB
bam-8877	32	4	in	in	ADP
bam-8877	32	5	accordance	accordance	NOUN
bam-8877	32	6	with	with	ADP
bam-8877	32	7	the	the	DET
bam-8877	32	8	declaration	declaration	NOUN
bam-8877	32	9	of	of	ADP
bam-8877	32	10	helsinki	helsinki	PROPN
bam-8877	32	11	for	for	ADP
bam-8877	32	12	human	human	ADJ
bam-8877	32	13	studies	study	NOUN
bam-8877	32	14	of	of	ADP
bam-8877	32	15	the	the	DET
bam-8877	32	16	world	world	PROPN
bam-8877	32	17	medical	medical	PROPN
bam-8877	32	18	association	association	PROPN
bam-8877	32	19	.	.	PUNCT
bam-8877	33	1	setting	set	VERB
bam-8877	33	2	and	and	CCONJ
bam-8877	33	3	procedure	procedure	NOUN
bam-8877	33	4	this	this	DET
bam-8877	33	5	study	study	NOUN
bam-8877	33	6	was	be	AUX
bam-8877	33	7	a	a	DET
bam-8877	33	8	randomised	randomised	ADJ
bam-8877	33	9	,	,	PUNCT
bam-8877	33	10	double	double	ADJ
bam-8877	33	11	-	-	PUNCT
bam-8877	33	12	blind	blind	ADJ
bam-8877	33	13	clinical	clinical	ADJ
bam-8877	33	14	trial	trial	NOUN
bam-8877	33	15	that	that	PRON
bam-8877	33	16	was	be	AUX
bam-8877	33	17	performed	perform	VERB
bam-8877	33	18	on	on	ADP
bam-8877	33	19	patients	patient	NOUN
bam-8877	33	20	who	who	PRON
bam-8877	33	21	were	be	AUX
bam-8877	33	22	considered	consider	VERB
bam-8877	33	23	to	to	PART
bam-8877	33	24	be	be	AUX
bam-8877	33	25	mood	mood	NOUN
bam-8877	33	26	disorder	disorder	NOUN
bam-8877	33	27	candidates	candidate	NOUN
bam-8877	33	28	for	for	ADP
bam-8877	33	29	ect	ect	X
bam-8877	33	30	(	(	PUNCT
bam-8877	33	31	18	18	NUM
bam-8877	33	32	-	-	SYM
bam-8877	33	33	55	55	NUM
bam-8877	33	34	years	year	NOUN
bam-8877	33	35	old	old	ADJ
bam-8877	33	36	)	)	PUNCT
bam-8877	33	37	,	,	PUNCT
bam-8877	33	38	referred	refer	VERB
bam-8877	33	39	to	to	ADP
bam-8877	33	40	the	the	DET
bam-8877	33	41	amir	amir	PROPN
bam-8877	33	42	kabir	kabir	PROPN
bam-8877	33	43	hospital	hospital	PROPN
bam-8877	33	44	,	,	PUNCT
bam-8877	33	45	arak	arak	PROPN
bam-8877	33	46	,	,	PUNCT
bam-8877	33	47	iran	iran	PROPN
bam-8877	33	48	.	.	PUNCT
bam-8877	34	1	demographic	demographic	ADJ
bam-8877	34	2	characteristics	characteristic	NOUN
bam-8877	34	3	such	such	ADJ
bam-8877	34	4	as	as	ADP
bam-8877	34	5	heart	heart	NOUN
bam-8877	34	6	pulse	pulse	NOUN
bam-8877	34	7	rate	rate	NOUN
bam-8877	34	8	,	,	PUNCT
bam-8877	34	9	seizure	seizure	NOUN
bam-8877	34	10	time	time	NOUN
bam-8877	34	11	,	,	PUNCT
bam-8877	34	12	mean	mean	NOUN
bam-8877	34	13	of	of	ADP
bam-8877	34	14	arterial	arterial	ADJ
bam-8877	34	15	blood	blood	NOUN
bam-8877	34	16	pressure	pressure	NOUN
bam-8877	34	17	,	,	PUNCT
bam-8877	34	18	recovery	recovery	NOUN
bam-8877	34	19	duration	duration	NOUN
bam-8877	34	20	and	and	CCONJ
bam-8877	34	21	the	the	DET
bam-8877	34	22	arterial	arterial	ADJ
bam-8877	34	23	saturation	saturation	NOUN
bam-8877	34	24	oxygen	oxygen	NOUN
bam-8877	34	25	recorded	record	VERB
bam-8877	34	26	by	by	ADP
bam-8877	34	27	monitoring	monitor	VERB
bam-8877	34	28	after	after	ADP
bam-8877	34	29	recovery	recovery	NOUN
bam-8877	34	30	were	be	AUX
bam-8877	34	31	collected	collect	VERB
bam-8877	34	32	through	through	ADP
bam-8877	34	33	use	use	NOUN
bam-8877	34	34	of	of	ADP
bam-8877	34	35	checklists	checklist	NOUN
bam-8877	34	36	.	.	PUNCT
bam-8877	35	1	all	all	DET
bam-8877	35	2	patients	patient	NOUN
bam-8877	35	3	were	be	AUX
bam-8877	35	4	classified	classify	VERB
bam-8877	35	5	as	as	ADP
bam-8877	35	6	either	either	PRON
bam-8877	35	7	being	be	AUX
bam-8877	35	8	grade	grade	NOUN
bam-8877	35	9	i	i	PRON
bam-8877	35	10	(	(	PUNCT
bam-8877	35	11	normal	normal	ADJ
bam-8877	35	12	healthy	healthy	ADJ
bam-8877	35	13	patient	patient	NOUN
bam-8877	35	14	)	)	PUNCT
bam-8877	35	15	or	or	CCONJ
bam-8877	35	16	grade	grade	PROPN
bam-8877	35	17	ii	ii	PROPN
bam-8877	35	18	(	(	PUNCT
bam-8877	35	19	patient	patient	ADJ
bam-8877	35	20	with	with	ADP
bam-8877	35	21	mild	mild	ADJ
bam-8877	35	22	systemic	systemic	ADJ
bam-8877	35	23	disease	disease	NOUN
bam-8877	35	24	)	)	PUNCT
bam-8877	35	25	,	,	PUNCT
bam-8877	35	26	in	in	ADP
bam-8877	35	27	accordance	accordance	NOUN
bam-8877	35	28	with	with	ADP
bam-8877	35	29	the	the	DET
bam-8877	35	30	american	american	ADJ
bam-8877	35	31	society	society	NOUN
bam-8877	35	32	of	of	ADP
bam-8877	35	33	anesthesiologists	anesthesiologists	PROPN
bam-8877	35	34	(	(	PUNCT
bam-8877	35	35	asa	asa	PROPN
bam-8877	35	36	)	)	PUNCT
bam-8877	35	37	classification	classification	NOUN
bam-8877	35	38	system	system	NOUN
bam-8877	35	39	.	.	PUNCT
bam-8877	36	1	a	a	DET
bam-8877	36	2	series	series	NOUN
bam-8877	36	3	of	of	ADP
bam-8877	36	4	inclusion	inclusion	NOUN
bam-8877	36	5	and	and	CCONJ
bam-8877	36	6	exclusion	exclusion	NOUN
bam-8877	36	7	criteria	criterion	NOUN
bam-8877	36	8	were	be	AUX
bam-8877	36	9	established	establish	VERB
bam-8877	36	10	for	for	ADP
bam-8877	36	11	this	this	DET
bam-8877	36	12	randomized	randomize	VERB
bam-8877	36	13	controlled	control	VERB
bam-8877	36	14	trial	trial	NOUN
bam-8877	36	15	study	study	NOUN
bam-8877	36	16	.	.	PUNCT
bam-8877	37	1	individuals	individual	NOUN
bam-8877	37	2	who	who	PRON
bam-8877	37	3	satisfied	satisfy	VERB
bam-8877	37	4	the	the	DET
bam-8877	37	5	inclusion	inclusion	NOUN
bam-8877	37	6	criteria	criterion	NOUN
bam-8877	37	7	were	be	AUX
bam-8877	37	8	invited	invite	VERB
bam-8877	37	9	to	to	PART
bam-8877	37	10	take	take	VERB
bam-8877	37	11	part	part	NOUN
bam-8877	37	12	in	in	ADP
bam-8877	37	13	the	the	DET
bam-8877	37	14	study	study	NOUN
bam-8877	37	15	.	.	PUNCT
bam-8877	38	1	informed	informed	ADJ
bam-8877	38	2	consent	consent	NOUN
bam-8877	38	3	was	be	AUX
bam-8877	38	4	obtained	obtain	VERB
bam-8877	38	5	from	from	ADP
bam-8877	38	6	each	each	DET
bam-8877	38	7	participant	participant	NOUN
bam-8877	38	8	who	who	PRON
bam-8877	38	9	was	be	AUX
bam-8877	38	10	deemed	deem	VERB
bam-8877	38	11	eligible	eligible	ADJ
bam-8877	38	12	to	to	PART
bam-8877	38	13	participate	participate	VERB
bam-8877	38	14	in	in	ADP
bam-8877	38	15	the	the	DET
bam-8877	38	16	study	study	NOUN
bam-8877	38	17	and	and	CCONJ
bam-8877	38	18	accepted	accept	VERB
bam-8877	38	19	invitation	invitation	NOUN
bam-8877	38	20	.	.	PUNCT
bam-8877	39	1	inclusion	inclusion	NOUN
bam-8877	39	2	criteria	criterion	NOUN
bam-8877	39	3	were	be	AUX
bam-8877	39	4	:	:	PUNCT
bam-8877	39	5			PRON
bam-8877	39	6	patients	patient	NOUN
bam-8877	39	7	with	with	ADP
bam-8877	39	8	mood	mood	NOUN
bam-8877	39	9	disorder	disorder	NOUN
bam-8877	39	10	who	who	PRON
bam-8877	39	11	were	be	AUX
bam-8877	39	12	candidates	candidate	NOUN
bam-8877	39	13	for	for	ADP
bam-8877	39	14	ect	ect	NOUN
bam-8877	39	15	,	,	PUNCT
bam-8877	39	16	having	have	VERB
bam-8877	39	17	informed	inform	VERB
bam-8877	39	18	consent	consent	NOUN
bam-8877	39	19	.	.	PUNCT
bam-8877	40	1			NOUN
bam-8877	40	2	age	age	NOUN
bam-8877	40	3	range	range	VERB
bam-8877	40	4	from	from	ADP
bam-8877	40	5	18	18	NUM
bam-8877	40	6	to	to	PART
bam-8877	40	7	55	55	NUM
bam-8877	40	8	years	year	NOUN
bam-8877	40	9	.	.	PUNCT
bam-8877	41	1			X
bam-8877	42	1	no	no	DET
bam-8877	42	2	underlying	underlie	VERB
bam-8877	42	3	renal	renal	ADJ
bam-8877	42	4	,	,	PUNCT
bam-8877	42	5	hepatic	hepatic	ADJ
bam-8877	42	6	,	,	PUNCT
bam-8877	42	7	cardiac	cardiac	ADJ
bam-8877	42	8	and	and	CCONJ
bam-8877	42	9	pulmonary	pulmonary	ADJ
bam-8877	42	10	diseases	disease	NOUN
bam-8877	42	11	.	.	PUNCT
bam-8877	43	1			X
bam-8877	43	2	patients	patient	NOUN
bam-8877	43	3	who	who	PRON
bam-8877	43	4	were	be	AUX
bam-8877	43	5	not	not	PART
bam-8877	43	6	psychotic	psychotic	ADJ
bam-8877	43	7	except	except	SCONJ
bam-8877	43	8	for	for	ADP
bam-8877	43	9	mood	mood	NOUN
bam-8877	43	10	disorder	disorder	NOUN
bam-8877	43	11	.	.	PUNCT
bam-8877	44	1			X
bam-8877	44	2	patients	patient	NOUN
bam-8877	44	3	who	who	PRON
bam-8877	44	4	did	do	AUX
bam-8877	44	5	not	not	PART
bam-8877	44	6	have	have	VERB
bam-8877	44	7	contraindication	contraindication	NOUN
bam-8877	44	8	for	for	ADP
bam-8877	44	9	ect	ect	NOUN
bam-8877	44	10	.	.	PUNCT
bam-8877	45	1			X
bam-8877	45	2	no	no	DET
bam-8877	45	3	head	head	NOUN
bam-8877	45	4	trauma	trauma	NOUN
bam-8877	45	5	.	.	PUNCT
bam-8877	46	1	exclusion	exclusion	NOUN
bam-8877	46	2	criteria	criterion	NOUN
bam-8877	46	3	included	include	VERB
bam-8877	46	4	:	:	PUNCT
bam-8877	46	5			X
bam-8877	46	6	all	all	DET
bam-8877	46	7	patients	patient	NOUN
bam-8877	46	8	who	who	PRON
bam-8877	46	9	required	require	VERB
bam-8877	46	10	intubation	intubation	NOUN
bam-8877	46	11	after	after	ADP
bam-8877	46	12	ect	ect	X
bam-8877	46	13	due	due	ADP
bam-8877	46	14	to	to	ADP
bam-8877	46	15	respiratory	respiratory	ADJ
bam-8877	46	16	distress	distress	NOUN
bam-8877	46	17	and	and	CCONJ
bam-8877	46	18	prolonged	prolonged	ADJ
bam-8877	46	19	apnea	apnea	NOUN
bam-8877	46	20			NOUN
bam-8877	46	21	patients	patient	NOUN
bam-8877	46	22	who	who	PRON
bam-8877	46	23	do	do	AUX
bam-8877	46	24	not	not	PART
bam-8877	46	25	have	have	VERB
bam-8877	46	26	seizures	seizure	NOUN
bam-8877	46	27	after	after	ADP
bam-8877	46	28	receiving	receive	VERB
bam-8877	46	29	ect	ect	NOUN
bam-8877	46	30	.	.	PUNCT
bam-8877	47	1	in	in	ADP
bam-8877	47	2	this	this	DET
bam-8877	47	3	study	study	NOUN
bam-8877	47	4	,	,	PUNCT
bam-8877	47	5	90	90	NUM
bam-8877	47	6	patients	patient	NOUN
bam-8877	47	7	who	who	PRON
bam-8877	47	8	were	be	AUX
bam-8877	47	9	mood	mood	NOUN
bam-8877	47	10	disorder	disorder	NOUN
bam-8877	47	11	candidates	candidate	NOUN
bam-8877	47	12	for	for	ADP
bam-8877	47	13	ect	ect	PROPN
bam-8877	47	14	were	be	AUX
bam-8877	47	15	randomly	randomly	ADV
bam-8877	47	16	divided	divide	VERB
bam-8877	47	17	into	into	ADP
bam-8877	47	18	two	two	NUM
bam-8877	47	19	groups	group	NOUN
bam-8877	47	20	:	:	PUNCT
bam-8877	47	21	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	47	22	(	(	PUNCT
bam-8877	47	23	gd	gd	NOUN
bam-8877	47	24	)	)	PUNCT
bam-8877	47	25	and	and	CCONJ
bam-8877	47	26	remifentanil	remifentanil	NOUN
bam-8877	47	27	(	(	PUNCT
bam-8877	47	28	gr	gr	NOUN
bam-8877	47	29	)	)	PUNCT
bam-8877	47	30	.	.	PUNCT
bam-8877	48	1	the	the	DET
bam-8877	48	2	division	division	NOUN
bam-8877	48	3	was	be	AUX
bam-8877	48	4	equal	equal	ADJ
bam-8877	48	5	,	,	PUNCT
bam-8877	48	6	with	with	ADP
bam-8877	48	7	both	both	CCONJ
bam-8877	48	8	the	the	DET
bam-8877	48	9	gd	gd	PROPN
bam-8877	48	10	andg	andg	NOUN
bam-8877	48	11	r	r	NOUN
bam-8877	48	12	groups	group	NOUN
bam-8877	48	13	each	each	PRON
bam-8877	48	14	having	have	VERB
bam-8877	48	15	45	45	NUM
bam-8877	48	16	patients	patient	NOUN
bam-8877	48	17	.	.	PUNCT
bam-8877	49	1	patients	patient	NOUN
bam-8877	49	2	were	be	AUX
bam-8877	49	3	then	then	ADV
bam-8877	49	4	placed	place	VERB
bam-8877	49	5	on	on	ADP
bam-8877	49	6	an	an	DET
bam-8877	49	7	ect	ect	ADJ
bam-8877	49	8	bed	bed	NOUN
bam-8877	49	9	in	in	ADP
bam-8877	49	10	a	a	DET
bam-8877	49	11	supine	supine	ADJ
bam-8877	49	12	position	position	NOUN
bam-8877	49	13	and	and	CCONJ
bam-8877	49	14	an	an	DET
bam-8877	49	15	intravenous	intravenous	ADJ
bam-8877	49	16	angiocath	angiocath	NOUN
bam-8877	49	17	20	20	NUM
bam-8877	49	18	was	be	AUX
bam-8877	49	19	inserted	insert	VERB
bam-8877	49	20	.	.	PUNCT
bam-8877	50	1	patients	patient	NOUN
bam-8877	50	2	were	be	AUX
bam-8877	50	3	given	give	VERB
bam-8877	50	4	about	about	ADV
bam-8877	50	5	1	1	NUM
bam-8877	50	6	-	-	SYM
bam-8877	50	7	3	3	NUM
bam-8877	50	8	ml	ml	NOUN
bam-8877	50	9	/	/	SYM
bam-8877	50	10	kg	kg	NOUN
bam-8877	50	11	of	of	ADP
bam-8877	50	12	fluid	fluid	NOUN
bam-8877	50	13	prior	prior	ADV
bam-8877	50	14	to	to	ADP
bam-8877	50	15	anesthesia	anesthesia	NOUN
bam-8877	50	16	as	as	ADP
bam-8877	50	17	compensatory	compensatory	ADJ
bam-8877	50	18	intravascular	intravascular	ADJ
bam-8877	50	19	volume	volume	NOUN
bam-8877	50	20	expansion	expansion	NOUN
bam-8877	50	21	(	(	PUNCT
bam-8877	50	22	cve	cve	NOUN
bam-8877	50	23	)	)	PUNCT
bam-8877	50	24	.	.	PUNCT
bam-8877	51	1	then	then	ADV
bam-8877	51	2	,	,	PUNCT
bam-8877	51	3	necessary	necessary	ADJ
bam-8877	51	4	monitoring	monitoring	NOUN
bam-8877	51	5	was	be	AUX
bam-8877	51	6	performed	perform	VERB
bam-8877	51	7	,	,	PUNCT
bam-8877	51	8	including	include	VERB
bam-8877	51	9	(	(	PUNCT
bam-8877	51	10	hr	hr	NOUN
bam-8877	51	11	)	)	PUNCT
bam-8877	51	12	,	,	PUNCT
bam-8877	51	13	respiratory	respiratory	ADJ
bam-8877	51	14	rate	rate	NOUN
bam-8877	51	15	(	(	PUNCT
bam-8877	51	16	rr	rr	NOUN
bam-8877	51	17	)	)	PUNCT
bam-8877	51	18	,	,	PUNCT
bam-8877	51	19	arterial	arterial	ADJ
bam-8877	51	20	oxygen	oxygen	NOUN
bam-8877	51	21	saturation	saturation	NOUN
bam-8877	51	22	,	,	PUNCT
bam-8877	51	23	and	and	CCONJ
bam-8877	51	24	non	non	ADJ
bam-8877	51	25	-	-	ADJ
bam-8877	51	26	invasive	invasive	ADJ
bam-8877	51	27	blood	blood	NOUN
bam-8877	51	28	pressure	pressure	NOUN
bam-8877	51	29	(	(	PUNCT
bam-8877	51	30	nibp	nibp	PROPN
bam-8877	51	31	)	)	PUNCT
bam-8877	51	32	.	.	PUNCT
bam-8877	52	1	in	in	ADP
bam-8877	52	2	the	the	DET
bam-8877	52	3	first	first	ADJ
bam-8877	52	4	group	group	NOUN
bam-8877	52	5	(	(	PUNCT
bam-8877	52	6	gd	gd	NOUN
bam-8877	52	7	)	)	PUNCT
bam-8877	52	8	,	,	PUNCT
bam-8877	52	9	patients	patient	NOUN
bam-8877	52	10	were	be	AUX
bam-8877	52	11	treated	treat	VERB
bam-8877	52	12	with	with	ADP
bam-8877	52	13	0.5	0.5	NUM
bam-8877	52	14	μg	μg	PROPN
bam-8877	52	15	/	/	SYM
bam-8877	52	16	kg	kg	PROPN
bam-8877	52	17	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	52	18	(	(	PUNCT
bam-8877	52	19	volume	volume	NOUN
bam-8877	52	20	reached	reach	VERB
bam-8877	52	21	to	to	ADP
bam-8877	52	22	5	5	NUM
bam-8877	52	23	cc	cc	NOUN
bam-8877	52	24	)	)	PUNCT
bam-8877	52	25	intravenously	intravenously	ADV
bam-8877	52	26	and	and	CCONJ
bam-8877	52	27	slowly	slowly	ADV
bam-8877	52	28	before	before	ADP
bam-8877	52	29	induction	induction	NOUN
bam-8877	52	30	of	of	ADP
bam-8877	52	31	anesthesia	anesthesia	NOUN
bam-8877	52	32	.	.	PUNCT
bam-8877	53	1	in	in	ADP
bam-8877	53	2	the	the	DET
bam-8877	53	3	second	second	ADJ
bam-8877	53	4	group	group	NOUN
bam-8877	53	5	(	(	PUNCT
bam-8877	53	6	gr	gr	PROPN
bam-8877	53	7	)	)	PUNCT
bam-8877	53	8	(	(	PUNCT
bam-8877	53	9	100	100	NUM
bam-8877	53	10	μg	μg	NOUN
bam-8877	53	11	of	of	ADP
bam-8877	53	12	remifentanil	remifentanil	NOUN
bam-8877	53	13	,	,	PUNCT
bam-8877	53	14	intravenous	intravenous	ADJ
bam-8877	53	15	therapy	therapy	NOUN
bam-8877	53	16	(	(	PUNCT
bam-8877	53	17	iv	iv	NOUN
bam-8877	53	18	)	)	PUNCT
bam-8877	53	19	)	)	PUNCT
bam-8877	53	20	was	be	AUX
bam-8877	53	21	injected	inject	VERB
bam-8877	53	22	.	.	PUNCT
bam-8877	54	1	patients	patient	NOUN
bam-8877	54	2	in	in	ADP
bam-8877	54	3	both	both	DET
bam-8877	54	4	groups	group	NOUN
bam-8877	54	5	were	be	AUX
bam-8877	54	6	anesthetized	anesthetize	VERB
bam-8877	54	7	with	with	ADP
bam-8877	54	8	2–3	2–3	NUM
bam-8877	54	9	mg	mg	PROPN
bam-8877	54	10	/	/	SYM
bam-8877	54	11	kg	kg	PROPN
bam-8877	54	12	thiopental	thiopental	ADJ
bam-8877	54	13	sodium	sodium	NOUN
bam-8877	54	14	,	,	PUNCT
bam-8877	54	15	0.5	0.5	NUM
bam-8877	54	16	mg	mg	PROPN
bam-8877	54	17	/	/	SYM
bam-8877	54	18	kg	kg	PROPN
bam-8877	54	19	succinylcholine	succinylcholine	NOUN
bam-8877	54	20	and	and	CCONJ
bam-8877	54	21	0.5	0.5	NUM
bam-8877	54	22	mg	mg	PROPN
bam-8877	54	23	atropine	atropine	NOUN
bam-8877	54	24	.	.	PUNCT
bam-8877	55	1	table	table	NOUN
bam-8877	55	2	1	1	NUM
bam-8877	55	3	:	:	PUNCT
bam-8877	55	4	comparison	comparison	NOUN
bam-8877	55	5	of	of	ADP
bam-8877	55	6	mean	mean	ADJ
bam-8877	55	7	blood	blood	NOUN
bam-8877	55	8	pressure	pressure	NOUN
bam-8877	55	9	,	,	PUNCT
bam-8877	55	10	heart	heart	NOUN
bam-8877	55	11	rate	rate	NOUN
bam-8877	55	12	and	and	CCONJ
bam-8877	55	13	arterial	arterial	ADJ
bam-8877	55	14	oxygen	oxygen	NOUN
bam-8877	55	15	saturation	saturation	NOUN
bam-8877	55	16	before	before	ADP
bam-8877	55	17	shock	shock	NOUN
bam-8877	55	18	therapy	therapy	NOUN
bam-8877	55	19	cardiovascular	cardiovascular	ADJ
bam-8877	55	20	parameter	parameter	PROPN
bam-8877	55	21	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	55	22	group	group	PROPN
bam-8877	55	23	remifentanil	remifentanil	PROPN
bam-8877	55	24	group	group	NOUN
bam-8877	55	25	p	p	NOUN
bam-8877	55	26	-	-	PUNCT
bam-8877	55	27	value	value	NOUN
bam-8877	55	28	mean	mean	NOUN
bam-8877	55	29	arterial	arterial	ADJ
bam-8877	55	30	blood	blood	NOUN
bam-8877	55	31	pressure	pressure	NOUN
bam-8877	55	32	before	before	ADP
bam-8877	55	33	shock	shock	NOUN
bam-8877	55	34	09	09	NUM
bam-8877	55	35	.	.	SYM
bam-8877	56	1	2	2	NUM
bam-8877	56	2	±8	±8	NOUN
bam-8877	56	3	.9	.9	NUM
bam-8877	56	4	92	92	NUM
bam-8877	56	5	.	.	SYM
bam-8877	56	6	3	3	NUM
bam-8877	56	7	±5	±5	VERB
bam-8877	56	8	.8	.8	PROPN
bam-8877	56	9	p	p	NOUN
bam-8877	56	10	=	=	SYM
bam-8877	56	11	0.4	0.4	NUM
bam-8877	56	12	heart	heart	NOUN
bam-8877	56	13	rate	rate	NOUN
bam-8877	56	14	before	before	ADP
bam-8877	56	15	shock	shock	NOUN
bam-8877	56	16	100	100	NUM
bam-8877	56	17	.	.	PUNCT
bam-8877	56	18	3	3	NUM
bam-8877	56	19	±8	±8	NOUN
bam-8877	56	20	.7	.7	PROPN
bam-8877	56	21	101	101	NUM
bam-8877	56	22	.	.	NOUN
bam-8877	56	23	4	4	NUM
bam-8877	57	1	±9	±9	VERB
bam-8877	57	2	.6	.6	NUM
bam-8877	57	3	p	p	NOUN
bam-8877	57	4	=	=	SYM
bam-8877	57	5	0.6	0.6	NUM
bam-8877	57	6	arterial	arterial	NOUN
bam-8877	57	7	oxygen	oxygen	NOUN
bam-8877	57	8	saturation	saturation	NOUN
bam-8877	57	9	before	before	ADP
bam-8877	57	10	shock	shock	NOUN
bam-8877	57	11	95	95	NUM
bam-8877	57	12	.	.	NOUN
bam-8877	57	13	4	4	NUM
bam-8877	57	14	±2	±2	NOUN
bam-8877	57	15	.6	.6	NUM
bam-8877	57	16	94	94	NUM
bam-8877	57	17	.	.	NOUN
bam-8877	57	18	3	3	NUM
bam-8877	58	1	±9	±9	ADP
bam-8877	58	2	.8	.8	NUM
bam-8877	59	1	p	p	NOUN
bam-8877	59	2	=	=	PUNCT
bam-8877	59	3	0.4	0.4	NUM
bam-8877	59	4	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	59	5	or	or	CCONJ
bam-8877	59	6	remifentanil	remifentanil	NOUN
bam-8877	59	7	added	add	VERB
bam-8877	59	8	to	to	AUX
bam-8877	59	9	thiopental	thiopental	PROPN
bam-8877	59	10	eur	eur	PROPN
bam-8877	59	11	j	j	PROPN
bam-8877	59	12	transl	transl	PROPN
bam-8877	59	13	myol	myol	ADV
bam-8877	59	14	2020;30	2020;30	PROPN
bam-8877	59	15	(	(	PUNCT
bam-8877	59	16	3	3	NUM
bam-8877	59	17	):	):	PUNCT
bam-8877	59	18	8877	8877	NUM
bam-8877	59	19	.	.	PUNCT
bam-8877	60	1	doi	doi	NOUN
bam-8877	60	2	:	:	PUNCT
bam-8877	60	3	10.4081	10.4081	NUM
bam-8877	60	4	/	/	SYM
bam-8877	60	5	ejtm.2020.8877	ejtm.2020.8877	PROPN
bam-8877	60	6	3	3	NUM
bam-8877	60	7	data	datum	NOUN
bam-8877	60	8	analysis	analysis	NOUN
bam-8877	60	9	all	all	DET
bam-8877	60	10	data	datum	NOUN
bam-8877	60	11	obtained	obtain	VERB
bam-8877	60	12	from	from	ADP
bam-8877	60	13	the	the	DET
bam-8877	60	14	questionnaires	questionnaire	NOUN
bam-8877	60	15	were	be	AUX
bam-8877	60	16	analyzed	analyze	VERB
bam-8877	60	17	using	use	VERB
bam-8877	60	18	spss-23	spss-23	NOUN
bam-8877	60	19	statistical	statistical	ADJ
bam-8877	60	20	software	software	NOUN
bam-8877	60	21	,	,	PUNCT
bam-8877	60	22	t	t	NOUN
bam-8877	60	23	-	-	PUNCT
bam-8877	60	24	test	test	NOUN
bam-8877	60	25	and	and	CCONJ
bam-8877	60	26	analysis	analysis	NOUN
bam-8877	60	27	of	of	ADP
bam-8877	60	28	variance	variance	NOUN
bam-8877	60	29	(	(	PUNCT
bam-8877	60	30	anova	anova	PROPN
bam-8877	60	31	)	)	PUNCT
bam-8877	60	32	.	.	PUNCT
bam-8877	61	1	after	after	ADP
bam-8877	61	2	anesthesia	anesthesia	NOUN
bam-8877	61	3	,	,	PUNCT
bam-8877	61	4	the	the	DET
bam-8877	61	5	patients	patient	NOUN
bam-8877	61	6	were	be	AUX
bam-8877	61	7	re	re	VERB
bam-8877	61	8	-	-	VERB
bam-8877	61	9	hyperoxygenated	hyperoxygenate	VERB
bam-8877	61	10	and	and	CCONJ
bam-8877	61	11	transferred	transfer	VERB
bam-8877	61	12	to	to	ADP
bam-8877	61	13	recovery	recovery	NOUN
bam-8877	61	14	.	.	PUNCT
bam-8877	62	1	questionnaires	questionnaire	NOUN
bam-8877	62	2	including	include	VERB
bam-8877	62	3	demographic	demographic	ADJ
bam-8877	62	4	data	datum	NOUN
bam-8877	62	5	,	,	PUNCT
bam-8877	62	6	duration	duration	NOUN
bam-8877	62	7	of	of	ADP
bam-8877	62	8	seizure	seizure	NOUN
bam-8877	62	9	,	,	PUNCT
bam-8877	62	10	hemodynamic	hemodynamic	ADJ
bam-8877	62	11	status	status	NOUN
bam-8877	62	12	of	of	ADP
bam-8877	62	13	patients	patient	NOUN
bam-8877	62	14	,	,	PUNCT
bam-8877	62	15	recovery	recovery	NOUN
bam-8877	62	16	time	time	NOUN
bam-8877	62	17	,	,	PUNCT
bam-8877	62	18	agitation	agitation	NOUN
bam-8877	62	19	score	score	NOUN
bam-8877	62	20	and	and	CCONJ
bam-8877	62	21	satisfaction	satisfaction	NOUN
bam-8877	62	22	score	score	NOUN
bam-8877	62	23	were	be	AUX
bam-8877	62	24	completed	complete	VERB
bam-8877	62	25	for	for	ADP
bam-8877	62	26	each	each	DET
bam-8877	62	27	patient	patient	NOUN
bam-8877	62	28	,	,	PUNCT
bam-8877	62	29	and	and	CCONJ
bam-8877	62	30	descriptive	descriptive	ADJ
bam-8877	62	31	statistics	statistic	NOUN
bam-8877	62	32	including	include	VERB
bam-8877	62	33	mean	mean	NOUN
bam-8877	62	34	and	and	CCONJ
bam-8877	62	35	percent	percent	NOUN
bam-8877	62	36	was	be	AUX
bam-8877	62	37	used	use	VERB
bam-8877	62	38	.	.	PUNCT
bam-8877	63	1	results	result	VERB
bam-8877	63	2	the	the	DET
bam-8877	63	3	mean	mean	ADJ
bam-8877	63	4	age	age	NOUN
bam-8877	63	5	distribution	distribution	NOUN
bam-8877	63	6	in	in	ADP
bam-8877	63	7	the	the	DET
bam-8877	63	8	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	63	9	group	group	NOUN
bam-8877	63	10	was	be	AUX
bam-8877	63	11	37.8	37.8	NUM
bam-8877	63	12	±	±	NUM
bam-8877	63	13	2.7	2.7	NUM
bam-8877	63	14	years	year	NOUN
bam-8877	63	15	and	and	CCONJ
bam-8877	63	16	in	in	ADP
bam-8877	63	17	the	the	DET
bam-8877	63	18	remifentanil	remifentanil	NOUN
bam-8877	63	19	group	group	NOUN
bam-8877	63	20	36.9	36.9	NUM
bam-8877	63	21	±	±	NUM
bam-8877	63	22	1.1	1.1	NUM
bam-8877	63	23	years	year	NOUN
bam-8877	63	24	.	.	PUNCT
bam-8877	64	1	the	the	DET
bam-8877	64	2	mean	mean	ADJ
bam-8877	64	3	age	age	NOUN
bam-8877	64	4	was	be	AUX
bam-8877	64	5	approximately	approximately	ADV
bam-8877	64	6	37	37	NUM
bam-8877	64	7	years	year	NOUN
bam-8877	64	8	in	in	ADP
bam-8877	64	9	both	both	DET
bam-8877	64	10	groups	group	NOUN
bam-8877	64	11	.	.	PUNCT
bam-8877	65	1	t	t	NOUN
bam-8877	65	2	-	-	PUNCT
bam-8877	65	3	test	test	NOUN
bam-8877	65	4	analysis	analysis	NOUN
bam-8877	65	5	showed	show	VERB
bam-8877	65	6	that	that	SCONJ
bam-8877	65	7	there	there	PRON
bam-8877	65	8	was	be	VERB
bam-8877	65	9	no	no	DET
bam-8877	65	10	statistically	statistically	ADV
bam-8877	65	11	significant	significant	ADJ
bam-8877	65	12	difference	difference	NOUN
bam-8877	65	13	between	between	ADP
bam-8877	65	14	the	the	DET
bam-8877	65	15	two	two	NUM
bam-8877	65	16	groups	group	NOUN
bam-8877	65	17	(	(	PUNCT
bam-8877	65	18	p	p	X
bam-8877	65	19	=	=	NOUN
bam-8877	65	20	0.1	0.1	NUM
bam-8877	65	21	)	)	PUNCT
bam-8877	65	22	.	.	PUNCT
bam-8877	66	1	frequency	frequency	NOUN
bam-8877	66	2	distribution	distribution	NOUN
bam-8877	66	3	in	in	ADP
bam-8877	66	4	the	the	DET
bam-8877	66	5	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	66	6	group	group	NOUN
bam-8877	66	7	was	be	AUX
bam-8877	66	8	70.7	70.7	NUM
bam-8877	66	9	%	%	NOUN
bam-8877	66	10	for	for	ADP
bam-8877	66	11	males	male	NOUN
bam-8877	66	12	and	and	CCONJ
bam-8877	66	13	29.3	29.3	NUM
bam-8877	66	14	%	%	NOUN
bam-8877	66	15	for	for	ADP
bam-8877	66	16	females	female	NOUN
bam-8877	66	17	and	and	CCONJ
bam-8877	66	18	for	for	ADP
bam-8877	66	19	remifentanil	remifentanil	NOUN
bam-8877	66	20	group	group	NOUN
bam-8877	66	21	71.9	71.9	NUM
bam-8877	66	22	%	%	NOUN
bam-8877	66	23	for	for	ADP
bam-8877	66	24	males	male	NOUN
bam-8877	66	25	and	and	CCONJ
bam-8877	66	26	28.1	28.1	NUM
bam-8877	66	27	%	%	NOUN
bam-8877	66	28	for	for	ADP
bam-8877	66	29	females	female	NOUN
bam-8877	66	30	.	.	PUNCT
bam-8877	67	1	there	there	PRON
bam-8877	67	2	was	be	VERB
bam-8877	67	3	no	no	DET
bam-8877	67	4	significant	significant	ADJ
bam-8877	67	5	difference	difference	NOUN
bam-8877	67	6	between	between	ADP
bam-8877	67	7	the	the	DET
bam-8877	67	8	two	two	NUM
bam-8877	67	9	groups	group	NOUN
bam-8877	67	10	(	(	PUNCT
bam-8877	67	11	p	p	X
bam-8877	67	12	=	=	NOUN
bam-8877	67	13	0.2	0.2	NUM
bam-8877	67	14	)	)	PUNCT
bam-8877	67	15	.	.	PUNCT
bam-8877	68	1	comparison	comparison	NOUN
bam-8877	68	2	of	of	ADP
bam-8877	68	3	mean	mean	ADJ
bam-8877	68	4	blood	blood	NOUN
bam-8877	68	5	pressure	pressure	NOUN
bam-8877	68	6	,	,	PUNCT
bam-8877	68	7	hr	hr	NOUN
bam-8877	68	8	and	and	CCONJ
bam-8877	68	9	arterial	arterial	ADJ
bam-8877	68	10	oxygen	oxygen	NOUN
bam-8877	68	11	saturation	saturation	NOUN
bam-8877	68	12	before	before	ADP
bam-8877	68	13	shock	shock	NOUN
bam-8877	68	14	therapy	therapy	NOUN
bam-8877	68	15	in	in	ADP
bam-8877	68	16	patients	patient	NOUN
bam-8877	68	17	with	with	ADP
bam-8877	68	18	mood	mood	NOUN
bam-8877	68	19	disorders	disorder	NOUN
bam-8877	68	20	(	(	PUNCT
bam-8877	68	21	ect	ect	VERB
bam-8877	68	22	candidates	candidate	NOUN
bam-8877	68	23	)	)	PUNCT
bam-8877	68	24	in	in	ADP
bam-8877	68	25	the	the	DET
bam-8877	68	26	two	two	NUM
bam-8877	68	27	groups	group	NOUN
bam-8877	68	28	of	of	ADP
bam-8877	68	29	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	68	30	or	or	CCONJ
bam-8877	68	31	remifentanil	remifentanil	NOUN
bam-8877	68	32	were	be	AUX
bam-8877	68	33	evaluated	evaluate	VERB
bam-8877	68	34	in	in	ADP
bam-8877	68	35	table	table	NOUN
bam-8877	68	36	1	1	NUM
bam-8877	68	37	.	.	PUNCT
bam-8877	69	1	as	as	SCONJ
bam-8877	69	2	can	can	AUX
bam-8877	69	3	be	be	AUX
bam-8877	69	4	seen	see	VERB
bam-8877	69	5	,	,	PUNCT
bam-8877	69	6	all	all	DET
bam-8877	69	7	p	p	ADJ
bam-8877	69	8	values	value	NOUN
bam-8877	69	9	were	be	AUX
bam-8877	69	10	greater	great	ADJ
bam-8877	69	11	than	than	ADP
bam-8877	69	12	0.05	0.05	NUM
bam-8877	69	13	.	.	PUNCT
bam-8877	70	1	thus	thus	ADV
bam-8877	70	2	indicated	indicate	VERB
bam-8877	70	3	that	that	SCONJ
bam-8877	70	4	there	there	PRON
bam-8877	70	5	was	be	VERB
bam-8877	70	6	no	no	DET
bam-8877	70	7	significant	significant	ADJ
bam-8877	70	8	difference	difference	NOUN
bam-8877	70	9	between	between	ADP
bam-8877	70	10	the	the	DET
bam-8877	70	11	two	two	NUM
bam-8877	70	12	groups	group	NOUN
bam-8877	70	13	in	in	ADP
bam-8877	70	14	mean	mean	ADJ
bam-8877	70	15	blood	blood	NOUN
bam-8877	70	16	pressure	pressure	NOUN
bam-8877	70	17	,	,	PUNCT
bam-8877	70	18	hr	hr	NOUN
bam-8877	70	19	and	and	CCONJ
bam-8877	70	20	arterial	arterial	ADJ
bam-8877	70	21	oxygen	oxygen	NOUN
bam-8877	70	22	saturation	saturation	NOUN
bam-8877	70	23	before	before	ADP
bam-8877	70	24	ect	ect	PROPN
bam-8877	70	25	.	.	PUNCT
bam-8877	71	1	results	result	NOUN
bam-8877	71	2	differed	differ	VERB
bam-8877	71	3	for	for	ADP
bam-8877	71	4	the	the	DET
bam-8877	71	5	post	post	ADJ
bam-8877	71	6	-	-	ADJ
bam-8877	71	7	ect	ect	ADJ
bam-8877	71	8	comparisons	comparison	NOUN
bam-8877	71	9	between	between	ADP
bam-8877	71	10	the	the	DET
bam-8877	71	11	gd	gd	PROPN
bam-8877	71	12	group	group	NOUN
bam-8877	71	13	and	and	CCONJ
bam-8877	71	14	the	the	DET
bam-8877	71	15	gr	gr	PROPN
bam-8877	71	16	group	group	NOUN
bam-8877	71	17	.	.	PUNCT
bam-8877	72	1	there	there	PRON
bam-8877	72	2	was	be	VERB
bam-8877	72	3	a	a	DET
bam-8877	72	4	significant	significant	ADJ
bam-8877	72	5	difference	difference	NOUN
bam-8877	72	6	between	between	ADP
bam-8877	72	7	the	the	DET
bam-8877	72	8	two	two	NUM
bam-8877	72	9	groups	group	NOUN
bam-8877	72	10	in	in	ADP
bam-8877	72	11	the	the	DET
bam-8877	72	12	mean	mean	ADJ
bam-8877	72	13	blood	blood	NOUN
bam-8877	72	14	pressure	pressure	NOUN
bam-8877	72	15	and	and	CCONJ
bam-8877	72	16	hr	hr	NOUN
bam-8877	72	17	in	in	ADP
bam-8877	72	18	the	the	DET
bam-8877	72	19	recovery	recovery	NOUN
bam-8877	72	20	group	group	NOUN
bam-8877	72	21	,	,	PUNCT
bam-8877	72	22	which	which	PRON
bam-8877	72	23	was	be	AUX
bam-8877	72	24	significantly	significantly	ADV
bam-8877	72	25	lower	low	ADJ
bam-8877	72	26	in	in	ADP
bam-8877	72	27	the	the	DET
bam-8877	72	28	dexmedetomidine	dexmedetomidine	ADJ
bam-8877	72	29	group	group	NOUN
bam-8877	72	30	than	than	ADP
bam-8877	72	31	in	in	ADP
bam-8877	72	32	the	the	DET
bam-8877	72	33	remifentanil	remifentanil	NOUN
bam-8877	72	34	group	group	NOUN
bam-8877	72	35	(	(	PUNCT
bam-8877	72	36	p	p	X
bam-8877	72	37	=	=	NOUN
bam-8877	72	38	0.02	0.02	NUM
bam-8877	72	39	,	,	PUNCT
bam-8877	72	40	p	p	NOUN
bam-8877	72	41	=	=	NOUN
bam-8877	72	42	0.001	0.001	NUM
bam-8877	72	43	)	)	PUNCT
bam-8877	72	44	.	.	PUNCT
bam-8877	73	1	in	in	ADP
bam-8877	73	2	other	other	ADJ
bam-8877	73	3	words	word	NOUN
bam-8877	73	4	,	,	PUNCT
bam-8877	73	5	the	the	DET
bam-8877	73	6	hemodynamics	hemodynamic	NOUN
bam-8877	73	7	of	of	ADP
bam-8877	73	8	patients	patient	NOUN
bam-8877	73	9	in	in	ADP
bam-8877	73	10	the	the	DET
bam-8877	73	11	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	73	12	group	group	NOUN
bam-8877	73	13	was	be	AUX
bam-8877	73	14	more	more	ADV
bam-8877	73	15	stable	stable	ADJ
bam-8877	73	16	.	.	PUNCT
bam-8877	74	1	however	however	ADV
bam-8877	74	2	,	,	PUNCT
bam-8877	74	3	there	there	PRON
bam-8877	74	4	was	be	VERB
bam-8877	74	5	no	no	DET
bam-8877	74	6	significant	significant	ADJ
bam-8877	74	7	difference	difference	NOUN
bam-8877	74	8	in	in	ADP
bam-8877	74	9	arterial	arterial	ADJ
bam-8877	74	10	oxygen	oxygen	NOUN
bam-8877	74	11	saturation	saturation	NOUN
bam-8877	74	12	between	between	ADP
bam-8877	74	13	the	the	DET
bam-8877	74	14	gd	gd	PROPN
bam-8877	74	15	and	and	CCONJ
bam-8877	74	16	gr	gr	PROPN
bam-8877	74	17	group	group	NOUN
bam-8877	74	18	in	in	ADP
bam-8877	74	19	recovery	recovery	NOUN
bam-8877	74	20	(	(	PUNCT
bam-8877	74	21	p	p	X
bam-8877	74	22	=	=	NOUN
bam-8877	74	23	0.4	0.4	NUM
bam-8877	74	24	)	)	PUNCT
bam-8877	74	25	(	(	PUNCT
bam-8877	74	26	table	table	NOUN
bam-8877	74	27	2	2	NUM
bam-8877	74	28	and	and	CCONJ
bam-8877	74	29	figure	figure	NOUN
bam-8877	74	30	1	1	NUM
bam-8877	74	31	)	)	PUNCT
bam-8877	74	32	.	.	PUNCT
bam-8877	75	1	statistical	statistical	ADJ
bam-8877	75	2	comparison	comparison	NOUN
bam-8877	75	3	was	be	AUX
bam-8877	75	4	also	also	ADV
bam-8877	75	5	performed	perform	VERB
bam-8877	75	6	between	between	ADP
bam-8877	75	7	the	the	DET
bam-8877	75	8	groups	group	NOUN
bam-8877	75	9	with	with	ADP
bam-8877	75	10	regards	regard	NOUN
bam-8877	75	11	to	to	PART
bam-8877	75	12	seizure	seizure	VERB
bam-8877	75	13	duration	duration	NOUN
bam-8877	75	14	and	and	CCONJ
bam-8877	75	15	duration	duration	NOUN
bam-8877	75	16	of	of	ADP
bam-8877	75	17	recovery	recovery	NOUN
bam-8877	75	18	.	.	PUNCT
bam-8877	76	1	it	it	PRON
bam-8877	76	2	was	be	AUX
bam-8877	76	3	found	find	VERB
bam-8877	76	4	that	that	SCONJ
bam-8877	76	5	there	there	PRON
bam-8877	76	6	was	be	VERB
bam-8877	76	7	no	no	DET
bam-8877	76	8	significant	significant	ADJ
bam-8877	76	9	difference	difference	NOUN
bam-8877	76	10	between	between	ADP
bam-8877	76	11	the	the	DET
bam-8877	76	12	two	two	NUM
bam-8877	76	13	groups	group	NOUN
bam-8877	76	14	in	in	ADP
bam-8877	76	15	terms	term	NOUN
bam-8877	76	16	of	of	ADP
bam-8877	76	17	duration	duration	NOUN
bam-8877	76	18	of	of	ADP
bam-8877	76	19	seizures	seizure	NOUN
bam-8877	76	20	(	(	PUNCT
bam-8877	76	21	in	in	ADP
bam-8877	76	22	seconds	second	NOUN
bam-8877	76	23	)	)	PUNCT
bam-8877	77	1	(	(	PUNCT
bam-8877	77	2	p	p	X
bam-8877	77	3	=	=	NOUN
bam-8877	77	4	0.08	0.08	NUM
bam-8877	77	5	)	)	PUNCT
bam-8877	77	6	,	,	PUNCT
bam-8877	77	7	although	although	SCONJ
bam-8877	77	8	the	the	DET
bam-8877	77	9	duration	duration	NOUN
bam-8877	77	10	of	of	ADP
bam-8877	77	11	seizures	seizure	NOUN
bam-8877	77	12	was	be	AUX
bam-8877	77	13	somewhat	somewhat	ADV
bam-8877	77	14	longer	long	ADJ
bam-8877	77	15	in	in	ADP
bam-8877	77	16	the	the	DET
bam-8877	77	17	remifentanil	remifentanil	NOUN
bam-8877	77	18	group	group	NOUN
bam-8877	77	19	;	;	PUNCT
bam-8877	77	20	but	but	CCONJ
bam-8877	77	21	this	this	DET
bam-8877	77	22	difference	difference	NOUN
bam-8877	77	23	was	be	AUX
bam-8877	77	24	not	not	PART
bam-8877	77	25	significant	significant	ADJ
bam-8877	77	26	.	.	PUNCT
bam-8877	78	1	there	there	PRON
bam-8877	78	2	was	be	VERB
bam-8877	78	3	a	a	DET
bam-8877	78	4	significant	significant	ADJ
bam-8877	78	5	difference	difference	NOUN
bam-8877	78	6	between	between	ADP
bam-8877	78	7	the	the	DET
bam-8877	78	8	two	two	NUM
bam-8877	78	9	groups	group	NOUN
bam-8877	78	10	in	in	ADP
bam-8877	78	11	terms	term	NOUN
bam-8877	78	12	of	of	ADP
bam-8877	78	13	recovery	recovery	NOUN
bam-8877	78	14	time	time	NOUN
bam-8877	78	15	(	(	PUNCT
bam-8877	78	16	in	in	ADP
bam-8877	78	17	minutes	minute	NOUN
bam-8877	78	18	)	)	PUNCT
bam-8877	78	19	and	and	CCONJ
bam-8877	78	20	the	the	DET
bam-8877	78	21	recovery	recovery	NOUN
bam-8877	78	22	time	time	NOUN
bam-8877	78	23	was	be	AUX
bam-8877	78	24	significantly	significantly	ADV
bam-8877	78	25	longer	long	ADJ
bam-8877	78	26	in	in	ADP
bam-8877	78	27	the	the	DET
bam-8877	78	28	dexmedetomidine	dexmedetomidine	ADJ
bam-8877	78	29	group	group	NOUN
bam-8877	78	30	than	than	ADP
bam-8877	78	31	in	in	ADP
bam-8877	78	32	the	the	DET
bam-8877	78	33	remifentanil	remifentanil	NOUN
bam-8877	78	34	group	group	NOUN
bam-8877	78	35	(	(	PUNCT
bam-8877	78	36	p	p	X
bam-8877	78	37	=	=	NOUN
bam-8877	78	38	0.01	0.01	NUM
bam-8877	78	39	)	)	PUNCT
bam-8877	78	40	(	(	PUNCT
bam-8877	78	41	figure	figure	NOUN
bam-8877	78	42	2	2	NUM
bam-8877	78	43	and	and	CCONJ
bam-8877	78	44	table	table	NOUN
bam-8877	78	45	3	3	NUM
bam-8877	78	46	)	)	PUNCT
bam-8877	78	47	.	.	PUNCT
bam-8877	79	1	the	the	DET
bam-8877	79	2	comparison	comparison	NOUN
bam-8877	79	3	of	of	ADP
bam-8877	79	4	satisfaction	satisfaction	NOUN
bam-8877	79	5	score	score	NOUN
bam-8877	79	6	and	and	CCONJ
bam-8877	79	7	agitation	agitation	NOUN
bam-8877	79	8	in	in	ADP
bam-8877	79	9	patients	patient	NOUN
bam-8877	79	10	with	with	ADP
bam-8877	79	11	mood	mood	NOUN
bam-8877	79	12	disorders	disorder	NOUN
bam-8877	79	13	,	,	PUNCT
bam-8877	79	14	in	in	ADP
bam-8877	79	15	the	the	DET
bam-8877	79	16	two	two	NUM
bam-8877	79	17	groups	group	NOUN
bam-8877	79	18	of	of	ADP
bam-8877	79	19	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	79	20	and	and	CCONJ
bam-8877	79	21	remifentanil	remifentanil	NOUN
bam-8877	79	22	,	,	PUNCT
bam-8877	79	23	was	be	AUX
bam-8877	79	24	also	also	ADV
bam-8877	79	25	evaluated	evaluate	VERB
bam-8877	79	26	.	.	PUNCT
bam-8877	80	1	there	there	PRON
bam-8877	80	2	was	be	VERB
bam-8877	80	3	no	no	DET
bam-8877	80	4	significant	significant	ADJ
bam-8877	80	5	difference	difference	NOUN
bam-8877	80	6	between	between	ADP
bam-8877	80	7	the	the	DET
bam-8877	80	8	two	two	NUM
bam-8877	80	9	groups	group	NOUN
bam-8877	80	10	in	in	ADP
bam-8877	80	11	terms	term	NOUN
bam-8877	80	12	of	of	ADP
bam-8877	80	13	satisfaction	satisfaction	NOUN
bam-8877	80	14	and	and	CCONJ
bam-8877	80	15	agitation	agitation	NOUN
bam-8877	80	16	.	.	PUNCT
bam-8877	81	1	(	(	PUNCT
bam-8877	81	2	p	p	NOUN
bam-8877	81	3	=	=	PROPN
bam-8877	81	4	0.4	0.4	NUM
bam-8877	81	5	,	,	PUNCT
bam-8877	81	6	p	p	X
bam-8877	81	7	=	=	NOUN
bam-8877	81	8	0.1	0.1	NUM
bam-8877	81	9	)	)	PUNCT
bam-8877	81	10	(	(	PUNCT
bam-8877	81	11	table	table	NOUN
bam-8877	81	12	4	4	NUM
bam-8877	81	13	)	)	PUNCT
bam-8877	81	14	.	.	PUNCT
bam-8877	82	1	discussion	discussion	NOUN
bam-8877	82	2	ect	ect	VERB
bam-8877	82	3	is	be	AUX
bam-8877	82	4	one	one	NUM
bam-8877	82	5	of	of	ADP
bam-8877	82	6	the	the	DET
bam-8877	82	7	appropriate	appropriate	ADJ
bam-8877	82	8	treatments	treatment	NOUN
bam-8877	82	9	for	for	ADP
bam-8877	82	10	many	many	ADJ
bam-8877	82	11	neuropsychiatric	neuropsychiatric	ADJ
bam-8877	82	12	patients	patient	NOUN
bam-8877	82	13	,	,	PUNCT
bam-8877	82	14	especially	especially	ADV
bam-8877	82	15	mood	mood	NOUN
bam-8877	82	16	disorders.11	disorders.11	ADJ
bam-8877	82	17	fig	fig	NOUN
bam-8877	82	18	1	1	NUM
bam-8877	82	19	.	.	PUNCT
bam-8877	82	20	comparison	comparison	NOUN
bam-8877	82	21	of	of	ADP
bam-8877	82	22	mean	mean	ADJ
bam-8877	82	23	blood	blood	NOUN
bam-8877	82	24	pressure	pressure	NOUN
bam-8877	82	25	,	,	PUNCT
bam-8877	82	26	heart	heart	NOUN
bam-8877	82	27	rate	rate	NOUN
bam-8877	82	28	and	and	CCONJ
bam-8877	82	29	arterial	arterial	ADJ
bam-8877	82	30	oxygen	oxygen	NOUN
bam-8877	82	31	saturation	saturation	NOUN
bam-8877	82	32	after	after	ADP
bam-8877	82	33	recovery	recovery	NOUN
bam-8877	82	34	of	of	ADP
bam-8877	82	35	shock	shock	NOUN
bam-8877	82	36	therapy	therapy	NOUN
bam-8877	82	37	table	table	NOUN
bam-8877	83	1	2	2	NUM
bam-8877	83	2	:	:	PUNCT
bam-8877	83	3	mean	mean	VERB
bam-8877	83	4	blood	blood	NOUN
bam-8877	83	5	pressure	pressure	NOUN
bam-8877	83	6	,	,	PUNCT
bam-8877	83	7	heart	heart	NOUN
bam-8877	83	8	rate	rate	NOUN
bam-8877	83	9	and	and	CCONJ
bam-8877	83	10	arterial	arterial	ADJ
bam-8877	83	11	oxygen	oxygen	NOUN
bam-8877	83	12	saturation	saturation	NOUN
bam-8877	83	13	during	during	ADP
bam-8877	83	14	recovery	recovery	NOUN
bam-8877	83	15	after	after	ADP
bam-8877	83	16	shock	shock	NOUN
bam-8877	83	17	therapy	therapy	NOUN
bam-8877	83	18	cardiovascular	cardiovascular	ADJ
bam-8877	83	19	parameter	parameter	PROPN
bam-8877	83	20	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	83	21	group	group	PROPN
bam-8877	83	22	(	(	PUNCT
bam-8877	83	23	dg	dg	PROPN
bam-8877	83	24	)	)	PUNCT
bam-8877	83	25	remifentanil	remifentanil	NOUN
bam-8877	83	26	group	group	NOUN
bam-8877	83	27	(	(	PUNCT
bam-8877	83	28	rg	rg	NOUN
bam-8877	83	29	)	)	PUNCT
bam-8877	83	30	p	p	NOUN
bam-8877	83	31	-	-	PUNCT
bam-8877	83	32	value	value	NOUN
bam-8877	83	33	mean	mean	NOUN
bam-8877	83	34	arterial	arterial	ADJ
bam-8877	83	35	blood	blood	NOUN
bam-8877	83	36	pressure	pressure	NOUN
bam-8877	83	37	80.9	80.9	NUM
bam-8877	83	38	.	.	PUNCT
bam-8877	84	1	4	4	NUM
bam-8877	84	2	±	±	NUM
bam-8877	84	3	.1	.1	NUM
bam-8877	84	4	92	92	NUM
bam-8877	84	5	.	.	NOUN
bam-8877	84	6	4	4	NUM
bam-8877	84	7	±4	±4	NOUN
bam-8877	84	8	.92	.92	NUM
bam-8877	84	9	p	p	NOUN
bam-8877	84	10	=	=	SYM
bam-8877	84	11	0.02	0.02	NUM
bam-8877	84	12	average	average	ADJ
bam-8877	84	13	heart	heart	NOUN
bam-8877	84	14	rate	rate	NOUN
bam-8877	84	15	2.3	2.3	NUM
bam-8877	84	16	±380	±380	NOUN
bam-8877	84	17	.	.	PUNCT
bam-8877	85	1	.80	.80	NUM
bam-8877	85	2	108	108	NUM
bam-8877	85	3	.	.	PUNCT
bam-8877	85	4	5	5	NUM
bam-8877	85	5	±2	±2	NOUN
bam-8877	85	6	.108	.108	NUM
bam-8877	86	1	p	p	X
bam-8877	86	2	=	=	NOUN
bam-8877	86	3	0.001	0.001	NUM
bam-8877	86	4	mean	mean	NOUN
bam-8877	86	5	arterial	arterial	ADJ
bam-8877	86	6	oxygen	oxygen	NOUN
bam-8877	86	7	saturation	saturation	NOUN
bam-8877	86	8	94	94	NUM
bam-8877	86	9	.	.	NOUN
bam-8877	86	10	5	5	NUM
bam-8877	86	11	±2	±2	NOUN
bam-8877	86	12	.1	.1	NUM
bam-8877	86	13	93	93	NUM
bam-8877	86	14	.	.	PUNCT
bam-8877	87	1	4	4	NUM
bam-8877	87	2	±8	±8	NOUN
bam-8877	87	3	.93	.93	NUM
bam-8877	88	1	p	p	NOUN
bam-8877	88	2	=	=	NOUN
bam-8877	88	3	0.40	0.40	NUM
bam-8877	88	4	fig	fig	NOUN
bam-8877	88	5	2	2	NUM
bam-8877	88	6	.	.	PUNCT
bam-8877	88	7	comparison	comparison	NOUN
bam-8877	88	8	of	of	ADP
bam-8877	88	9	mean	mean	ADJ
bam-8877	88	10	blood	blood	NOUN
bam-8877	88	11	pressure	pressure	NOUN
bam-8877	88	12	,	,	PUNCT
bam-8877	88	13	heart	heart	NOUN
bam-8877	88	14	rate	rate	NOUN
bam-8877	88	15	and	and	CCONJ
bam-8877	88	16	arterial	arterial	ADJ
bam-8877	88	17	oxygen	oxygen	NOUN
bam-8877	88	18	saturation	saturation	NOUN
bam-8877	88	19	after	after	ADP
bam-8877	88	20	recovery	recovery	NOUN
bam-8877	88	21	of	of	ADP
bam-8877	88	22	shock	shock	NOUN
bam-8877	88	23	therapy	therapy	NOUN
bam-8877	88	24	dexmedetomidine	dexmedetomidine	VERB
bam-8877	88	25	or	or	CCONJ
bam-8877	88	26	remifentanil	remifentanil	NOUN
bam-8877	88	27	added	add	VERB
bam-8877	88	28	to	to	AUX
bam-8877	88	29	thiopental	thiopental	PROPN
bam-8877	88	30	eur	eur	PROPN
bam-8877	88	31	j	j	PROPN
bam-8877	88	32	transl	transl	PROPN
bam-8877	88	33	myol	myol	ADV
bam-8877	88	34	2020;30	2020;30	PROPN
bam-8877	88	35	(	(	PUNCT
bam-8877	88	36	3	3	NUM
bam-8877	88	37	):	):	PUNCT
bam-8877	88	38	8877	8877	NUM
bam-8877	88	39	.	.	PUNCT
bam-8877	89	1	doi	doi	NOUN
bam-8877	89	2	:	:	PUNCT
bam-8877	89	3	10.4081	10.4081	NUM
bam-8877	89	4	/	/	SYM
bam-8877	89	5	ejtm.2020.8877	ejtm.2020.8877	PROPN
bam-8877	89	6	4	4	NUM
bam-8877	89	7	the	the	DET
bam-8877	89	8	short	short	ADJ
bam-8877	89	9	-	-	PUNCT
bam-8877	89	10	term	term	NOUN
bam-8877	89	11	effects	effect	NOUN
bam-8877	89	12	of	of	ADP
bam-8877	89	13	ect	ect	NOUN
bam-8877	89	14	can	can	AUX
bam-8877	89	15	be	be	AUX
bam-8877	89	16	attributed	attribute	VERB
bam-8877	89	17	to	to	ADP
bam-8877	89	18	patients	patient	NOUN
bam-8877	89	19	'	'	PART
bam-8877	89	20	postictal	postictal	ADJ
bam-8877	89	21	agitation.12	agitation.12	NOUN
bam-8877	89	22	due	due	ADP
bam-8877	89	23	to	to	ADP
bam-8877	89	24	these	these	DET
bam-8877	89	25	side	side	NOUN
bam-8877	89	26	effects	effect	NOUN
bam-8877	89	27	and	and	CCONJ
bam-8877	89	28	to	to	PART
bam-8877	89	29	reduce	reduce	VERB
bam-8877	89	30	hemodynamic	hemodynamic	ADJ
bam-8877	89	31	changes	change	NOUN
bam-8877	89	32	,	,	PUNCT
bam-8877	89	33	the	the	DET
bam-8877	89	34	use	use	NOUN
bam-8877	89	35	of	of	ADP
bam-8877	89	36	two	two	NUM
bam-8877	89	37	adjuvants	adjuvant	NOUN
bam-8877	89	38	such	such	ADJ
bam-8877	89	39	as	as	ADP
bam-8877	89	40	remifentanil	remifentanil	NOUN
bam-8877	89	41	or	or	CCONJ
bam-8877	89	42	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	89	43	along	along	ADP
bam-8877	89	44	with	with	ADP
bam-8877	89	45	thiopental	thiopental	NOUN
bam-8877	89	46	can	can	AUX
bam-8877	89	47	lead	lead	VERB
bam-8877	89	48	to	to	ADP
bam-8877	89	49	hemodynamic	hemodynamic	ADJ
bam-8877	89	50	stability	stability	NOUN
bam-8877	89	51	and	and	CCONJ
bam-8877	89	52	reduction	reduction	NOUN
bam-8877	89	53	of	of	ADP
bam-8877	89	54	agitation	agitation	NOUN
bam-8877	89	55	in	in	ADP
bam-8877	89	56	patients	patient	NOUN
bam-8877	89	57	after	after	SCONJ
bam-8877	89	58	ect.13	ect.13	PRON
bam-8877	89	59	the	the	DET
bam-8877	89	60	results	result	NOUN
bam-8877	89	61	of	of	ADP
bam-8877	89	62	our	our	PRON
bam-8877	89	63	study	study	NOUN
bam-8877	89	64	are	be	AUX
bam-8877	89	65	in	in	ADP
bam-8877	89	66	line	line	NOUN
bam-8877	89	67	with	with	ADP
bam-8877	89	68	the	the	DET
bam-8877	89	69	results	result	NOUN
bam-8877	89	70	of	of	ADP
bam-8877	89	71	previous	previous	ADJ
bam-8877	89	72	studies	study	NOUN
bam-8877	89	73	.	.	PUNCT
bam-8877	90	1	one	one	NUM
bam-8877	90	2	example	example	NOUN
bam-8877	90	3	is	be	AUX
bam-8877	90	4	the	the	DET
bam-8877	90	5	study	study	NOUN
bam-8877	90	6	by	by	ADP
bam-8877	90	7	recart	recart	NOUN
bam-8877	90	8	et	et	PROPN
bam-8877	90	9	al	al	PROPN
bam-8877	90	10	.	.	PROPN
bam-8877	90	11	2003	2003	NUM
bam-8877	90	12	in	in	ADP
bam-8877	90	13	the	the	DET
bam-8877	90	14	united	united	PROPN
bam-8877	90	15	states.7	states.7	VERB
bam-8877	90	16	this	this	DET
bam-8877	90	17	study	study	NOUN
bam-8877	90	18	examined	examine	VERB
bam-8877	90	19	the	the	DET
bam-8877	90	20	effect	effect	NOUN
bam-8877	90	21	of	of	ADP
bam-8877	90	22	remifentanil	remifentanil	NOUN
bam-8877	90	23	on	on	ADP
bam-8877	90	24	blood	blood	NOUN
bam-8877	90	25	pressure	pressure	NOUN
bam-8877	90	26	in	in	ADP
bam-8877	90	27	patients	patient	NOUN
bam-8877	90	28	.	.	PUNCT
bam-8877	91	1	in	in	ADP
bam-8877	91	2	comparison	comparison	NOUN
bam-8877	91	3	with	with	ADP
bam-8877	91	4	the	the	DET
bam-8877	91	5	control	control	NOUN
bam-8877	91	6	group	group	NOUN
bam-8877	91	7	after	after	ADP
bam-8877	91	8	ect	ect	PROPN
bam-8877	91	9	,	,	PUNCT
bam-8877	91	10	it	it	PRON
bam-8877	91	11	was	be	AUX
bam-8877	91	12	significantly	significantly	ADV
bam-8877	91	13	reduced	reduce	VERB
bam-8877	91	14	.	.	PUNCT
bam-8877	92	1	however	however	ADV
bam-8877	92	2	,	,	PUNCT
bam-8877	92	3	remifentanil	remifentanil	PROPN
bam-8877	92	4	had	have	VERB
bam-8877	92	5	no	no	DET
bam-8877	92	6	adverse	adverse	ADJ
bam-8877	92	7	effect	effect	NOUN
bam-8877	92	8	on	on	ADP
bam-8877	92	9	the	the	DET
bam-8877	92	10	duration	duration	NOUN
bam-8877	92	11	of	of	ADP
bam-8877	92	12	seizures	seizure	NOUN
bam-8877	92	13	(	(	PUNCT
bam-8877	92	14	with	with	ADP
bam-8877	92	15	different	different	ADJ
bam-8877	92	16	periods	period	NOUN
bam-8877	92	17	)	)	PUNCT
bam-8877	92	18	.	.	PUNCT
bam-8877	93	1	also	also	ADV
bam-8877	93	2	,	,	PUNCT
bam-8877	93	3	the	the	DET
bam-8877	93	4	recovery	recovery	NOUN
bam-8877	93	5	time	time	NOUN
bam-8877	93	6	was	be	AUX
bam-8877	93	7	not	not	PART
bam-8877	93	8	affected	affect	VERB
bam-8877	93	9	by	by	ADP
bam-8877	93	10	remifentanil	remifentanil	NOUN
bam-8877	93	11	,	,	PUNCT
bam-8877	93	12	and	and	CCONJ
bam-8877	93	13	the	the	DET
bam-8877	93	14	final	final	ADJ
bam-8877	93	15	finding	finding	NOUN
bam-8877	93	16	indicated	indicate	VERB
bam-8877	93	17	that	that	SCONJ
bam-8877	93	18	remifentanil	remifentanil	NOUN
bam-8877	93	19	did	do	AUX
bam-8877	93	20	not	not	PART
bam-8877	93	21	adversely	adversely	ADV
bam-8877	93	22	affect	affect	VERB
bam-8877	93	23	recovery	recovery	NOUN
bam-8877	93	24	and	and	CCONJ
bam-8877	93	25	seizure	seizure	VERB
bam-8877	93	26	duration	duration	NOUN
bam-8877	93	27	but	but	CCONJ
bam-8877	93	28	prevented	prevent	VERB
bam-8877	93	29	postect	postect	PROPN
bam-8877	93	30	htn	htn	PROPN
bam-8877	93	31	,	,	PUNCT
bam-8877	93	32	a	a	DET
bam-8877	93	33	serious	serious	ADJ
bam-8877	93	34	ect	ect	ADJ
bam-8877	93	35	complication.7	complication.7	VERB
bam-8877	93	36	the	the	DET
bam-8877	93	37	results	result	NOUN
bam-8877	93	38	of	of	ADP
bam-8877	93	39	this	this	DET
bam-8877	93	40	study	study	NOUN
bam-8877	93	41	were	be	AUX
bam-8877	93	42	consistent	consistent	ADJ
bam-8877	93	43	with	with	ADP
bam-8877	93	44	our	our	PRON
bam-8877	93	45	study	study	NOUN
bam-8877	93	46	that	that	SCONJ
bam-8877	93	47	in	in	ADP
bam-8877	93	48	our	our	PRON
bam-8877	93	49	study	study	NOUN
bam-8877	93	50	remifentanil	remifentanil	NOUN
bam-8877	93	51	as	as	ADP
bam-8877	93	52	a	a	DET
bam-8877	93	53	thiopental	thiopental	ADJ
bam-8877	93	54	adjuvant	adjuvant	NOUN
bam-8877	93	55	led	lead	VERB
bam-8877	93	56	to	to	ADP
bam-8877	93	57	a	a	DET
bam-8877	93	58	decrease	decrease	NOUN
bam-8877	93	59	in	in	ADP
bam-8877	93	60	blood	blood	NOUN
bam-8877	93	61	pressure	pressure	NOUN
bam-8877	93	62	and	and	CCONJ
bam-8877	93	63	hr	hr	NOUN
bam-8877	93	64	(	(	PUNCT
bam-8877	93	65	this	this	DET
bam-8877	93	66	decrease	decrease	NOUN
bam-8877	93	67	was	be	AUX
bam-8877	93	68	acceptable	acceptable	ADJ
bam-8877	93	69	)	)	PUNCT
bam-8877	93	70	;	;	PUNCT
bam-8877	93	71	but	but	CCONJ
bam-8877	93	72	had	have	VERB
bam-8877	93	73	no	no	DET
bam-8877	93	74	effect	effect	NOUN
bam-8877	93	75	on	on	ADP
bam-8877	93	76	seizure	seizure	NOUN
bam-8877	93	77	duration	duration	NOUN
bam-8877	93	78	and	and	CCONJ
bam-8877	93	79	recovery	recovery	NOUN
bam-8877	93	80	.	.	PUNCT
bam-8877	94	1	in	in	ADP
bam-8877	94	2	another	another	DET
bam-8877	94	3	study	study	NOUN
bam-8877	94	4	conducted	conduct	VERB
bam-8877	94	5	in	in	ADP
bam-8877	94	6	china	china	PROPN
bam-8877	94	7	li	li	PROPN
bam-8877	94	8	et	et	PROPN
bam-8877	94	9	al	al	PROPN
bam-8877	94	10	.	.	PROPN
bam-8877	95	1	2016,14	2016,14	NUM
bam-8877	95	2	investigated	investigate	VERB
bam-8877	95	3	the	the	DET
bam-8877	95	4	effect	effect	NOUN
bam-8877	95	5	of	of	ADP
bam-8877	95	6	low	low	ADJ
bam-8877	95	7	dose	dose	NOUN
bam-8877	95	8	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	95	9	on	on	ADP
bam-8877	95	10	hyperdynamic	hyperdynamic	PROPN
bam-8877	95	11	ect	ect	VERB
bam-8877	95	12	responses	response	NOUN
bam-8877	95	13	.	.	PUNCT
bam-8877	96	1	they	they	PRON
bam-8877	96	2	indicated	indicate	VERB
bam-8877	96	3	that	that	SCONJ
bam-8877	96	4	hr	hr	NOUN
bam-8877	96	5	and	and	CCONJ
bam-8877	96	6	mean	mean	VERB
bam-8877	96	7	arterial	arterial	ADJ
bam-8877	96	8	blood	blood	NOUN
bam-8877	96	9	pressure	pressure	NOUN
bam-8877	96	10	in	in	ADP
bam-8877	96	11	the	the	DET
bam-8877	96	12	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	96	13	group	group	NOUN
bam-8877	96	14	were	be	AUX
bam-8877	96	15	significantly	significantly	ADV
bam-8877	96	16	decreased	decrease	VERB
bam-8877	96	17	compared	compare	VERB
bam-8877	96	18	to	to	ADP
bam-8877	96	19	the	the	DET
bam-8877	96	20	control	control	NOUN
bam-8877	96	21	group	group	NOUN
bam-8877	96	22	,	,	PUNCT
bam-8877	96	23	while	while	SCONJ
bam-8877	96	24	the	the	DET
bam-8877	96	25	duration	duration	NOUN
bam-8877	96	26	of	of	ADP
bam-8877	96	27	seizure	seizure	NOUN
bam-8877	96	28	,	,	PUNCT
bam-8877	96	29	recovery	recovery	NOUN
bam-8877	96	30	time	time	NOUN
bam-8877	96	31	and	and	CCONJ
bam-8877	96	32	spontaneous	spontaneous	ADJ
bam-8877	96	33	breathing	breathing	NOUN
bam-8877	96	34	were	be	AUX
bam-8877	96	35	similar	similar	ADJ
bam-8877	96	36	to	to	ADP
bam-8877	96	37	those	those	PRON
bam-8877	96	38	in	in	ADP
bam-8877	96	39	the	the	DET
bam-8877	96	40	control	control	NOUN
bam-8877	96	41	group	group	NOUN
bam-8877	96	42	and	and	CCONJ
bam-8877	96	43	did	do	AUX
bam-8877	96	44	not	not	PART
bam-8877	96	45	have	have	VERB
bam-8877	96	46	a	a	DET
bam-8877	96	47	negative	negative	ADJ
bam-8877	96	48	effect	effect	NOUN
bam-8877	96	49	in	in	ADP
bam-8877	96	50	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	96	51	(	(	PUNCT
bam-8877	96	52	2	2	NUM
bam-8877	96	53	μg	μg	PROPN
bam-8877	96	54	/	/	SYM
bam-8877	96	55	mg	mg	PROPN
bam-8877	96	56	)	)	PUNCT
bam-8877	96	57	.	.	PUNCT
bam-8877	97	1	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	97	2	significantly	significantly	ADV
bam-8877	97	3	reduced	reduce	VERB
bam-8877	97	4	post	post	ADJ
bam-8877	97	5	-	-	ADJ
bam-8877	97	6	ect	ect	ADJ
bam-8877	97	7	headache	headache	NOUN
bam-8877	97	8	and	and	CCONJ
bam-8877	97	9	agitation.14	agitation.14	NOUN
bam-8877	97	10	the	the	DET
bam-8877	97	11	results	result	NOUN
bam-8877	97	12	of	of	ADP
bam-8877	97	13	our	our	PRON
bam-8877	97	14	study	study	NOUN
bam-8877	97	15	were	be	AUX
bam-8877	97	16	also	also	ADV
bam-8877	97	17	consistent	consistent	ADJ
bam-8877	97	18	with	with	ADP
bam-8877	97	19	this	this	DET
bam-8877	97	20	study	study	NOUN
bam-8877	97	21	in	in	ADP
bam-8877	97	22	that	that	DET
bam-8877	97	23	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	97	24	significantly	significantly	ADV
bam-8877	97	25	decreased	decrease	VERB
bam-8877	97	26	blood	blood	NOUN
bam-8877	97	27	pressure	pressure	NOUN
bam-8877	97	28	and	and	CCONJ
bam-8877	97	29	hr	hr	NOUN
bam-8877	97	30	after	after	ADP
bam-8877	97	31	ect	ect	ADJ
bam-8877	97	32	,	,	PUNCT
bam-8877	97	33	and	and	CCONJ
bam-8877	97	34	patients	patient	NOUN
bam-8877	97	35	'	'	PART
bam-8877	97	36	agitation	agitation	NOUN
bam-8877	97	37	score	score	NOUN
bam-8877	97	38	decreased	decrease	VERB
bam-8877	97	39	in	in	ADP
bam-8877	97	40	the	the	DET
bam-8877	97	41	group	group	NOUN
bam-8877	97	42	where	where	SCONJ
bam-8877	97	43	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	97	44	was	be	AUX
bam-8877	97	45	administered	administer	VERB
bam-8877	97	46	.	.	PUNCT
bam-8877	98	1	salehi	salehi	PROPN
bam-8877	98	2	et	et	PROPN
bam-8877	98	3	al	al	PROPN
bam-8877	98	4	.	.	PROPN
bam-8877	98	5	2008.15	2008.15	NUM
bam-8877	98	6	in	in	ADP
bam-8877	98	7	a	a	DET
bam-8877	98	8	study	study	NOUN
bam-8877	98	9	on	on	ADP
bam-8877	98	10	ect	ect	ADJ
bam-8877	98	11	candidates	candidate	NOUN
bam-8877	98	12	compared	compare	VERB
bam-8877	98	13	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	98	14	,	,	PUNCT
bam-8877	98	15	esmolol	esmolol	NOUN
bam-8877	98	16	and	and	CCONJ
bam-8877	98	17	lignocaine	lignocaine	ADJ
bam-8877	98	18	drugs	drug	NOUN
bam-8877	98	19	.	.	PUNCT
bam-8877	99	1	they	they	PRON
bam-8877	99	2	concluded	conclude	VERB
bam-8877	99	3	that	that	SCONJ
bam-8877	99	4	esmolol	esmolol	PROPN
bam-8877	99	5	and	and	CCONJ
bam-8877	99	6	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	99	7	significantly	significantly	ADV
bam-8877	99	8	decreased	decrease	VERB
bam-8877	99	9	mean	mean	ADJ
bam-8877	99	10	arterial	arterial	ADJ
bam-8877	99	11	blood	blood	NOUN
bam-8877	99	12	pressure	pressure	NOUN
bam-8877	99	13	and	and	CCONJ
bam-8877	99	14	hr	hr	NOUN
bam-8877	99	15	after	after	ADP
bam-8877	99	16	ect	ect	ADV
bam-8877	99	17	,	,	PUNCT
bam-8877	99	18	compared	compare	VERB
bam-8877	99	19	with	with	ADP
bam-8877	99	20	control	control	NOUN
bam-8877	99	21	and	and	CCONJ
bam-8877	99	22	lignocaine	lignocaine	ADJ
bam-8877	99	23	groups	group	NOUN
bam-8877	99	24	.	.	PUNCT
bam-8877	100	1	on	on	ADP
bam-8877	100	2	the	the	DET
bam-8877	100	3	other	other	ADJ
bam-8877	100	4	hand	hand	NOUN
bam-8877	100	5	,	,	PUNCT
bam-8877	100	6	the	the	DET
bam-8877	100	7	effect	effect	NOUN
bam-8877	100	8	of	of	ADP
bam-8877	100	9	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	100	10	and	and	CCONJ
bam-8877	100	11	esmolol	esmolol	PROPN
bam-8877	100	12	on	on	ADP
bam-8877	100	13	seizure	seizure	NOUN
bam-8877	100	14	duration	duration	NOUN
bam-8877	100	15	was	be	AUX
bam-8877	100	16	less	less	ADJ
bam-8877	100	17	than	than	ADP
bam-8877	100	18	that	that	PRON
bam-8877	100	19	of	of	ADP
bam-8877	100	20	lignocaine	lignocaine	NOUN
bam-8877	100	21	.	.	PUNCT
bam-8877	101	1	the	the	DET
bam-8877	101	2	overall	overall	ADJ
bam-8877	101	3	conclusion	conclusion	NOUN
bam-8877	101	4	of	of	ADP
bam-8877	101	5	the	the	DET
bam-8877	101	6	study	study	NOUN
bam-8877	101	7	was	be	AUX
bam-8877	101	8	that	that	DET
bam-8877	101	9	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	101	10	(	(	PUNCT
bam-8877	101	11	in	in	ADP
bam-8877	101	12	various	various	ADJ
bam-8877	101	13	combinations	combination	NOUN
bam-8877	101	14	)	)	PUNCT
bam-8877	101	15	and	and	CCONJ
bam-8877	101	16	esmolol	esmolol	PROPN
bam-8877	101	17	,	,	PUNCT
bam-8877	101	18	can	can	AUX
bam-8877	101	19	significantly	significantly	ADV
bam-8877	101	20	improve	improve	VERB
bam-8877	101	21	cardiovascular	cardiovascular	ADJ
bam-8877	101	22	response	response	NOUN
bam-8877	101	23	in	in	ADP
bam-8877	101	24	patients	patient	NOUN
bam-8877	101	25	after	after	ADP
bam-8877	101	26	ect	ect	ADJ
bam-8877	101	27	,	,	PUNCT
bam-8877	101	28	while	while	SCONJ
bam-8877	101	29	not	not	PART
bam-8877	101	30	having	have	VERB
bam-8877	101	31	a	a	DET
bam-8877	101	32	negative	negative	ADJ
bam-8877	101	33	effect	effect	NOUN
bam-8877	101	34	on	on	ADP
bam-8877	101	35	the	the	DET
bam-8877	101	36	duration	duration	NOUN
bam-8877	101	37	of	of	ADP
bam-8877	101	38	seizure.15	seizure.15	NOUN
bam-8877	101	39	the	the	DET
bam-8877	101	40	results	result	NOUN
bam-8877	101	41	of	of	ADP
bam-8877	101	42	this	this	DET
bam-8877	101	43	study	study	NOUN
bam-8877	101	44	are	be	AUX
bam-8877	101	45	consistent	consistent	ADJ
bam-8877	101	46	with	with	ADP
bam-8877	101	47	our	our	PRON
bam-8877	101	48	study	study	NOUN
bam-8877	101	49	,	,	PUNCT
bam-8877	101	50	because	because	SCONJ
bam-8877	101	51	in	in	ADP
bam-8877	101	52	our	our	PRON
bam-8877	101	53	study	study	NOUN
bam-8877	101	54	,	,	PUNCT
bam-8877	101	55	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	101	56	also	also	ADV
bam-8877	101	57	reduced	reduce	VERB
bam-8877	101	58	hr	hr	NOUN
bam-8877	101	59	and	and	CCONJ
bam-8877	101	60	blood	blood	NOUN
bam-8877	101	61	pressure	pressure	NOUN
bam-8877	101	62	and	and	CCONJ
bam-8877	101	63	decreased	decrease	VERB
bam-8877	101	64	cardiovascular	cardiovascular	ADJ
bam-8877	101	65	responses	response	NOUN
bam-8877	101	66	in	in	ADP
bam-8877	101	67	patients	patient	NOUN
bam-8877	101	68	,	,	PUNCT
bam-8877	101	69	with	with	ADP
bam-8877	101	70	no	no	DET
bam-8877	101	71	effect	effect	NOUN
bam-8877	101	72	on	on	ADP
bam-8877	101	73	seizure	seizure	NOUN
bam-8877	101	74	duration	duration	NOUN
bam-8877	101	75	and	and	CCONJ
bam-8877	101	76	recovery	recovery	NOUN
bam-8877	101	77	.	.	PUNCT
bam-8877	102	1	in	in	ADP
bam-8877	102	2	a	a	DET
bam-8877	102	3	study	study	NOUN
bam-8877	102	4	in	in	ADP
bam-8877	102	5	turkey	turkey	NOUN
bam-8877	102	6	,	,	PUNCT
bam-8877	102	7	bzthidsefo	bzthidsefo	PROPN
bam-8877	102	8	2008	2008	NUM
bam-8877	102	9	investigated	investigate	VERB
bam-8877	102	10	the	the	DET
bam-8877	102	11	effect	effect	NOUN
bam-8877	102	12	of	of	ADP
bam-8877	102	13	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	102	14	on	on	ADP
bam-8877	102	15	the	the	DET
bam-8877	102	16	reduction	reduction	NOUN
bam-8877	102	17	of	of	ADP
bam-8877	102	18	ectinduced	ectinduce	VERB
bam-8877	102	19	hemodynamic	hemodynamic	ADJ
bam-8877	102	20	response.16	response.16	PROPN
bam-8877	102	21	the	the	DET
bam-8877	102	22	author	author	NOUN
bam-8877	102	23	found	find	VERB
bam-8877	102	24	that	that	SCONJ
bam-8877	102	25	the	the	DET
bam-8877	102	26	duration	duration	NOUN
bam-8877	102	27	of	of	ADP
bam-8877	102	28	seizure	seizure	NOUN
bam-8877	102	29	and	and	CCONJ
bam-8877	102	30	recovery	recovery	NOUN
bam-8877	102	31	time	time	NOUN
bam-8877	102	32	in	in	ADP
bam-8877	102	33	the	the	DET
bam-8877	102	34	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	102	35	group	group	NOUN
bam-8877	102	36	did	do	AUX
bam-8877	102	37	not	not	PART
bam-8877	102	38	change	change	VERB
bam-8877	102	39	,	,	PUNCT
bam-8877	102	40	whereas	whereas	SCONJ
bam-8877	102	41	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	102	42	significantly	significantly	ADV
bam-8877	102	43	reduced	reduce	VERB
bam-8877	102	44	the	the	DET
bam-8877	102	45	ectinduced	ectinduce	VERB
bam-8877	102	46	hyperdynamic	hyperdynamic	ADJ
bam-8877	102	47	response	response	NOUN
bam-8877	102	48	and	and	CCONJ
bam-8877	102	49	decreased	decrease	VERB
bam-8877	102	50	blood	blood	NOUN
bam-8877	102	51	pressure	pressure	NOUN
bam-8877	102	52	and	and	CCONJ
bam-8877	102	53	hr	hr	NOUN
bam-8877	102	54	during	during	ADP
bam-8877	102	55	recovery.16	recovery.16	NOUN
bam-8877	102	56	those	those	DET
bam-8877	102	57	results	result	NOUN
bam-8877	102	58	are	be	AUX
bam-8877	102	59	also	also	ADV
bam-8877	102	60	consistent	consistent	ADJ
bam-8877	102	61	with	with	ADP
bam-8877	102	62	our	our	PRON
bam-8877	102	63	study	study	NOUN
bam-8877	102	64	because	because	SCONJ
bam-8877	102	65	we	we	PRON
bam-8877	102	66	here	here	ADV
bam-8877	102	67	show	show	VERB
bam-8877	102	68	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	102	69	reduced	reduce	VERB
bam-8877	102	70	the	the	DET
bam-8877	102	71	blood	blood	NOUN
bam-8877	102	72	pressure	pressure	NOUN
bam-8877	102	73	and	and	CCONJ
bam-8877	102	74	hr	hr	NOUN
bam-8877	102	75	of	of	ADP
bam-8877	102	76	the	the	DET
bam-8877	102	77	patients	patient	NOUN
bam-8877	102	78	in	in	ADP
bam-8877	102	79	recovery	recovery	NOUN
bam-8877	102	80	and	and	CCONJ
bam-8877	102	81	controlled	control	VERB
bam-8877	102	82	the	the	DET
bam-8877	102	83	hyperdynamic	hyperdynamic	ADJ
bam-8877	102	84	responses	response	NOUN
bam-8877	102	85	induced	induce	VERB
bam-8877	102	86	by	by	ADP
bam-8877	102	87	ect	ect	X
bam-8877	102	88	in	in	ADP
bam-8877	102	89	the	the	DET
bam-8877	102	90	patients	patient	NOUN
bam-8877	102	91	.	.	PUNCT
bam-8877	103	1	furthermore	furthermore	ADV
bam-8877	103	2	,	,	PUNCT
bam-8877	103	3	it	it	PRON
bam-8877	103	4	had	have	VERB
bam-8877	103	5	no	no	DET
bam-8877	103	6	negative	negative	ADJ
bam-8877	103	7	effect	effect	NOUN
bam-8877	103	8	on	on	ADP
bam-8877	103	9	the	the	DET
bam-8877	103	10	duration	duration	NOUN
bam-8877	103	11	of	of	ADP
bam-8877	103	12	seizure	seizure	NOUN
bam-8877	103	13	and	and	CCONJ
bam-8877	103	14	recovery	recovery	NOUN
bam-8877	103	15	time	time	NOUN
bam-8877	103	16	.	.	PUNCT
bam-8877	104	1	results	result	NOUN
bam-8877	104	2	from	from	ADP
bam-8877	104	3	numerous	numerous	ADJ
bam-8877	104	4	studies	study	NOUN
bam-8877	104	5	indicate	indicate	VERB
bam-8877	104	6	that	that	SCONJ
bam-8877	104	7	both	both	CCONJ
bam-8877	104	8	remifentanil	remifentanil	NOUN
bam-8877	104	9	and	and	CCONJ
bam-8877	104	10	dexmedetomidine	dexmedetomidine	ADJ
bam-8877	104	11	decrease	decrease	NOUN
bam-8877	104	12	the	the	DET
bam-8877	104	13	ect	ect	ADV
bam-8877	104	14	-	-	PUNCT
bam-8877	104	15	induced	induced	ADJ
bam-8877	104	16	hyperdynamic	hyperdynamic	ADJ
bam-8877	104	17	responses	response	NOUN
bam-8877	104	18	in	in	ADP
bam-8877	104	19	recovery	recovery	NOUN
bam-8877	104	20	,	,	PUNCT
bam-8877	104	21	while	while	SCONJ
bam-8877	104	22	they	they	PRON
bam-8877	104	23	have	have	AUX
bam-8877	104	24	had	have	VERB
bam-8877	104	25	no	no	DET
bam-8877	104	26	specific	specific	ADJ
bam-8877	104	27	effect	effect	NOUN
bam-8877	104	28	on	on	ADP
bam-8877	104	29	duration	duration	NOUN
bam-8877	104	30	of	of	ADP
bam-8877	104	31	seizure	seizure	NOUN
bam-8877	104	32	or	or	CCONJ
bam-8877	104	33	recovery	recovery	NOUN
bam-8877	104	34	.	.	PUNCT
bam-8877	105	1	the	the	DET
bam-8877	105	2	results	result	NOUN
bam-8877	105	3	of	of	ADP
bam-8877	105	4	our	our	PRON
bam-8877	105	5	study	study	NOUN
bam-8877	105	6	also	also	ADV
bam-8877	105	7	confirm	confirm	VERB
bam-8877	105	8	exactly	exactly	ADV
bam-8877	105	9	this	this	PRON
bam-8877	105	10	and	and	CCONJ
bam-8877	105	11	suggested	suggest	VERB
bam-8877	105	12	stabilising	stabilise	VERB
bam-8877	105	13	hemodynamics	hemodynamic	NOUN
bam-8877	105	14	in	in	ADP
bam-8877	105	15	patient	patient	ADJ
bam-8877	105	16	recovery	recovery	NOUN
bam-8877	105	17	and	and	CCONJ
bam-8877	105	18	reducing	reduce	VERB
bam-8877	105	19	ect	ect	ADV
bam-8877	105	20	-	-	PUNCT
bam-8877	105	21	induced	induce	VERB
bam-8877	105	22	hyperdynamic	hyperdynamic	ADJ
bam-8877	105	23	responses	response	NOUN
bam-8877	105	24	.	.	PUNCT
bam-8877	106	1	however	however	ADV
bam-8877	106	2	,	,	PUNCT
bam-8877	106	3	the	the	DET
bam-8877	106	4	effect	effect	NOUN
bam-8877	106	5	of	of	ADP
bam-8877	106	6	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	106	7	in	in	ADP
bam-8877	106	8	controlling	control	VERB
bam-8877	106	9	the	the	DET
bam-8877	106	10	patients	patient	NOUN
bam-8877	106	11	'	'	PART
bam-8877	106	12	hyperdynamic	hyperdynamic	ADJ
bam-8877	106	13	responses	response	NOUN
bam-8877	106	14	was	be	AUX
bam-8877	106	15	more	more	ADJ
bam-8877	106	16	than	than	ADP
bam-8877	106	17	remifentanil	remifentanil	NOUN
bam-8877	106	18	.	.	PUNCT
bam-8877	107	1	both	both	DET
bam-8877	107	2	drugs	drug	NOUN
bam-8877	107	3	had	have	VERB
bam-8877	107	4	no	no	DET
bam-8877	107	5	adverse	adverse	ADJ
bam-8877	107	6	effect	effect	NOUN
bam-8877	107	7	on	on	ADP
bam-8877	107	8	the	the	DET
bam-8877	107	9	duration	duration	NOUN
bam-8877	107	10	of	of	ADP
bam-8877	107	11	seizures	seizure	NOUN
bam-8877	107	12	.	.	PUNCT
bam-8877	108	1	however	however	ADV
bam-8877	108	2	,	,	PUNCT
bam-8877	108	3	the	the	DET
bam-8877	108	4	recovery	recovery	NOUN
bam-8877	108	5	time	time	NOUN
bam-8877	108	6	was	be	AUX
bam-8877	108	7	significantly	significantly	ADV
bam-8877	108	8	increased	increase	VERB
bam-8877	108	9	in	in	ADP
bam-8877	108	10	the	the	DET
bam-8877	108	11	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	108	12	group	group	NOUN
bam-8877	108	13	.	.	PUNCT
bam-8877	109	1	it	it	PRON
bam-8877	109	2	is	be	AUX
bam-8877	109	3	important	important	ADJ
bam-8877	109	4	to	to	PART
bam-8877	109	5	note	note	VERB
bam-8877	109	6	that	that	SCONJ
bam-8877	109	7	the	the	DET
bam-8877	109	8	agitation	agitation	NOUN
bam-8877	109	9	score	score	NOUN
bam-8877	109	10	was	be	AUX
bam-8877	109	11	reduced	reduce	VERB
bam-8877	109	12	in	in	ADP
bam-8877	109	13	both	both	DET
bam-8877	109	14	groups	group	NOUN
bam-8877	109	15	.	.	PUNCT
bam-8877	110	1	furthermore	furthermore	ADV
bam-8877	110	2	,	,	PUNCT
bam-8877	110	3	no	no	DET
bam-8877	110	4	difference	difference	NOUN
bam-8877	110	5	was	be	AUX
bam-8877	110	6	found	find	VERB
bam-8877	110	7	between	between	ADP
bam-8877	110	8	groups	group	NOUN
bam-8877	110	9	with	with	ADP
bam-8877	110	10	regards	regard	NOUN
bam-8877	110	11	to	to	ADP
bam-8877	110	12	patient	patient	ADJ
bam-8877	110	13	satisfaction	satisfaction	NOUN
bam-8877	110	14	in	in	ADP
bam-8877	110	15	recovery	recovery	NOUN
bam-8877	110	16	,	,	PUNCT
bam-8877	110	17	and	and	CCONJ
bam-8877	110	18	there	there	PRON
bam-8877	110	19	was	be	VERB
bam-8877	110	20	a	a	DET
bam-8877	110	21	similar	similar	ADJ
bam-8877	110	22	result	result	NOUN
bam-8877	110	23	for	for	ADP
bam-8877	110	24	satisfaction	satisfaction	NOUN
bam-8877	110	25	scores	score	NOUN
bam-8877	110	26	in	in	ADP
bam-8877	110	27	both	both	DET
bam-8877	110	28	groups	group	NOUN
bam-8877	110	29	.	.	PUNCT
bam-8877	111	1	table	table	NOUN
bam-8877	111	2	3	3	NUM
bam-8877	111	3	.	.	PUNCT
bam-8877	112	1	duration	duration	NOUN
bam-8877	112	2	of	of	ADP
bam-8877	112	3	seizures	seizure	NOUN
bam-8877	112	4	and	and	CCONJ
bam-8877	112	5	mean	mean	VERB
bam-8877	112	6	duration	duration	NOUN
bam-8877	112	7	of	of	ADP
bam-8877	112	8	recovery	recovery	NOUN
bam-8877	112	9	group	group	NOUN
bam-8877	112	10	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	112	11	(	(	PUNCT
bam-8877	112	12	dg	dg	PROPN
bam-8877	112	13	)	)	PUNCT
bam-8877	112	14	remifentanil	remifentanil	NOUN
bam-8877	112	15	(	(	PUNCT
bam-8877	112	16	rg	rg	NOUN
bam-8877	112	17	)	)	PUNCT
bam-8877	112	18	p	p	ADJ
bam-8877	112	19	-	-	PUNCT
bam-8877	112	20	value	value	NOUN
bam-8877	112	21	duration	duration	NOUN
bam-8877	112	22	of	of	ADP
bam-8877	112	23	seizures	seizure	NOUN
bam-8877	112	24	(	(	PUNCT
bam-8877	112	25	sec	sec	PROPN
bam-8877	112	26	)	)	PUNCT
bam-8877	112	27	27	27	NUM
bam-8877	112	28	.	.	X
bam-8877	112	29	2	2	NUM
bam-8877	112	30	±4	±4	NOUN
bam-8877	112	31	.1	.1	NOUN
bam-8877	112	32	29	29	NUM
bam-8877	112	33	.	.	SYM
bam-8877	112	34	2	2	NUM
bam-8877	112	35	±7	±7	NOUN
bam-8877	112	36	.3	.3	NUM
bam-8877	113	1	p	p	NOUN
bam-8877	113	2	=	=	SYM
bam-8877	113	3	0.08	0.08	NUM
bam-8877	113	4	duration	duration	NOUN
bam-8877	113	5	of	of	ADP
bam-8877	113	6	recovery	recovery	NOUN
bam-8877	113	7	(	(	PUNCT
bam-8877	113	8	min	min	NOUN
bam-8877	113	9	)	)	PUNCT
bam-8877	113	10	15	15	NUM
bam-8877	113	11	.	.	NOUN
bam-8877	113	12	1	1	NUM
bam-8877	113	13	±8	±8	NOUN
bam-8877	113	14	.3	.3	NUM
bam-8877	113	15	10	10	NUM
bam-8877	113	16	.	.	SYM
bam-8877	113	17	2	2	NUM
bam-8877	113	18	±2	±2	NOUN
bam-8877	113	19	.4	.4	NUM
bam-8877	113	20	p	p	X
bam-8877	113	21	=	=	PUNCT
bam-8877	113	22	0.01	0.01	NUM
bam-8877	113	23	table	table	NOUN
bam-8877	113	24	4	4	NUM
bam-8877	113	25	.	.	X
bam-8877	114	1	satisfaction	satisfaction	NOUN
bam-8877	114	2	and	and	CCONJ
bam-8877	114	3	agitation	agitation	NOUN
bam-8877	114	4	scores	score	NOUN
bam-8877	114	5	score	score	PROPN
bam-8877	114	6	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	114	7	(	(	PUNCT
bam-8877	114	8	dg	dg	PROPN
bam-8877	114	9	)	)	PUNCT
bam-8877	114	10	remifentanil	remifentanil	NOUN
bam-8877	114	11	(	(	PUNCT
bam-8877	114	12	rg	rg	NOUN
bam-8877	114	13	)	)	PUNCT
bam-8877	114	14	p	p	ADJ
bam-8877	114	15	-	-	PUNCT
bam-8877	114	16	value	value	NOUN
bam-8877	114	17	satisfaction	satisfaction	NOUN
bam-8877	114	18	98	98	NUM
bam-8877	114	19	.	.	PUNCT
bam-8877	114	20	0	0	NUM
bam-8877	115	1	±68	±68	X
bam-8877	115	2	.1	.1	NUM
bam-8877	115	3	84	84	NUM
bam-8877	115	4	.	.	PUNCT
bam-8877	115	5	0	0	NUM
bam-8877	116	1	±71	±71	PRON
bam-8877	116	2	.1	.1	NUM
bam-8877	116	3	p	p	NOUN
bam-8877	116	4	=	=	SYM
bam-8877	116	5	0.4	0.4	NUM
bam-8877	116	6	agitation	agitation	NOUN
bam-8877	116	7	85	85	NUM
bam-8877	116	8	.	.	NOUN
bam-8877	116	9	0	0	NUM
bam-8877	117	1	±78	±78	NUM
bam-8877	117	2	.1	.1	NUM
bam-8877	117	3	92	92	NUM
bam-8877	117	4	.	.	PUNCT
bam-8877	117	5	0	0	NUM
bam-8877	118	1	±86	±86	NOUN
bam-8877	118	2	.1	.1	NUM
bam-8877	119	1	p	p	NOUN
bam-8877	119	2	=	=	SYM
bam-8877	119	3	0.1	0.1	NUM
bam-8877	119	4	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	119	5	or	or	CCONJ
bam-8877	119	6	remifentanil	remifentanil	NOUN
bam-8877	119	7	added	add	VERB
bam-8877	119	8	to	to	AUX
bam-8877	119	9	thiopental	thiopental	PROPN
bam-8877	119	10	eur	eur	PROPN
bam-8877	119	11	j	j	PROPN
bam-8877	119	12	transl	transl	PROPN
bam-8877	119	13	myol	myol	ADV
bam-8877	119	14	2020;30	2020;30	PROPN
bam-8877	119	15	(	(	PUNCT
bam-8877	119	16	3	3	NUM
bam-8877	119	17	):	):	PUNCT
bam-8877	119	18	8877	8877	NUM
bam-8877	119	19	.	.	PUNCT
bam-8877	120	1	doi	doi	NOUN
bam-8877	120	2	:	:	PUNCT
bam-8877	120	3	10.4081	10.4081	NUM
bam-8877	120	4	/	/	SYM
bam-8877	120	5	ejtm.2020.8877	ejtm.2020.8877	PROPN
bam-8877	120	6	5	5	NUM
bam-8877	120	7	in	in	ADP
bam-8877	120	8	conclusion	conclusion	NOUN
bam-8877	120	9	,	,	PUNCT
bam-8877	120	10	our	our	PRON
bam-8877	120	11	study	study	NOUN
bam-8877	120	12	found	find	VERB
bam-8877	120	13	that	that	SCONJ
bam-8877	120	14	both	both	CCONJ
bam-8877	120	15	remifentanil	remifentanil	NOUN
bam-8877	120	16	and	and	CCONJ
bam-8877	120	17	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	120	18	were	be	AUX
bam-8877	120	19	capable	capable	ADJ
bam-8877	120	20	of	of	ADP
bam-8877	120	21	reducing	reduce	VERB
bam-8877	120	22	the	the	DET
bam-8877	120	23	hyperdynamic	hyperdynamic	ADJ
bam-8877	120	24	responses	response	NOUN
bam-8877	120	25	of	of	ADP
bam-8877	120	26	patients	patient	NOUN
bam-8877	120	27	after	after	ADP
bam-8877	120	28	ect	ect	VERB
bam-8877	120	29	and	and	CCONJ
bam-8877	120	30	that	that	SCONJ
bam-8877	120	31	both	both	PRON
bam-8877	120	32	has	have	VERB
bam-8877	120	33	clinically	clinically	ADV
bam-8877	120	34	relevant	relevant	ADJ
bam-8877	120	35	effect	effect	NOUN
bam-8877	120	36	on	on	ADP
bam-8877	120	37	seizure	seizure	NOUN
bam-8877	120	38	duration	duration	NOUN
bam-8877	120	39	.	.	PUNCT
bam-8877	121	1	in	in	ADP
bam-8877	121	2	deed	deed	NOUN
bam-8877	121	3	,	,	PUNCT
bam-8877	121	4	we	we	PRON
bam-8877	121	5	showed	show	VERB
bam-8877	121	6	that	that	SCONJ
bam-8877	121	7	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	121	8	significantly	significantly	ADV
bam-8877	121	9	prolongs	prolong	VERB
bam-8877	121	10	recovery	recovery	NOUN
bam-8877	121	11	time	time	NOUN
bam-8877	121	12	compared	compare	VERB
bam-8877	121	13	to	to	PART
bam-8877	121	14	remifentanil	remifentanil	VERB
bam-8877	121	15	.	.	PUNCT
bam-8877	122	1	it	it	PRON
bam-8877	122	2	is	be	AUX
bam-8877	122	3	hoped	hope	VERB
bam-8877	122	4	that	that	SCONJ
bam-8877	122	5	these	these	DET
bam-8877	122	6	findings	finding	NOUN
bam-8877	122	7	may	may	AUX
bam-8877	122	8	guide	guide	VERB
bam-8877	122	9	therapies	therapy	NOUN
bam-8877	122	10	involving	involve	VERB
bam-8877	122	11	the	the	DET
bam-8877	122	12	use	use	NOUN
bam-8877	122	13	of	of	ADP
bam-8877	122	14	ect	ect	NOUN
bam-8877	122	15	for	for	ADP
bam-8877	122	16	patients	patient	NOUN
bam-8877	122	17	with	with	ADP
bam-8877	122	18	moods	mood	NOUN
bam-8877	122	19	disorders	disorder	NOUN
bam-8877	122	20	.	.	PUNCT
bam-8877	123	1	list	list	NOUN
bam-8877	123	2	of	of	ADP
bam-8877	123	3	acronyms	acronym	NOUN
bam-8877	123	4	anova	anova	VERB
bam-8877	123	5	analysis	analysis	NOUN
bam-8877	123	6	of	of	ADP
bam-8877	123	7	variance	variance	NOUN
bam-8877	123	8	cns	cns	PROPN
bam-8877	123	9	central	central	ADJ
bam-8877	123	10	nervous	nervous	ADJ
bam-8877	123	11	system	system	NOUN
bam-8877	123	12	cve	cve	NOUN
bam-8877	123	13	compensatory	compensatory	ADJ
bam-8877	123	14	intravascular	intravascular	ADJ
bam-8877	123	15	volume	volume	NOUN
bam-8877	123	16	expansion	expansion	NOUN
bam-8877	123	17	dg	dg	PROPN
bam-8877	123	18	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	123	19	group	group	PROPN
bam-8877	123	20	ect	ect	VERB
bam-8877	123	21	electroconvulsive	electroconvulsive	ADJ
bam-8877	123	22	therapy	therapy	NOUN
bam-8877	123	23	hr	hr	NOUN
bam-8877	123	24	–	–	PUNCT
bam-8877	123	25	heart	heart	NOUN
bam-8877	123	26	rate	rate	NOUN
bam-8877	123	27	htn	htn	PROPN
bam-8877	123	28	transient	transient	PROPN
bam-8877	123	29	hypertension	hypertension	NOUN
bam-8877	123	30	iv	iv	ADP
bam-8877	123	31	intravenous	intravenous	ADJ
bam-8877	123	32	therapy	therapy	NOUN
bam-8877	123	33	nibp	nibp	PROPN
bam-8877	123	34	non	non	ADJ
bam-8877	123	35	-	-	ADJ
bam-8877	123	36	invasive	invasive	ADJ
bam-8877	123	37	blood	blood	NOUN
bam-8877	123	38	pressure	pressure	NOUN
bam-8877	123	39	(	(	PUNCT
bam-8877	123	40	rg	rg	NOUN
bam-8877	123	41	–	–	PUNCT
bam-8877	123	42	remifentanil	remifentanil	NOUN
bam-8877	123	43	group	group	NOUN
bam-8877	123	44	rr	rr	PROPN
bam-8877	123	45	respiratory	respiratory	ADJ
bam-8877	123	46	rate	rate	NOUN
bam-8877	123	47	authors	author	NOUN
bam-8877	123	48	contributions	contribution	VERB
bam-8877	123	49	all	all	DET
bam-8877	123	50	authors	author	NOUN
bam-8877	123	51	participated	participate	VERB
bam-8877	123	52	in	in	ADP
bam-8877	123	53	designing	design	VERB
bam-8877	123	54	the	the	DET
bam-8877	123	55	study	study	NOUN
bam-8877	123	56	,	,	PUNCT
bam-8877	123	57	analyzing	analyze	VERB
bam-8877	123	58	the	the	DET
bam-8877	123	59	literature	literature	NOUN
bam-8877	123	60	,	,	PUNCT
bam-8877	123	61	collecting	collect	VERB
bam-8877	123	62	and	and	CCONJ
bam-8877	123	63	analyzing	analyze	VERB
bam-8877	123	64	data	datum	NOUN
bam-8877	123	65	and	and	CCONJ
bam-8877	123	66	writing	write	VERB
bam-8877	123	67	the	the	DET
bam-8877	123	68	paper	paper	NOUN
bam-8877	123	69	,	,	PUNCT
bam-8877	123	70	that	that	PRON
bam-8877	123	71	was	be	AUX
bam-8877	123	72	finally	finally	ADV
bam-8877	123	73	approved	approve	VERB
bam-8877	123	74	by	by	ADP
bam-8877	123	75	all	all	PRON
bam-8877	123	76	of	of	ADP
bam-8877	123	77	them	they	PRON
bam-8877	123	78	.	.	PUNCT
bam-8877	124	1	acknowledgments	acknowledgment	NOUN
bam-8877	124	2	funding	fund	VERB
bam-8877	124	3	none	none	NOUN
bam-8877	124	4	conflict	conflict	NOUN
bam-8877	125	1	o	o	NOUN
bam-8877	125	2	f	f	PROPN
bam-8877	125	3	interest	interest	NOUN
bam-8877	125	4	the	the	DET
bam-8877	125	5	authors	author	NOUN
bam-8877	125	6	declare	declare	VERB
bam-8877	125	7	no	no	DET
bam-8877	125	8	competing	compete	VERB
bam-8877	125	9	interests	interest	NOUN
bam-8877	125	10	.	.	PUNCT
bam-8877	126	1	ethical	ethical	ADJ
bam-8877	126	2	publication	publication	NOUN
bam-8877	126	3	statement	statement	NOUN
bam-8877	126	4	we	we	PRON
bam-8877	126	5	confirm	confirm	VERB
bam-8877	126	6	that	that	SCONJ
bam-8877	126	7	we	we	PRON
bam-8877	126	8	have	have	AUX
bam-8877	126	9	read	read	VERB
bam-8877	126	10	the	the	DET
bam-8877	126	11	journal	journal	NOUN
bam-8877	126	12	’s	’s	PART
bam-8877	126	13	position	position	NOUN
bam-8877	126	14	on	on	ADP
bam-8877	126	15	issues	issue	NOUN
bam-8877	126	16	involved	involve	VERB
bam-8877	126	17	in	in	ADP
bam-8877	126	18	ethical	ethical	ADJ
bam-8877	126	19	publication	publication	NOUN
bam-8877	126	20	and	and	CCONJ
bam-8877	126	21	affirm	affirm	NOUN
bam-8877	126	22	that	that	SCONJ
bam-8877	126	23	this	this	DET
bam-8877	126	24	report	report	NOUN
bam-8877	126	25	is	be	AUX
bam-8877	126	26	consistent	consistent	ADJ
bam-8877	126	27	with	with	ADP
bam-8877	126	28	those	those	DET
bam-8877	126	29	guidelines	guideline	NOUN
bam-8877	126	30	.	.	PUNCT
bam-8877	127	1	corresponding	correspond	VERB
bam-8877	127	2	author	author	NOUN
bam-8877	127	3	alireza	alireza	PROPN
bam-8877	127	4	kamali	kamali	PROPN
bam-8877	127	5	,	,	PUNCT
bam-8877	127	6	department	department	NOUN
bam-8877	127	7	of	of	ADP
bam-8877	127	8	anesthesiology	anesthesiology	NOUN
bam-8877	127	9	and	and	CCONJ
bam-8877	127	10	critical	critical	ADJ
bam-8877	127	11	care	care	NOUN
bam-8877	127	12	,	,	PUNCT
bam-8877	127	13	arak	arak	PROPN
bam-8877	127	14	university	university	PROPN
bam-8877	127	15	of	of	ADP
bam-8877	127	16	medical	medical	PROPN
bam-8877	127	17	sciences	sciences	PROPN
bam-8877	127	18	,	,	PUNCT
bam-8877	127	19	arak	arak	PROPN
bam-8877	127	20	,	,	PUNCT
bam-8877	127	21	iran	iran	PROPN
bam-8877	127	22	.	.	PUNCT
bam-8877	128	1	phone	phone	NOUN
bam-8877	128	2	:	:	PUNCT
bam-8877	128	3	00989181622810	00989181622810	NUM
bam-8877	128	4	orcid	orcid	NOUN
bam-8877	129	1	i	i	NOUN
bam-8877	129	2	d	d	NOUN
bam-8877	129	3	:	:	PUNCT
bam-8877	129	4	0000	0000	NUM
bam-8877	129	5	-	-	PUNCT
bam-8877	129	6	0003	0003	NUM
bam-8877	129	7	-	-	PUNCT
bam-8877	129	8	0698	0698	NUM
bam-8877	129	9	-	-	PUNCT
bam-8877	129	10	340x	340x	PROPN
bam-8877	129	11	.	.	PUNCT
bam-8877	130	1	e	e	X
bam-8877	130	2	-	-	NOUN
bam-8877	130	3	mail	mail	NOUN
bam-8877	130	4	:	:	PUNCT
bam-8877	130	5	dr.kamali@arakmu.ac.ir	dr.kamali@arakmu.ac.ir	VERB
bam-8877	130	6	e	e	NOUN
bam-8877	130	7	-	-	NOUN
bam-8877	130	8	mail	mail	NOUN
bam-8877	130	9	of	of	ADP
bam-8877	130	10	co	co	NOUN
bam-8877	130	11	-	-	NOUN
bam-8877	130	12	authors	author	NOUN
bam-8877	130	13	faezeh	faezeh	VERB
bam-8877	130	14	heidarbeigi	heidarbeigi	NOUN
bam-8877	130	15	:	:	PUNCT
bam-8877	130	16	faezeh.heydarbagi@gmail.com	faezeh.heydarbagi@gmail.com	X
bam-8877	130	17	orcid	orcid	NOUN
bam-8877	130	18	i	i	NOUN
bam-8877	130	19	d	d	NOUN
bam-8877	130	20	:	:	PUNCT
bam-8877	130	21	0000	0000	NUM
bam-8877	130	22	-	-	PUNCT
bam-8877	130	23	0003	0003	NUM
bam-8877	130	24	-	-	PUNCT
bam-8877	130	25	1932	1932	NUM
bam-8877	130	26	-	-	SYM
bam-8877	130	27	3793	3793	NUM
bam-8877	130	28	hamidreza	hamidreza	ADJ
bam-8877	130	29	jamilian	jamilian	NOUN
bam-8877	130	30	:	:	PUNCT
bam-8877	131	1	mjamilian@yahoo.com	mjamilian@yahoo.com	X
bam-8877	131	2	orcid	orcid	NOUN
bam-8877	132	1	i	i	PRON
bam-8877	132	2	d	d	NOUN
bam-8877	132	3	:	:	PUNCT
bam-8877	132	4	0000	0000	NUM
bam-8877	132	5	-	-	PUNCT
bam-8877	132	6	0002	0002	NUM
bam-8877	132	7	-	-	PUNCT
bam-8877	132	8	5938	5938	NUM
bam-8877	132	9	-	-	PUNCT
bam-8877	132	10	9810	9810	NUM
bam-8877	132	11	anita	anita	NOUN
bam-8877	132	12	alaghemand	alaghemand	NOUN
bam-8877	132	13	:	:	PUNCT
bam-8877	133	1	daalaghmand@yahoo.com	daalaghmand@yahoo.com	X
bam-8877	133	2	orcid	orcid	NOUN
bam-8877	134	1	i	i	PRON
bam-8877	134	2	d	d	NOUN
bam-8877	134	3	:	:	PUNCT
bam-8877	134	4	0000	0000	NUM
bam-8877	134	5	-	-	PUNCT
bam-8877	134	6	0003	0003	NUM
bam-8877	134	7	-	-	PUNCT
bam-8877	134	8	1856	1856	NUM
bam-8877	134	9	-	-	PUNCT
bam-8877	134	10	9257	9257	NUM
bam-8877	134	11	references	reference	NOUN
bam-8877	134	12	1bayati	1bayati	NUM
bam-8877	134	13	a	a	PRON
bam-8877	134	14	,	,	PUNCT
bam-8877	134	15	beigi	beigi	PROPN
bam-8877	134	16	m	m	PROPN
bam-8877	134	17	,	,	PUNCT
bam-8877	134	18	salehi	salehi	PROPN
bam-8877	134	19	m.	m.	NOUN
bam-8877	134	20	depression	depression	NOUN
bam-8877	134	21	prevalence	prevalence	NOUN
bam-8877	134	22	and	and	CCONJ
bam-8877	134	23	related	related	ADJ
bam-8877	134	24	factors	factor	NOUN
bam-8877	134	25	in	in	ADP
bam-8877	134	26	iranian	iranian	ADJ
bam-8877	134	27	students	student	NOUN
bam-8877	134	28	.	.	PUNCT
bam-8877	135	1	pak	pak	PROPN
bam-8877	135	2	j	j	PROPN
bam-8877	135	3	biol	biol	PROPN
bam-8877	135	4	sci	sci	PROPN
bam-8877	135	5	.	.	PROPN
bam-8877	135	6	2009	2009	NUM
bam-8877	135	7	;	;	PUNCT
bam-8877	135	8	12	12	NUM
bam-8877	135	9	:	:	SYM
bam-8877	135	10	1371	1371	NUM
bam-8877	135	11	-	-	SYM
bam-8877	135	12	5	5	NUM
bam-8877	135	13	.	.	PUNCT
bam-8877	135	14	doi	doi	NOUN
bam-8877	135	15	:	:	PUNCT
bam-8877	135	16	10.3923	10.3923	NUM
bam-8877	135	17	/	/	SYM
bam-8877	135	18	pjbs.2009.1371.1375	pjbs.2009.1371.1375	NOUN
bam-8877	135	19	2kessler	2kessler	NUM
bam-8877	135	20	rc1	rc1	NOUN
bam-8877	135	21	,	,	PUNCT
bam-8877	135	22	aguilar	aguilar	PROPN
bam-8877	135	23	-	-	PUNCT
bam-8877	135	24	gaxiola	gaxiola	PROPN
bam-8877	135	25	s	s	PROPN
bam-8877	135	26	,	,	PUNCT
bam-8877	135	27	alonso	alonso	PROPN
bam-8877	135	28	j	j	PROPN
bam-8877	135	29	,	,	PUNCT
bam-8877	135	30	et	et	PROPN
bam-8877	135	31	al.the	al.the	PRON
bam-8877	135	32	global	global	ADJ
bam-8877	135	33	burden	burden	NOUN
bam-8877	135	34	of	of	ADP
bam-8877	135	35	mental	mental	ADJ
bam-8877	135	36	disorders	disorder	NOUN
bam-8877	135	37	:	:	PUNCT
bam-8877	135	38	an	an	DET
bam-8877	135	39	update	update	NOUN
bam-8877	135	40	from	from	ADP
bam-8877	135	41	the	the	DET
bam-8877	135	42	who	who	PRON
bam-8877	135	43	world	world	VERB
bam-8877	135	44	mental	mental	ADJ
bam-8877	135	45	health	health	NOUN
bam-8877	135	46	(	(	PUNCT
bam-8877	135	47	wmh	wmh	NOUN
bam-8877	135	48	)	)	PUNCT
bam-8877	135	49	surveys	survey	NOUN
bam-8877	135	50	.	.	PUNCT
bam-8877	136	1	epidemiol	epidemiol	PROPN
bam-8877	136	2	psichiatr	psichiatr	PROPN
bam-8877	136	3	soc	soc	NOUN
bam-8877	136	4	2009;18:23	2009;18:23	NUM
bam-8877	136	5	-	-	SYM
bam-8877	136	6	33	33	NUM
bam-8877	136	7	.	.	PUNCT
bam-8877	137	1	3aksay	3aksay	NUM
bam-8877	137	2	ss	ss	NOUN
bam-8877	137	3	,	,	PUNCT
bam-8877	137	4	bumb	bumb	PROPN
bam-8877	137	5	jm	jm	PROPN
bam-8877	137	6	,	,	PUNCT
bam-8877	137	7	jank	jank	PROPN
bam-8877	137	8	c	c	PROPN
bam-8877	137	9	,	,	PUNCT
bam-8877	137	10	et	et	PROPN
bam-8877	137	11	al	al	PROPN
bam-8877	137	12	.	.	PROPN
bam-8877	137	13	serum	serum	PROPN
bam-8877	137	14	lipid	lipid	PROPN
bam-8877	137	15	profile	profile	NOUN
bam-8877	137	16	changes	change	NOUN
bam-8877	137	17	after	after	ADP
bam-8877	137	18	successful	successful	ADJ
bam-8877	137	19	treatment	treatment	NOUN
bam-8877	137	20	with	with	ADP
bam-8877	137	21	electroconvulsive	electroconvulsive	ADJ
bam-8877	137	22	therapy	therapy	NOUN
bam-8877	137	23	in	in	ADP
bam-8877	137	24	major	major	ADJ
bam-8877	137	25	depression	depression	NOUN
bam-8877	137	26	:	:	PUNCT
bam-8877	137	27	a	a	DET
bam-8877	137	28	prospective	prospective	ADJ
bam-8877	137	29	pilot	pilot	NOUN
bam-8877	137	30	trial	trial	NOUN
bam-8877	137	31	.	.	PUNCT
bam-8877	138	1	j	j	PROPN
bam-8877	138	2	affect	affect	VERB
bam-8877	138	3	disord	disord	NOUN
bam-8877	138	4	.	.	PUNCT
bam-8877	139	1	2016	2016	NUM
bam-8877	139	2	;	;	PUNCT
bam-8877	139	3	18	18	NUM
bam-8877	139	4	:	:	SYM
bam-8877	139	5	85	85	NUM
bam-8877	139	6	-	-	SYM
bam-8877	139	7	8	8	NUM
bam-8877	139	8	.	.	PUNCT
bam-8877	140	1	doi	doi	NOUN
bam-8877	140	2	:	:	PUNCT
bam-8877	140	3	10.1016	10.1016	NUM
bam-8877	140	4	/	/	SYM
bam-8877	140	5	j.jad.2015.09.037	j.jad.2015.09.037	PROPN
bam-8877	140	6	4moshiri	4moshiri	NUM
bam-8877	140	7	e	e	NOUN
bam-8877	140	8	,	,	PUNCT
bam-8877	140	9	modir	modir	PROPN
bam-8877	140	10	h	h	NOUN
bam-8877	140	11	,	,	PUNCT
bam-8877	140	12	bagheri	bagheri	PROPN
bam-8877	140	13	n	n	CCONJ
bam-8877	140	14	,	,	PUNCT
bam-8877	140	15	et	et	PROPN
bam-8877	140	16	al	al	PROPN
bam-8877	140	17	.	.	PUNCT
bam-8877	141	1	premedication	premedication	NOUN
bam-8877	141	2	effect	effect	NOUN
bam-8877	141	3	of	of	ADP
bam-8877	141	4	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	141	5	and	and	CCONJ
bam-8877	141	6	alfentanil	alfentanil	VERB
bam-8877	141	7	on	on	ADP
bam-8877	141	8	seizure	seizure	NOUN
bam-8877	141	9	time	time	NOUN
bam-8877	141	10	,	,	PUNCT
bam-8877	141	11	recovery	recovery	NOUN
bam-8877	141	12	duration	duration	NOUN
bam-8877	141	13	,	,	PUNCT
bam-8877	141	14	and	and	CCONJ
bam-8877	141	15	hemodynamic	hemodynamic	ADJ
bam-8877	141	16	responses	response	NOUN
bam-8877	141	17	in	in	ADP
bam-8877	141	18	electroconvulsive	electroconvulsive	ADJ
bam-8877	141	19	therapy	therapy	NOUN
bam-8877	141	20	.	.	PUNCT
bam-8877	142	1	ann	ann	PROPN
bam-8877	142	2	card	card	PROPN
bam-8877	142	3	anaesth	anaesth	PROPN
bam-8877	142	4	2016;19:263	2016;19:263	PROPN
bam-8877	142	5	-	-	SYM
bam-8877	142	6	8	8	NUM
bam-8877	142	7	.	.	PUNCT
bam-8877	143	1	doi	doi	NOUN
bam-8877	143	2	:	:	PUNCT
bam-8877	143	3	10.4103/09719784.179618	10.4103/09719784.179618	NUM
bam-8877	143	4	.	.	PUNCT
bam-8877	144	1	5aksay	5aksay	NUM
bam-8877	144	2	ss	ss	NOUN
bam-8877	144	3	,	,	PUNCT
bam-8877	144	4	bumb	bumb	PROPN
bam-8877	144	5	jm	jm	PROPN
bam-8877	144	6	,	,	PUNCT
bam-8877	144	7	remennik	remennik	X
bam-8877	144	8	d	d	PROPN
bam-8877	144	9	,	,	PUNCT
bam-8877	144	10	et	et	PROPN
bam-8877	144	11	al	al	PROPN
bam-8877	144	12	.	.	PROPN
bam-8877	144	13	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	144	14	for	for	ADP
bam-8877	144	15	the	the	DET
bam-8877	144	16	management	management	NOUN
bam-8877	144	17	of	of	ADP
bam-8877	144	18	postictal	postictal	ADJ
bam-8877	144	19	agitation	agitation	NOUN
bam-8877	144	20	after	after	ADP
bam-8877	144	21	electroconvulsive	electroconvulsive	ADJ
bam-8877	144	22	therapy	therapy	NOUN
bam-8877	144	23	with	with	ADP
bam-8877	144	24	sketamine	sketamine	NOUN
bam-8877	144	25	anesthesia	anesthesia	PROPN
bam-8877	144	26	.	.	PUNCT
bam-8877	145	1	neuropsychiatr	neuropsychiatr	PROPN
bam-8877	145	2	dis	dis	PROPN
bam-8877	145	3	treat	treat	VERB
bam-8877	145	4	2017	2017	NUM
bam-8877	145	5	;	;	PUNCT
bam-8877	145	6	13:1389	13:1389	NUM
bam-8877	145	7	-	-	SYM
bam-8877	145	8	1394	1394	NUM
bam-8877	145	9	.	.	PUNCT
bam-8877	146	1	doi	doi	NOUN
bam-8877	146	2	:	:	PUNCT
bam-8877	146	3	10.2147	10.2147	NUM
bam-8877	146	4	/	/	SYM
bam-8877	146	5	ndt.s134751	ndt.s134751	PROPN
bam-8877	146	6	6lisanby	6lisanby	PROPN
bam-8877	146	7	sh	sh	PROPN
bam-8877	146	8	.	.	PROPN
bam-8877	146	9	electroconvulsive	electroconvulsive	ADJ
bam-8877	146	10	therapy	therapy	NOUN
bam-8877	146	11	for	for	ADP
bam-8877	146	12	depression	depression	NOUN
bam-8877	146	13	.	.	PUNCT
bam-8877	147	1	n	n	PROPN
bam-8877	147	2	engl	engl	PROPN
bam-8877	147	3	j	j	PROPN
bam-8877	147	4	med	med	PROPN
bam-8877	147	5	.	.	PUNCT
bam-8877	147	6	2007	2007	NUM
bam-8877	147	7	;	;	PUNCT
bam-8877	147	8	357	357	NUM
bam-8877	147	9	:	:	SYM
bam-8877	147	10	1939	1939	NUM
bam-8877	147	11	-	-	SYM
bam-8877	147	12	45	45	NUM
bam-8877	147	13	.	.	PUNCT
bam-8877	148	1	doi	doi	NOUN
bam-8877	148	2	:	:	PUNCT
bam-8877	148	3	10.1056	10.1056	NUM
bam-8877	148	4	/	/	SYM
bam-8877	148	5	nejmct075234	nejmct075234	PROPN
bam-8877	148	6	7recart	7recart	NUM
bam-8877	148	7	a	a	PRON
bam-8877	148	8	,	,	PUNCT
bam-8877	148	9	rawal	rawal	PROPN
bam-8877	148	10	s	s	PROPN
bam-8877	148	11	,	,	PUNCT
bam-8877	148	12	white	white	ADJ
bam-8877	148	13	pf	pf	PROPN
bam-8877	148	14	,	,	PUNCT
bam-8877	148	15	et	et	PROPN
bam-8877	148	16	al	al	PROPN
bam-8877	148	17	.	.	PUNCT
bam-8877	149	1	the	the	DET
bam-8877	149	2	effect	effect	NOUN
bam-8877	149	3	of	of	ADP
bam-8877	149	4	remifentanil	remifentanil	NOUN
bam-8877	149	5	on	on	ADP
bam-8877	149	6	seizure	seizure	NOUN
bam-8877	149	7	duration	duration	NOUN
bam-8877	149	8	and	and	CCONJ
bam-8877	149	9	acute	acute	ADJ
bam-8877	149	10	hemodynamic	hemodynamic	ADJ
bam-8877	149	11	responses	response	NOUN
bam-8877	149	12	to	to	ADP
bam-8877	149	13	electroconvulsive	electroconvulsive	ADJ
bam-8877	149	14	therapy	therapy	NOUN
bam-8877	149	15	.	.	PUNCT
bam-8877	150	1	anesh	anesh	PROPN
bam-8877	150	2	analg	analg	NOUN
bam-8877	150	3	2003;98:1047	2003;98:1047	NUM
bam-8877	150	4	-	-	SYM
bam-8877	150	5	50	50	NUM
bam-8877	150	6	.	.	PUNCT
bam-8877	151	1	doi	doi	NOUN
bam-8877	151	2	:	:	PUNCT
bam-8877	151	3	10.1213/01.ane.0000054002.65040.b3	10.1213/01.ane.0000054002.65040.b3	NUM
bam-8877	151	4	.	.	PUNCT
bam-8877	152	1	8augoustides	8augoustides	NUM
bam-8877	152	2	jg	jg	PROPN
bam-8877	152	3	,	,	PUNCT
bam-8877	152	4	greenblatt	greenblatt	PROPN
bam-8877	152	5	e	e	PROPN
bam-8877	152	6	,	,	PUNCT
bam-8877	152	7	abbas	abbas	PROPN
bam-8877	152	8	ma	ma	PROPN
bam-8877	152	9	,	,	PUNCT
bam-8877	152	10	et	et	PROPN
bam-8877	152	11	al	al	PROPN
bam-8877	152	12	.	.	PROPN
bam-8877	153	1	clinical	clinical	ADJ
bam-8877	153	2	approach	approach	NOUN
bam-8877	153	3	to	to	ADP
bam-8877	153	4	agitation	agitation	NOUN
bam-8877	153	5	after	after	ADP
bam-8877	153	6	electroconvulsive	electroconvulsive	ADJ
bam-8877	153	7	therapy	therapy	NOUN
bam-8877	153	8	,	,	PUNCT
bam-8877	153	9	a	a	DET
bam-8877	153	10	case	case	NOUN
bam-8877	153	11	report	report	NOUN
bam-8877	153	12	and	and	CCONJ
bam-8877	153	13	literature	literature	NOUN
bam-8877	153	14	review	review	PROPN
bam-8877	153	15	.	.	PUNCT
bam-8877	154	1	j	j	PROPN
bam-8877	154	2	ect	ect	VERB
bam-8877	154	3	2002;18:213	2002;18:213	NUM
bam-8877	154	4	-	-	SYM
bam-8877	154	5	7	7	NUM
bam-8877	154	6	.	.	PUNCT
bam-8877	154	7	doi	doi	NOUN
bam-8877	154	8	:	:	PUNCT
bam-8877	154	9	10.1097/00124509	10.1097/00124509	NUM
bam-8877	154	10	-	-	SYM
bam-8877	154	11	200212000	200212000	NUM
bam-8877	154	12	-	-	PUNCT
bam-8877	154	13	00009	00009	NUM
bam-8877	154	14	.	.	PUNCT
bam-8877	155	1	9shams	9shams	NUM
bam-8877	155	2	t	t	PROPN
bam-8877	155	3	,	,	PUNCT
bam-8877	155	4	el	el	PROPN
bam-8877	155	5	masry	masry	PROPN
bam-8877	155	6	r.	r.	PROPN
bam-8877	155	7	ketofol	ketofol	PROPN
bam-8877	155	8	–	–	PUNCT
bam-8877	155	9	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	155	10	combination	combination	NOUN
bam-8877	155	11	in	in	ADP
bam-8877	155	12	ect	ect	PROPN
bam-8877	155	13	:	:	PUNCT
bam-8877	155	14	a	a	DET
bam-8877	155	15	punch	punch	NOUN
bam-8877	155	16	for	for	ADP
bam-8877	155	17	depression	depression	NOUN
bam-8877	155	18	and	and	CCONJ
bam-8877	155	19	agitation	agitation	NOUN
bam-8877	155	20	.	.	PUNCT
bam-8877	156	1	indian	indian	PROPN
bam-8877	156	2	j	j	PROPN
bam-8877	156	3	anaesth	anaesth	PROPN
bam-8877	156	4	2014	2014	NUM
bam-8877	156	5	;	;	PUNCT
bam-8877	156	6	58	58	NUM
bam-8877	156	7	:	:	PUNCT
bam-8877	156	8	275	275	NUM
bam-8877	156	9	-	-	SYM
bam-8877	156	10	80	80	NUM
bam-8877	156	11	.	.	PUNCT
bam-8877	157	1	doi	doi	NOUN
bam-8877	157	2	:	:	PUNCT
bam-8877	157	3	10.4103/0019	10.4103/0019	NUM
bam-8877	157	4	-	-	SYM
bam-8877	157	5	5049.135037	5049.135037	NUM
bam-8877	157	6	10wijeysundera	10wijeysundera	NUM
bam-8877	157	7	dn	dn	PROPN
bam-8877	157	8	,	,	PUNCT
bam-8877	157	9	bender	bender	PROPN
bam-8877	157	10	js	js	PROPN
bam-8877	157	11	,	,	PUNCT
bam-8877	157	12	beattie	beattie	PROPN
bam-8877	157	13	ws	ws	PROPN
bam-8877	157	14	.	.	PUNCT
bam-8877	158	1	alpha-2	alpha-2	NUM
bam-8877	158	2	adrenergic	adrenergic	ADJ
bam-8877	158	3	agonists	agonist	NOUN
bam-8877	158	4	for	for	ADP
bam-8877	158	5	the	the	DET
bam-8877	158	6	prevention	prevention	NOUN
bam-8877	158	7	of	of	ADP
bam-8877	158	8	cardiac	cardiac	ADJ
bam-8877	158	9	complication	complication	NOUN
bam-8877	158	10	among	among	ADP
bam-8877	158	11	patients	patient	NOUN
bam-8877	158	12	undergoing	undergo	VERB
bam-8877	158	13	surgery	surgery	NOUN
bam-8877	158	14	.	.	PUNCT
bam-8877	159	1	cochrane	cochrane	NOUN
bam-8877	159	2	database	database	PROPN
bam-8877	159	3	syst	syst	PROPN
bam-8877	159	4	rev	rev	PROPN
bam-8877	159	5	2009	2009	NUM
bam-8877	159	6	;	;	PUNCT
bam-8877	159	7	4	4	NUM
bam-8877	159	8	:	:	SYM
bam-8877	159	9	4126	4126	NUM
bam-8877	159	10	-	-	SYM
bam-8877	159	11	31	31	NUM
bam-8877	159	12	.	.	PUNCT
bam-8877	160	1	doi	doi	NOUN
bam-8877	160	2	:	:	PUNCT
bam-8877	160	3	10.1002/14651858.cd004126.pub2	10.1002/14651858.cd004126.pub2	PROPN
bam-8877	160	4	11singh	11singh	PROPN
bam-8877	160	5	ak	ak	PROPN
bam-8877	160	6	,	,	PUNCT
bam-8877	160	7	kumar	kumar	PROPN
bam-8877	160	8	a	a	PROPN
bam-8877	160	9	,	,	PUNCT
bam-8877	160	10	kumar	kumar	PROPN
bam-8877	160	11	a	a	PROPN
bam-8877	160	12	,	,	PUNCT
bam-8877	160	13	et	et	PROPN
bam-8877	160	14	al	al	PROPN
bam-8877	160	15	.	.	PUNCT
bam-8877	161	1	a	a	DET
bam-8877	161	2	comparison	comparison	NOUN
bam-8877	161	3	of	of	ADP
bam-8877	161	4	intrathecal	intrathecal	ADJ
bam-8877	161	5	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	161	6	and	and	CCONJ
bam-8877	161	7	neostigmine	neostigmine	VERB
bam-8877	161	8	as	as	ADP
bam-8877	161	9	adjuvant	adjuvant	ADJ
bam-8877	161	10	to	to	PART
bam-8877	161	11	ropivacaine	ropivacaine	VERB
bam-8877	161	12	for	for	ADP
bam-8877	161	13	lower	low	ADJ
bam-8877	161	14	limb	limb	NOUN
bam-8877	161	15	surgeries	surgery	NOUN
bam-8877	161	16	:	:	PUNCT
bam-8877	161	17	a	a	DET
bam-8877	161	18	double	double	ADJ
bam-8877	161	19	-	-	PUNCT
bam-8877	161	20	blind	blind	ADJ
bam-8877	161	21	randomized	randomized	ADJ
bam-8877	161	22	controlled	control	VERB
bam-8877	161	23	study	study	NOUN
bam-8877	161	24	.	.	PUNCT
bam-8877	162	1	anesth	anesth	VERB
bam-8877	162	2	essays	essay	NOUN
bam-8877	162	3	res	res	PROPN
bam-8877	162	4	2017;11:987	2017;11:987	PROPN
bam-8877	162	5	-	-	SYM
bam-8877	162	6	92	92	NUM
bam-8877	162	7	.	.	PUNCT
bam-8877	163	1	doi	doi	NOUN
bam-8877	163	2	:	:	PUNCT
bam-8877	163	3	10.4103	10.4103	NUM
bam-8877	163	4	/	/	SYM
bam-8877	163	5	aer.aer_62_17	aer.aer_62_17	PROPN
bam-8877	163	6	12anderson	12anderson	NUM
bam-8877	163	7	jh	jh	PROPN
bam-8877	163	8	,	,	PUNCT
bam-8877	163	9	grevstad	grevstad	PROPN
bam-8877	163	10	u	u	PROPN
bam-8877	163	11	,	,	PUNCT
bam-8877	163	12	siegel	siegel	PROPN
bam-8877	163	13	h	h	PROPN
bam-8877	163	14	,	,	PUNCT
bam-8877	163	15	et	et	PROPN
bam-8877	163	16	al	al	PROPN
bam-8877	163	17	.	.	PROPN
bam-8877	163	18	does	do	AUX
bam-8877	163	19	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	163	20	have	have	VERB
bam-8877	163	21	a	a	DET
bam-8877	163	22	perineural	perineural	ADJ
bam-8877	163	23	mechanism	mechanism	NOUN
bam-8877	163	24	of	of	ADP
bam-8877	163	25	action	action	NOUN
bam-8877	163	26	when	when	SCONJ
bam-8877	163	27	used	use	VERB
bam-8877	163	28	as	as	ADP
bam-8877	163	29	an	an	DET
bam-8877	163	30	adjuvant	adjuvant	NOUN
bam-8877	163	31	to	to	PART
bam-8877	163	32	ropivacaine	ropivacaine	VERB
bam-8877	163	33	?	?	PUNCT
bam-8877	163	34	:	:	PUNCT
bam-8877	163	35	a	a	DET
bam-8877	163	36	paired	pair	VERB
bam-8877	163	37	,	,	PUNCT
bam-8877	163	38	blinded	blind	VERB
bam-8877	163	39	,	,	PUNCT
bam-8877	163	40	randomized	randomize	VERB
bam-8877	163	41	trial	trial	NOUN
bam-8877	163	42	in	in	ADP
bam-8877	163	43	healthy	healthy	ADJ
bam-8877	163	44	volunteer	volunteer	NOUN
bam-8877	163	45	.	.	PUNCT
bam-8877	164	1	anesthesiol	anesthesiol	PROPN
bam-8877	164	2	2017;126:66	2017;126:66	NUM
bam-8877	164	3	-	-	SYM
bam-8877	164	4	73	73	NUM
bam-8877	164	5	.	.	PUNCT
bam-8877	165	1	doi	doi	NOUN
bam-8877	165	2	:	:	PUNCT
bam-8877	165	3	10.1097	10.1097	NUM
bam-8877	165	4	/	/	SYM
bam-8877	165	5	aln.0000000000001429	aln.0000000000001429	PROPN
bam-8877	165	6	.	.	PUNCT
bam-8877	166	1	13dubovsky	13dubovsky	NUM
bam-8877	166	2	sl	sl	PROPN
bam-8877	166	3	,	,	PUNCT
bam-8877	166	4	thomas	thomas	PROPN
bam-8877	166	5	mj	mj	PROPN
bam-8877	166	6	.	.	PROPN
bam-8877	166	7	nicardipine	nicardipine	PROPN
bam-8877	166	8	improves	improve	VERB
bam-8877	166	9	the	the	DET
bam-8877	166	10	antidepressant	antidepressant	ADJ
bam-8877	166	11	action	action	NOUN
bam-8877	166	12	of	of	ADP
bam-8877	166	13	ect	ect	NOUN
bam-8877	166	14	but	but	CCONJ
bam-8877	166	15	does	do	AUX
bam-8877	166	16	not	not	PART
bam-8877	166	17	improve	improve	VERB
bam-8877	166	18	cognition	cognition	NOUN
bam-8877	166	19	.	.	PUNCT
bam-8877	167	1	j	j	PROPN
bam-8877	167	2	ect	ect	VERB
bam-8877	167	3	2001;17:3	2001;17:3	NUM
bam-8877	167	4	-	-	SYM
bam-8877	167	5	10	10	NUM
bam-8877	167	6	.	.	PUNCT
bam-8877	168	1	doi	doi	NOUN
bam-8877	168	2	:	:	PUNCT
bam-8877	168	3	10.1097/00124509	10.1097/00124509	NUM
bam-8877	168	4	-	-	SYM
bam-8877	168	5	200103000	200103000	NUM
bam-8877	168	6	-	-	PUNCT
bam-8877	168	7	00002	00002	NUM
bam-8877	168	8	.	.	PUNCT
bam-8877	169	1	mailto:dr.kamali@arakmu.ac.ir	mailto:dr.kamali@arakmu.ac.ir	NOUN
bam-8877	169	2	https://orcid.org/0000-0003-1932-3793	https://orcid.org/0000-0003-1932-3793	ADJ
bam-8877	169	3	https://dx.doi.org/10.4103%2faer.aer_62_17	https://dx.doi.org/10.4103%2faer.aer_62_17	X
bam-8877	169	4	dexmedetomidine	dexmedetomidine	PROPN
bam-8877	169	5	or	or	CCONJ
bam-8877	169	6	remifentanil	remifentanil	NOUN
bam-8877	169	7	added	add	VERB
bam-8877	169	8	to	to	AUX
bam-8877	169	9	thiopental	thiopental	PROPN
bam-8877	169	10	eur	eur	PROPN
bam-8877	169	11	j	j	PROPN
bam-8877	169	12	transl	transl	PROPN
bam-8877	169	13	myol	myol	ADV
bam-8877	169	14	2020;30	2020;30	PROPN
bam-8877	169	15	(	(	PUNCT
bam-8877	169	16	3	3	NUM
bam-8877	169	17	):	):	PUNCT
bam-8877	169	18	8877	8877	NUM
bam-8877	169	19	.	.	PUNCT
bam-8877	170	1	doi	doi	NOUN
bam-8877	170	2	:	:	PUNCT
bam-8877	170	3	10.4081	10.4081	NUM
bam-8877	170	4	/	/	SYM
bam-8877	170	5	ejtm.2020.8877	ejtm.2020.8877	PROPN
bam-8877	170	6	6	6	NUM
bam-8877	170	7	14li	14li	NUM
bam-8877	170	8	x	x	NOUN
bam-8877	170	9	,	,	PUNCT
bam-8877	170	10	tan	tan	PROPN
bam-8877	170	11	f	f	PROPN
bam-8877	170	12	,	,	PUNCT
bam-8877	170	13	jian	jian	PROPN
bam-8877	170	14	cj	cj	PROPN
bam-8877	170	15	,	,	PUNCT
bam-8877	170	16	et	et	PROPN
bam-8877	170	17	al	al	PROPN
bam-8877	170	18	.	.	PUNCT
bam-8877	171	1	effects	effect	NOUN
bam-8877	171	2	of	of	ADP
bam-8877	171	3	small	small	ADJ
bam-8877	171	4	dose	dose	NOUN
bam-8877	171	5	dexmedetomidine	dexmedetomidine	NOUN
bam-8877	171	6	on	on	ADP
bam-8877	171	7	hyperdynamic	hyperdynamic	ADJ
bam-8877	171	8	responses	response	NOUN
bam-8877	171	9	to	to	ADP
bam-8877	171	10	electroconvulsive	electroconvulsive	ADJ
bam-8877	171	11	therapy	therapy	NOUN
bam-8877	171	12	.	.	PUNCT
bam-8877	172	1	j	j	PROPN
bam-8877	172	2	chin	chin	PROPN
bam-8877	172	3	med	med	PROPN
bam-8877	172	4	assoc	assoc	PROPN
bam-8877	172	5	2017;80:476	2017;80:476	PROPN
bam-8877	172	6	-	-	SYM
bam-8877	172	7	81	81	NUM
bam-8877	172	8	.	.	PUNCT
bam-8877	172	9	doi	doi	NOUN
bam-8877	172	10	:	:	PUNCT
bam-8877	172	11	10.1016	10.1016	NUM
bam-8877	172	12	/	/	SYM
bam-8877	172	13	j.jcma.2017.02.008	j.jcma.2017.02.008	PROPN
bam-8877	172	14	15salehi	15salehi	X
bam-8877	172	15	b	b	X
bam-8877	172	16	,	,	PUNCT
bam-8877	172	17	mohammadbeigi	mohammadbeigi	PROPN
bam-8877	172	18	a	a	PROPN
bam-8877	172	19	,	,	PUNCT
bam-8877	172	20	kamali	kamali	PROPN
bam-8877	172	21	ar	ar	PROPN
bam-8877	172	22	,	,	PUNCT
bam-8877	172	23	et	et	PROPN
bam-8877	172	24	al	al	PROPN
bam-8877	172	25	.	.	PROPN
bam-8877	173	1	impact	impact	PROPN
bam-8877	173	2	comparison	comparison	NOUN
bam-8877	173	3	of	of	ADP
bam-8877	173	4	ketamine	ketamine	PROPN
bam-8877	173	5	and	and	CCONJ
bam-8877	173	6	sodium	sodium	NOUN
bam-8877	173	7	thiopental	thiopental	NOUN
bam-8877	173	8	on	on	ADP
bam-8877	173	9	anesthesia	anesthesia	NOUN
bam-8877	173	10	during	during	ADP
bam-8877	173	11	electroconvulsive	electroconvulsive	ADJ
bam-8877	173	12	therapy	therapy	NOUN
bam-8877	173	13	in	in	ADP
bam-8877	173	14	major	major	ADJ
bam-8877	173	15	depression	depression	NOUN
bam-8877	173	16	patients	patient	NOUN
bam-8877	173	17	with	with	ADP
bam-8877	173	18	drugresistant	drugresistant	NOUN
bam-8877	173	19	;	;	PUNCT
bam-8877	173	20	a	a	DET
bam-8877	173	21	double	double	ADJ
bam-8877	173	22	-	-	PUNCT
bam-8877	173	23	blind	blind	ADJ
bam-8877	173	24	randomized	randomize	VERB
bam-8877	173	25	clinical	clinical	ADJ
bam-8877	173	26	trial	trial	NOUN
bam-8877	173	27	;	;	PUNCT
bam-8877	173	28	ann	ann	PROPN
bam-8877	173	29	cardiac	cardiac	PROPN
bam-8877	173	30	an	an	DET
bam-8877	173	31	aesthesia	aesthesia	NOUN
bam-8877	173	32	2015;4:486	2015;4:486	NOUN
bam-8877	173	33	-	-	SYM
bam-8877	173	34	90	90	NUM
bam-8877	173	35	.	.	PUNCT
bam-8877	174	1	doi	doi	NOUN
bam-8877	174	2	:	:	PUNCT
bam-8877	174	3	10.4103/0971	10.4103/0971	NUM
bam-8877	174	4	-	-	SYM
bam-8877	174	5	9784.166444	9784.166444	NUM
bam-8877	174	6	16bzthidsefo	16bzthidsefo	NUM
bam-8877	174	7	d.	d.	PROPN
bam-8877	174	8	dexmedetomiane	dexmedetomiane	PROPN
bam-8877	174	9	biunts	biunt	NOUN
bam-8877	174	10	acute	acute	VERB
bam-8877	174	11	hyperdynamic	hyperdynamic	ADJ
bam-8877	174	12	responses	response	NOUN
bam-8877	174	13	to	to	ADP
bam-8877	174	14	electroconvulsive	electroconvulsive	ADJ
bam-8877	174	15	therapy	therapy	NOUN
bam-8877	174	16	without	without	ADP
bam-8877	174	17	altering	alter	VERB
bam-8877	174	18	seizure	seizure	NOUN
bam-8877	174	19	duration	duration	NOUN
bam-8877	174	20	.	.	PUNCT
bam-8877	175	1	acta	acta	PROPN
bam-8877	175	2	anaesthesiol	anaesthesiol	PROPN
bam-8877	175	3	scand	scand	PROPN
bam-8877	175	4	2008	2008	NUM
bam-8877	175	5	;	;	PUNCT
bam-8877	176	1	52	52	NUM
bam-8877	176	2	:	:	SYM
bam-8877	176	3	302	302	NUM
bam-8877	176	4	-	-	SYM
bam-8877	176	5	6	6	NUM
bam-8877	176	6	.	.	PUNCT
bam-8877	176	7	submission	submission	NOUN
bam-8877	176	8	:	:	PUNCT
bam-8877	176	9	february05	february05	NOUN
bam-8877	176	10	,	,	PUNCT
bam-8877	176	11	2019	2019	NUM
bam-8877	176	12	revision	revision	NOUN
bam-8877	176	13	received	receive	VERB
bam-8877	176	14	:	:	PUNCT
bam-8877	176	15	april	april	PROPN
bam-8877	176	16	17	17	NUM
bam-8877	176	17	,	,	PUNCT
bam-8877	176	18	2019	2019	NUM
bam-8877	176	19	accepted	accept	VERB
bam-8877	176	20	for	for	ADP
bam-8877	176	21	publication	publication	NOUN
bam-8877	176	22	:	:	PUNCT
bam-8877	176	23	april	april	PROPN
bam-8877	176	24	21	21	NUM
bam-8877	176	25	,	,	PUNCT
bam-8877	176	26	2019	2019	NUM